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 During development, gradients of transcription factors regulate patterning along a body 
axis by activation or repression of target genes above distinct threshold levels.  In the Drosophila 
wing, expression of genes such as spalt (sal) and optomotor-blind (omb) is restricted along the 
A/P axis by lateral-to-medial gradients of the transcriptional repressor Brinker (Brk).  sal is more 
sensitive to repression by Brk than omb, and thus has a narrower expression domain compared to 
omb.  The Brk expression pattern is established by Decapentaplegic (Dpp), a TGF-β superfamily 
member, which forms a complementary medial-to-lateral morphogen gradient along the (A/P) 
axis of the wing.  We have investigated the mechanisms Brk uses to repress gene expression to 
gain an understanding of why some targets such as sal are more sensitive to Brk than others such 
as omb.  Previous studies have suggested that Brk represses gene expression simply by 
competing with activators, but we show that Brk requires an active repression domain along with 
the DNA binding domain for repressor activity.  Brk possesses four repression domains, but 
these domains are not equivalent; for example, 3R is sufficient to repress omb but not sal.  
Consequently, although sal and omb show quantitative differences in their response to Brk, there 
are qualitative differences in the mechanisms that Brk uses to repress each of these genes. 
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PREFACE 
 
 My thesis contains work completed in two different laboratories: Chapter 2 describes the 
research completed in the laboratory of Dr. Gerard Campbell and Chapter 3 describes the 
research completed in the laboratory of Dr. Richard Carthew. 
 
 xii
  
1 Chapter 1:  Introduction 
 
 One of the fundamental questions in developmental biology is: How does a single, 
undifferentiated cell produce millions of cells that give rise to structures such as arms, legs, 
organs and ultimately the entire organism?  How do these dividing cells, derived from a single 
cell, become different from each other?  What influences direct these cells to form organized 
structures?  What controls the behavior of these cells and allows complex pattern formation 
within each tissue?  The ability of cells to become different from their neighbors relies on 
differential gene expression in which genes are turned on and off according to temporal and 
spatial cues received from their environment.  The cues in the environment correspond 
predominantly to different types of secreted signaling polypeptides, and these molecules control 
gene expression via signaling pathways that regulate the activity of transcription factors.  
However, a given signal can be interpreted and elicit different responses depending on the 
particular cell type or the position of a cell within a cellular field (Wolpert, 1969).  Furthermore, 
it has been determined that there are only a limited number of signaling pathways utilized for 
setting up the body pattern during development (Gerhart, 1999). 
 
1.1 Morphogens/Secreted signaling molecules 
Several of these secreted signaling molecules function as morphogens or “form-
generating” substances that diffuse through a tissue, their distribution directing the development 
of cells in a tissue (Turing, 1952).  Wolpert (1969) proposed a model of positional information, 
where the position of the cell within a cellular field is defined by a coordinate system.  Inherent 
 1
 in the model is the presence of a positional signaling factor or morphogen produced at a localized 
source that diffuses across the cellular field producing an extracellular gradient which can define 
the position along the ordinate or abscissa (x, y, if we are dealing with 2D Cartesian 
coordinates).  Cells will adopt different fates if they can measure different levels of this factor 
along one developing axis within a tissue, and can respond in a concentration dependent manner 
(Fig. 1) (Wolpert, 1969).  In molecular terms, this translates into different genes being activated 
above distinct threshold levels of signaling within a cell.  The ability of a morphogen to activate 
gene expression decreases as a function of its distance from the source (Vincent and Perrimon, 
2001).  Genes receptive to low levels of signal should be expressed by cells at a farther distance 
from the source of the secreted ligand than those requiring higher levels of activity (Strigini and 
Cohen, 1999).  Consequently, the intracellular signal transduction pathway receiving the signal 
must be able to discriminate the concentration of the morphogen and only activate target genes 
above corresponding threshold levels.  For example, threshold levels can be thought of as the 
amount of morphogen required to bind receptor molecules to elicit activation of intracellular 
signaling pathways to an appropriate level.  Therefore, cells will take on different fates 
depending on their position in a cellular field relative to the source of the morphogen (Vincent 
and Perrimon, 2001).   
 
1.2 Regulation of Eukaryotic gene expression 
 In addition to the regions coding for a particular protein, a eukaryotic gene also contains 
control regions consisting of promoter and response elements that regulate the genes expression 
(Maniatis et al., 1987).  The promoter region is the sequence specific site where RNA 
Polymerase II and other proteins known as general transcription factors bind DNA to form the 
 2
  
 
Figure 1.  Morphogen Model. 
 
(A) Cellular field.  (B) Signal 1 represents a localized source of a diffusible signaling molecule 
with high levels near the source (red hatched circles).  (C) Diffusion will generate a gradient 
across the cellular field with the highest level of morphogen nearest the source and the lowest 
levels furthest from the source  (dark red circles, high levels and light pink circles, low levels).  
(D) Different target genes will be activated above distinct threshold levels; gene x (red) will be 
activated by high levels, gene y (green) by intermediate levels and gene z (blue) by low levels of 
the morphogen. 
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 pre-initiation complex (Gaston and Jayaraman, 2003).  This region can be either the TATA box 
or a Downstream Promoter Element (DPE).  Transcriptional regulation in eukaryotes differs 
from prokaryotes because RNA polymerase II cannot initiate transcription without other general  
transcription factors, which must be assembled at the promoter for transcription to begin (Novina 
and Roy, 1996).  Response elements may be adjacent to the promoter or thousands of base pairs 
away from the promoter, and can activate (enhancer) or repress (silencer) transcription at a 
specific promoter (Maniatis et al., 1987).  Promoters and enhancers contain binding sites for 
regulatory proteins known as regulatory transcription factors, and transcription of a gene can be 
activated or inhibited by transcription factors binding at these sites (Maniatis et al., 1987).  
Enhancer regions are crucial in regulating the expression of genes during development, and the 
interaction of transcription factors with transcriptional machinery (RNA Polymerase II and 
general transcription factors) regulates transcription initiation (Gaston and Jayaraman, 2003; 
Hanna-Rose and Hansen, 1996; Johnson, 1995).  Eukaryotic genes contain extremely complex 
regulatory regions (response elements) with binding sites for many different regulatory 
transcription factors, allowing for differential gene expression.  Regulatory transcription factors 
can be either activator or repressor proteins.   
 
1.2.1 Transcriptional Activation 
Transcriptional activation is mediated by activator proteins, sequence specific DNA-
binding proteins that stimulate transcription at a promoter (Gaston and Jayaraman, 2003).  
Activator proteins are usually modular, containing a DNA binding domain (DBD) that 
recognizes a specific regulatory sequence and an activation domain that interacts with 
transcriptional machinery to initiate transcription (Kornberg, 1999).  Activator proteins 
 4
 frequently interact with another group of proteins known as co-activators, that cannot bind DNA 
directly, but rather they assist the activator in the stimulation of pre-initiation complex formation 
(Gaston and Jayaraman, 2003).  Activators and co-activators can also stimulate transcription by 
promoting changes in chromatin (complex of DNA and associated proteins that make up 
chromosomes) structure near the promoter by recruitment of histone modification enzymes, 
chromatin binding proteins and ATP-dependent nucleosome remodeling proteins (Gaston and 
Jayaraman, 2003; Kornberg, 1999).  Co-activators may recruit histone acetyltransferases or 
possess histone acetyltransferase activity, leading to acetylation of histone proteins and 
remodeling of chromatin structure (Kornberg, 1999).  One of the best known co-activators is 
CREB binding protein (CRB), which contains a histone acetyltransferase activity implicated in 
chromatin decondensation, allowing the transcriptional machinery to bind the promoter 
(Bannister and Kouzarides, 1996; Ogryzko et al., 1996).  These changes in chromatin structure 
regulate transcription by altering the accessibility of DNA to transcription factors or the 
transcriptional machinery (Kornberg, 1999; Kornberg and Lorch, 2002). 
 
1.2.2 Transcriptional Repression 
 Transcriptional repression also plays a critical role in gene regulation.  During 
development, gene expression boundaries can be established by spatially restricted localization 
or activity of transcriptional repressors (Mannervik et al., 1999).  In addition, gene expression is 
controlled by extracellular signaling molecules, and signal responsive genes are maintained in 
the ‘off’ state by repressor proteins until an appropriate signal is transduced resulting in de-
repression (Roose and Clevers, 1999).  Transcription factors that function as repressors bind to 
specific sequences in control regions of genes they regulate, and prevent the initiation of 
 5
 transcription by RNA polymerase II (Cowell, 1994).  Similar to transcriptional activators, 
repressors can also recruit additional proteins, known as co-repressors, which assist the repressor 
in inhibiting transcription initiation (Gaston and Jayaraman, 2003).  Transcriptional repressors 
can function in a number of ways including passive repression or active repression which is 
broken down into two classes, direct repression and quenching (Hanna-Rose and Hansen, 1996).  
In addition, transcriptional repressors can be grouped by their ability to mediate long-range or 
short-range repression (Gray and Levine, 1996).   
 
1.2.2.1 Passive Repression 
 Passive repression can involve a repressor blocking transcription by competing for DNA 
binding sites with an activator protein.  If the repressor protein is present at a higher 
concentration, it will out compete the activator (Cowell, 1994).  In addition, passive repression 
could also involve competing for something besides a binding site that is needed for transcription 
initiation (Johnson, 1995).  However, passive repression appears to be used infrequently as a 
mechanism for repression in eukaryotes, possibly due to the complex organization of regulatory 
regions in eukaryotic genes (Johnson, 1995).   
 
1.2.2.2 Active Repression 
In order for DNA binding proteins to repress by active mechanisms, they require 
additional domains or motifs in addition to the DNA binding domain (Hanna-Rose and Hansen, 
1996).  These domains/motifs may function autonomously, or they may function by recruiting 
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 additional proteins or co-repressors which are able to mediate direct repression or quenching, 
usually by remodeling chromatin structure (Hanna-Rose and Hansen, 1996). 
 
1.2.2.2.1 Direct Repression 
Direct repression refers to the ability of a repressor to interfere with the activity of the 
basal transcriptional machinery at the promoter.  This type of repression can be very specific for 
a single component of the transcriptional machinery such as binding to a general transcription 
factor or RNA Polymerase II (Hanna-Rose and Hansen, 1996).  Interactions of repressors with 
co-repressors that interfere with the transcriptional machinery are also classified under direct 
repression.  Ultimately, the interactions between repressor/co-repressor and the transcriptional 
machinery prevent pre-initiation complex formation or further interactions with other activator 
proteins required for transcription initiation (Hanna-Rose and Hansen, 1996). 
 
1.2.2.2.2 Quenching 
 The complexity of regulatory regions allows both activators and repressors to bind DNA, 
but the repressor may interfere with the activity of an activator, known as quenching (Hanna-
Rose and Hansen, 1996).  Repression via quenching can potentially be specific for individual 
promoters or activators, or non-specific with general blocking of any activator protein (Hanna-
Rose and Hansen, 1996).  Quenching can occur by direct interaction of a repressor protein with 
an activator, with a co-activator or by interaction with a general transcription factor that is 
receptive to specific activators (Hanna-Rose and Hansen, 1996).   
 
 7
 1.2.2.2.3 Chromatin Modification 
 Adding to the complexity of active mechanisms of repression, there are the mechanisms 
that modify chromatin structure to make genes less accessible to RNA polymerase (Gaston and 
Jayaraman, 2003).  If a repressor/co-repressor complex can modify chromatin structure when 
bound close to the promoter, then it could appear to be directly repressing or quenching, and may 
appear as a non-specific quencher.  Therefore, chromatin modification and some mechanisms of 
active repression are interconnected. 
 
1.2.3 Long and Short Range Repression 
For long-range repression, a repressor protein renders a promoter inactive to all 
enhancers, even when the enhancers are located thousands of base pairs from where the repressor 
protein is bound (Courey and Jia, 2001).  The co-repressor Groucho (Gro), a protein that does 
not bind DNA directly, but is recruited to DNA by a transcriptional repressor, mediates long-
range repression and acts over 1 kb of DNA (Cai et al., 1996; Chen and Courey, 2000; Fisher 
and Caudy, 1998; Mannervik et al., 1999; Parkhurst, 1998). The interaction of Gro with 
repressors functions to actively silence transcription of promoters in a global manner (Barolo and 
Levine, 1997).  Gro was originally identified as a transcriptional co-repressor via its role in 
repression by the Hairy family of repressor proteins that contain a characteristic WRPW motif, 
and this motif is necessary and sufficient for recruitment of Gro (Chen and Courey, 2000; Fisher 
et al., 1996; Grbavec and Stifani, 1996; Paroush et al., 1994).  Variations of the WRPW motif 
such as WRPY in Drosophila have also been shown to recruit Gro (Aronson et al., 1997). 
There are several ways in which repressor proteins can mediate long range repression 
including: a) regulation of chromatin structure, by modifying the acetylation state of histones 
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 (hypoacetylated) via recruitment of deacetylases (Chen et al., 1999; Choi et al., 1999) and b) 
interference with basal transcriptional machinery.  Long-range repression may also involve the 
formation of a DNA loop that allows a silencer element to be in close proximity with the 
promoter (Yu et al., 2001). 
In contrast to long-range repression, short-range repression involves repressors blocking 
activators bound close to repressor binding sites, while not blocking activation by more distantly 
bound activators (Courey and Jia, 2001).  It appears that the distance over which a short-range 
repressor can exert its action is dependent upon the repressor concentration, enabling a sensitive 
way of responding to a transcription factor gradient (Hewitt et al., 1999).  In the Drosophila 
embryo, the even-skipped (eve) gene provides a prime example of an autonomous enhancer 
regulated by short-range repression (Akam, 1989).  Moreover, many short-range repressors in 
the embryo including Giant, Krüppel, Knirps and Snail are partially dependent on C-terminal 
Binding Protein (CtBP) as a co-repressor (Mannervik et al., 1999; Nibu et al., 2001).  CtBP, like 
Gro, is a protein that does not bind DNA directly, but is recruited to DNA by a repressor protein 
and mediates short-range repression, acting over a distance of up to 150 bp (Gray and Levine, 
1996; Nibu et al., 1998a; Nibu et al., 1998b; Poortinga et al., 1998; Zhang and Levine, 1999).  
CtBP is recruited by a motif having similarity to a PxDLS consensus sequence (Schaeper et al., 
1995; Schaeper et al., 1998).  There are several possible mechanisms CtBP uses to exert short-
range repression including: a) CtBP may recruit histone deacetylases (Criqui-Filipe et al., 1999; 
Sundqvist et al., 1998; Zhang et al., 2001a) and b) CtBP may act by quenching, which involves 
interactions of repressor/co-repressor complex with activators bound to nearby sites (Gray and 
Levine, 1996). 
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 The major advantage for recruitment of CtBP is that it allows repression of one enhancer 
without interfering with activity of a nearby enhancer, which would be repressed with Gro 
recruitment (Chen and Courey, 2000; Chinnadurai, 2002; Nibu et al., 2001).  Therefore, most 
transcriptional repressors recruit only one of these co-repressors.  There are two transcription 
factors that recruit CtBP and Gro, Hairy and Hairless.  But in the case of Hairy, CtBP functions 
to antagonize Gro activity rather than its typical role as a co-repressor (Phippen et al., 2000; 
Zhang and Levine, 1999).  In contrast, both CtBP and Gro confer repressor activity for Hairless 
(Barolo et al., 2002).  In addition to Hairy and Hairless, Brinker (Brk) is another transcriptional 
repressor containing interaction motifs for CtBP and Gro and has been shown to interact with 
both of these co-repressors (Hasson et al., 2001). 
 
1.3 Transcriptional regulators and signaling pathways 
Some transcription factors are always active and available to bind at regulatory elements, 
but the activity of other transcription factors are regulated by signaling pathways.  Upon pathway 
activation, transcription factors can be modified (e.g. phosphorylated), resulting in changes of 
their activity.  Consequently, for these signal regulated factors to be activated and exert their 
action, they require input from a signaling pathway which modifies the activity of a particular 
transcription factor (Barolo and Posakony, 2002).  To analyze the activity of the input of a 
signaling pathway that controls regulatory transcription factors, reporter constructs can be 
generated in which a LacZ or GFP reporter can be fused to the enhancer/promoter of a gene and 
transcriptional output can be assessed based on the level of reporter gene expression (Barolo et 
al., 2000).  Binding sites contained within enhancer/promoter regions can be altered to analyze 
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 the difference in reporter gene expression compared to normal regions to determine the 
importance of these sites for regulation of gene expression. 
 
1.4 Signal Transduction Pathways 
Although there are multiple developmental outputs, there are a limited number of 
signaling pathways controlling cell fate decisions, including Wnt, TGF-β, Hedgehog, receptor 
tyrosine kinase, nuclear receptor, Jak/STAT and Notch pathways (Barolo and Posakony, 2002; 
Gerhart, 1999).  Each of these signaling pathways are used over and over again throughout the 
development of an organism to activate target gene expression corresponding to various 
developmental contexts via signal regulated transcription factors.  Mechanisms of signal 
transduction utilized by each of these pathways are very different from one another, but the 
output is the same, activation of target genes (Barolo and Posakony, 2002).  The seven signaling 
pathways listed above utilize different mechanisms of signal transduction from direct 
transcriptional regulation by nuclear receptor proteins to the phosphorylation cascades of 
receptor tyrosine kinase pathways (Barolo and Posakony, 2002). 
A primary role of signaling pathways is to regulate transcription of a subset of target 
genes following binding of a ligand to its corresponding receptor, but the ultimate function of the 
pathways is to regulate the activity of one or more transcription factors specific to that pathway 
(Barolo and Posakony, 2002).  In most cases, signaling results in activation of a transcription 
factor to promote transcription of specific target genes containing binding sites for this 
transcription factor.  However, transcriptional regulation via signaling pathways is more complex 
than this simple picture, and three basic properties have been described for this process during 
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 development:  ‘activator insufficiency’, ‘cooperative activation’ and ‘default repression’ (Barolo 
and Posakony, 2002). 
Activator insufficiency describes the observation that activation of a single signaling 
pathway in a cell, and consequently activation or one or more transcription factors by this 
pathway, is not usually sufficient on its own to induce expression of a known ‘target’ gene 
(Barolo and Posakony, 2002).  The reason for this is inherent in ‘cooperative activation’, which 
describes the general requirement for more than one transcription factor for activation of a 
particular target gene (Barolo and Posakony, 2002).  Activation of target genes is not simply 
dependent upon the positive action of a transcriptional activator, because these targets are often 
being actively repressed in the absence of signal, a property referred to as ‘default repression’ 
(Barolo and Posakony, 2002).  The Wnt and Notch signaling pathways have the interesting 
property that the transcription factor responsible for default repression, dTCF/LEF and Su(H), 
respectively, is also the factor responsible for activating target genes.  Thus in the absence of 
signal, these factors act as repressors, but in the presence of signal, they are converted into 
activators (Bray and Furriols, 2001; Klein et al., 2000; van de Wetering et al., 1997).   
A combination of multiple transcription factors and tissue specific activator binding may 
provide the synergistic effect required for transcriptional activation (Barolo and Posakony, 
2002).  Following pathway activation, transcription factors along with tissue specific factors can 
bind to specific response elements in promoters or enhancer regions of target genes and activate 
transcription.  Although local activators are present, transcriptional repressors keep target genes 
in an inactive state until an appropriate signal is transduced via the receptor signaling complex 
(Barolo and Posakony, 2002).  A combination of the above mentioned transcriptional controls 
enable the limited number of signaling pathways to specifically activate target gene expression 
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 only under the proper conditions, otherwise transcription at these genes remains inactive (Barolo 
and Posakony, 2002).  Furthermore, the ability of a limited number of signaling pathways to 
elicit a multitude of cellular responses demonstrates the exceptional specificity in both repression 
and activation of target genes leading to such responses.   
 
1.5 Patterning in the Drosophila embryo by transcription factor gradients 
During development, a single transcription factor can provide the information to establish 
different spatial patterns of gene expression along a body axis (either A/P or D/V) if the 
transcription factor concentration forms a gradient along the axis and if target genes are 
differentially sensitive to different concentrations of the transcription factor.  In the Drosophila 
egg, bcd mRNA is localized at the anterior of the egg, but following fertilization, it is translated 
and Bcd protein diffuses posteriorly producing a gradient along the anterioposterior axis (St 
Johnston and Nusslein-Volhard, 1992).  The Bcd gradient sets up segmentation of anterior 
structures including the head and thorax (Driever and Nusslein-Volhard, 1988a; Driever and 
Nusslein-Volhard, 1988b; Frohnhofer et al., 1986).  In addition, Bcd activates high levels of 
hunchback, another transcription factor that forms a gradient along the A/P axis and establishes 
specific domains of gap (giant, Krüppel and knirps) and pair rule (even-skipped, fushi tarazu and 
hairy) genes along this axis (Rivera-Pomar and Jackle, 1996).  For example, high levels of Bcd 
in the anterior activate expression of buttonhead and orthodenticle, whereas lower levels activate 
hunchback and Krüppel, and even lower levels activate knirps (Burz et al., 1998; Cohen and 
Jurgens, 1990; Finkelstein and Perrimon, 1990).  The proteins produced by the gap and pair rule 
genes in turn form concentration gradients controlling genes that further define segmental 
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 compartments of the embryo including the segment polarity genes and homeotic selector genes 
(Lewis, 1978; Nusslein-Volhard and Wieschaus, 1980). 
Patterning of the embryonic dorsoventral (D/V) axis is dependent upon a nuclear-
cytoplasmic gradient of the transcription factor Dorsal.  Dorsal protein is localized in the nucleus 
in the ventral region of the embryo and in the cytoplasm in dorsal regions of the embryo 
(Stathopoulos and Levine, 2002).  The expression patterns of genes along the D/V axis such as 
rhomboid, tolloid, decapentaplegic (dpp), zerknullt, twist, snail and single-minded are 
determined by their sensitivity to either activation or repression by Dorsal protein, and these 
gradient thresholds established along the D/V axis initiate differentiation of mesoderm, 
neurogenic ectoderm and dorsal ectoderm (Stathopoulos and Levine, 2002).  For example, high 
levels of Dorsal activate twist and snail, and low levels activate rhomboid, short gastrulation and 
single minded, to name a few.  
 In the early Drosophila embryo, gradients of transcription factors such as Bcd and Hb 
can be established along the A/P axis from a localized source of RNA because the embryo is a 
syncytium and the factors can diffuse in the cytoplasm (St Johnston and Nusslein-Volhard, 
1992).  In other systems gradients of transcription factors, or more correctly, gradients of 
activated transcription factors (in D/V this corresponds to a gradient of nuclear Dorsal) are also 
established along developing axes.  However, the gradients cannot be established in the same 
way as for the A/P axis in the embryo because there are membranes between the cells, so 
gradients are usually established by a gradient of an extracellular signal.  For example, in D/V 
patterning, a gradient is produced by a processed form of the Spatzle protein, which is present in 
the perivitelline space surrounding the embryo, where it is processed in the ventral region 
producing a ventral to lateral to dorsal gradient (Morisato and Anderson, 1994).  Activation of 
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 the Toll receptor by Spatzle promotes nuclear localization of Dorsal (Morisato and Anderson, 
1994; Stathopoulos and Levine, 2002).  In other systems including the Drosophila wing, 
gradients of extracellular signaling proteins result in a similar gradient of the activated form of 
the transcription factor, in which modification of the transcription factor by the signaling 
pathway occurs downstream of the signaling protein.  One of these signaling proteins is 
Decapentaplegic (Dpp), a TGF-β homolog, whose gradient controls patterning along the antero-
posterior axis of the developing Drosophila wing. 
 
1.6 Imaginal discs and the adult wing 
Imaginal disc transplantation studies revealed that the primordia of adult structures, such 
as wing blade or notum, originate at specific regions within the disc and allowed fate maps to be 
developed (Cohen, 1993).  For example, the center of the wing pouch corresponds to the distal 
tip of the adult wing blade and the line delineating the A/P axis of the wing disc corresponds to 
the center of the wing blade just anterior to wing vein IV (Fig. 2A,B) (Blair, 1995; Cohen, 1993).  
When the wing forms at metamorphosis, the ventral surface folds under the dorsal surface in the 
distal region to form the adult wing (Cohen, 1993).  Consequently, the adult wing is composed of 
two sheets of cuticle, previously secreted by epidermal cells, which are fused at the margin (Fig. 
2B) (Cohen, 1993).  Each wing has several distinct invariant features including veins and bristles 
that can be used to identify abnormalities.   
We are interested in understanding regulation of patterning during animal development 
and how these intricate patterns of differentiated cells produce functioning structures such as 
appendages. The Drosophila wing is an excellent system to study pattern formation due to the 
vast knowledge of the regulation of gene function and the numerous techniques developed in  
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Figure 2.  Fate map of wing imaginal disc and projection onto adult wing. 
 
(A) Wing imaginal disc showing regions that correspond to adult wing regions.  Only a portion 
of the wing disc gives rise to the future wing blade (dashed region).  The wing disc is divided 
into anterior (A) and posterior (P) compartments, as well as dorsal (D) and ventral (V) 
compartments.  (B) The adult wing is composed of dorsal and ventral sheets fused at the margin.  
Designation of the anterior and posterior regions of the wing and positioning of the five invariant 
wing veins. 
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Drosophila, allowing genetic and molecular analysis of regulation of differential gene 
expression.   
In Drosophila, adult appendages derive from larval imaginal discs.  An imaginal disc is a 
single-layered sac composed of columnar epithelial cells that originate in the embryo and give 
rise to adult structures such as legs and wings (Cohen, 1993).  During early larval development 
the fate of imaginal disc cells are uncommitted, but by the third instar, the discs are fully 
patterned and divided into distinct regions or compartments (Blair, 1995).  The wing imaginal 
disc is divided into anterior (A) and posterior (P) compartments along the A/P axis and into 
dorsal (D) and ventral (V) compartments along the D/V axis (Fig. 2A), and cells within one 
compartment do not intermix with cells from another compartment, as compartments are regions 
of lineage restriction (Garcia-Bellido et al., 1973; Garcia-Bellido et al., 1976).  Expression of the 
selector gene engrailed (en), by cells in the posterior compartment but not the anterior 
compartment, provides these cells with their posterior identity (Guillen et al., 1995; Simmonds et 
al., 1995; Tabata et al., 1995).  
 
1.7 Control of Drosophila wing development by TGF-β homolog Dpp 
 The morphogen patterning an axis lies at the boundary between compartments.  In the 
wing disc, dpp RNA is expressed as a narrow stripe along the center of the A/P axis just anterior 
to the interface between the anterior and posterior compartments (Fig. 3) (Blackman et al., 1991; 
Masucci et al., 1990).  Following synthesis, the secreted Dpp protein forms an almost 
symmetrical medial to lateral gradient in the anterior and posterior compartments (Fig. 3) 
(Entchev et al., 2000; Teleman and Cohen, 2000).  Genes requiring high levels of Dpp are 
 17
 activated nearest to the Dpp source, whereas genes requiring lower levels of activity are 
transcribed in a wider expression domain, producing nested expression domains of target genes 
around the Dpp source (Lecuit et al., 1996; Nellen et al., 1996; Zecca et al., 1995).  For example, 
the spalt (sal) gene is transcribed in regions where Dpp levels are high, while the optomotor 
blind (omb) gene is transcribed in a wider domain responding to both higher and lower levels of 
Dpp and the vestigial quadrant enhancer (vg-QE, an enhancer recapitulating a portion of the 
expression of the vestigial gene) responds to even lower levels of Dpp (Fig. 3) (Kim et al., 1996; 
Lecuit and Cohen, 1998; Nellen et al., 1996; Zecca et al., 1995).  Consequently, the 
corresponding expression patterns of these genes along the A/P axis relates to their response to 
Dpp signaling: the sal expression domain is more narrow than omb which is more narrow than 
vg-QE (Fig. 3).  Although sal and omb are each regulated by distinct levels of Dpp, it remains to 
be determined how Dpp regulates gene expression in a concentration dependent manner.   
 
1.8 Transforming Growth Factor-β Signaling Pathway 
 Members of the Transforming Growth Factor-β (TGF-β) superfamily of secreted 
signaling molecules/growth factors influence a plethora of developmental processes in 
multicellular organisms, by controlling the transcription of target genes in responding cells (Shi 
and Massague, 2003; ten Dijke et al., 2000; Whitman, 1998; Wozney, 1998).  Some of the 
cellular responses controlled by TGF-β superfamily members include changes in cell shape, 
proliferation, cell cycle regulation, apoptosis and specification of cell fate (Raftery and 
Sutherland, 1999). 
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Figure 3. Regulation of gene expression in the Drosophila wing by Dpp and Brk. 
 
dpp RNA is expressed in the center of the anteroposterior (A/P) axis of the wing disc.  Following 
secretion, the protein becomes distributed in a medial-to-lateral gradient in the anterior and 
posterior halves.  How this would project onto the adult wings is also shown, although Dpp is not 
expressed there at this stage.  Brk is expressed at high levels in the lateral regions of the wing 
disc and shows graded expression towards the center; its expression is directly regulated by Dpp.  
Dpp target genes, sal and omb are expressed in a nested pattern centered on the stripe of Dpp 
expression with sal requiring higher levels of Dpp than omb.  sal and omb are repressed by Brk 
and the model proposes that they are differentially sensitive to Brk so that sal is repressed by 
lower levels than omb and this explains why the sal expression domain is narrower. 
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1.8.1 Receptor Complex and signaling 
 The effectors of TGF-β signaling are transmembrane serine-threonine kinases designated 
type I and type II receptors (Massague, 1998; ten Dijke et al., 1996) .  Type I receptors possess a  
glycine-serine rich region (GS domain) located N-terminal to the kinase domain.  
Phosphorylation of the GS domain by the type II receptor is critical for signaling by the receptor 
complex (Padgett et al., 1998).  In contrast, the type II receptor is a constitutively active kinase 
that activates the type I receptor upon phosphorylation (Padgett et al., 1998).  Following ligand 
binding, the type I and type II receptors dimerize forming a heteromeric complex in which the 
type II receptor will then phosphorylate the type I receptor (ten Dijke et al., 2000).  In order for 
signaling to occur, both the type I and type II receptors must be present, otherwise signaling is 
blocked (Luo and Lodish, 1996).  Moreover, the type I receptor is required to phosphorylate its 
substrates, the Smad protein, for transmission of the signal (Kretzschmar et al., 1997; Macias-
Silva et al., 1996; Souchelnytskyi et al., 1997). 
 
1.8.2 Smad Family of signal transducers 
 The Smad family of proteins is classified into three groups: the receptor-regulated Smads 
(R-Smad), the Co-mediator Smads (Co-Smad) and the inhibitory Smads (I-Smad) (Mehra and 
Wrana, 2002; Shi and Massague, 2003).  Smads are predominantly cytoplasmic in the absence of 
ligand, but upon ligand binding, R-Smads (vertebrate Smad 1, 2, 3, 5, 6, 7, 8 and Drosophila 
Mad) are phosphorylated by activated type I receptors leading to formation of a heteromeric 
complex with a Co-Smad (Kretzschmar et al., 1997; Lagna et al., 1996; Macias-Silva et al., 
1996).  Association of R-Smads with the activated receptor complex may be facilitated by an 
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 anchor protein, SARA, allowing for increased recruitment to the receptor (Tsukazaki et al., 
1998).  The Smad complex is then translocated into the nucleus where it regulates the 
transcription of target genes (Kretzschmar et al., 1997; Lagna et al., 1996; Macias-Silva et al., 
1996).  The inhibitory Smads, on the other hand, compete with R-Smads for binding to activated 
receptors or for association with Co-Smads and target receptors for degradation (Shi and 
Massague, 2003).  However, the I-Smads are only expressed in the presence of TGF-β ligand 
compared to the ubiquitous expression of the other Smads, implicating the I-Smads as a 
component of a negative feedback mechanism to downregulate TGF-β signaling (Christian and 
Nakayama, 1999).  Ultimately, the Smad-Co-Smad complex regulates transcription as a 
sequence specific transcription factor by binding to cis-regulatory elements in TGF-β responsive 
genes and through interaction with tissue specific transcription factors (Massague and Wotton, 
2000). 
 
1.9 Decapentaplegic (Dpp) Signaling Pathway 
 The Decapentaplegic (Dpp) protein of Drosophila is a member of the TGF-β superfamily 
of signaling molecules closely related to vertebrate Bone Morphogenic Proteins (BMPs).  Dpp is 
involved in numerous developmental processes including specification of the embryonic 
dorsoventral axis (Ferguson and Anderson, 1992; Irish and Gelbart, 1987; Podos and Ferguson, 
1999), endoderm and mesoderm induction (Bienz, 1997; Frasch, 1995), and tracheal cell 
migration (Vincent et al., 1997).  Dpp acts as a long-range morphogen, providing positional 
information to pattern tissues, most notably the embryonic ectoderm and the wing imaginal disc 
(Gelbart, 1989; Padgett et al., 1998; Spencer et al., 1982).  As with other TGF-β superfamily 
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 members, extracellular Dpp ligand binds to the type I transmembrane serine-threonine kinase 
receptors, Thickveins (Tkv) or Saxophone (Sax), that in turn recruit the type II receptor, Punt 
(Put), forming a heteromeric receptor complex (Fig. 4) (Brummel et al., 1994; Letsou et al., 
1995; Nellen et al., 1996; Penton and Hoffmann, 1996; Ruberte et al., 1995).  Punt, a 
constitutively active kinase, phosphorylates Tkv, which in turn recruits and phosphorylates the 
founding member of the Smad family of signal transducers, Mothers against Dpp (Mad) 
(Newfeld et al., 1996; Sekelsky et al., 1995).  Phosphorylated Mad (P-Mad) interacts with a Co- 
Smad, Medea and the heteromeric complex translocates to the nucleus where it can bind cis-
regulatory elements in Dpp target genes to activate or repress transcription (Fig 4) (Das et al., 
1998; Hudson et al., 1998; Xu et al., 1998).   
 
1.10 Dpp activates or represses gene expression directly 
 As stated previously, Dpp signaling follows the canonical TGF-β signal transduction 
pathway resulting in Mad (R-Smad) and Medea (Co-Smad) binding to cis-regulatory elements of 
target genes in various tissues to drive reporter gene expression.  This includes the vestigial 
enhancer expressed across the entire wing blade and a tinman enhancer with expression in the 
dorsal mesoderm of embryos (Kim et al., 1997; Xu et al., 1998).  In contrast, Dpp has also been 
shown to repress gene expression, again via Mad and Medea (Pyrowolakis et al., 2004).  In the 
larval wing disc, brk is expressed in a lateral to medial gradient with highest levels of Brk protein 
at the marginal region, forming a complementary gradient to the medial to lateral Dpp gradient 
(Fig. 4) (Muller et al., 2003).  The brk response elements can be divided into an enhancer and a 
silencer, in which the enhancer can drive ubiquitous reporter gene expression in the wing disc 
(Muller et al., 2003).  In contrast, the Mad/Medea complex can bind the silencer region, recruit  
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Figure 4. Model for regulation of gene expression by Dpp and Brk in the Drosophila wing. 
 
(A) In the absence of Dpp, the R-Smad, Mad, and the Co-Smad, Medea, remain in the cytoplasm 
and this allows high-level expression of brk under the control of an unidentified activator, Act-B.  
Brk protein binds to response elements at Dpp target genes, such as sal and omb and represses 
their expression.  (B) In the presence of Dpp, Mad is recruited to the activated receptors, 
Thickveins and Punt, and is phosphorylated.  Mad then translocates to the nucleus in 
combination with Medea.  In the nucleus, Mad/Medea bind to response elements in the brk gene 
and in combination with Shn, represses its expression.  The absence of Brk relieves repression of 
Dpp target genes, which are then activated by tissue specific transcriptional activators, possibly 
Vg/Sd in the case of sal; the activator for omb, Act-O is unknown.  Mad/Medea may also bind to 
Dpp targets such as sal and enhance activation.  (C) In the absence of Dpp and Brk, Dpp targets 
are expressed because the tissue specific activators are sufficient, although those targets whose 
activation is enhanced by Mad/Medea, may be expressed at lower levels than in the presence of 
Dpp. 
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 the zinc finger protein Schnurri (Shn) and act as a transcriptional repressor (Marty et al., 2000; 
Muller et al., 2003; Pyrowolakis et al., 2004).  Experimental evidence suggests the spacing 
between Mad and Medea sites is critical for recruitment of Shn and is present in cis-regulatory 
regions of genes repressed by Dpp activity, such as brk, but not those genes activated by Dpp 
signaling (Pyrowolakis et al., 2004).  The transcriptional output provided by Dpp signaling can 
rely solely on direct Mad/Medea activation or repression, but the transcriptional output of some 
target genes is regulated by repression of the Brinker (Brk) protein (Campbell and Tomlinson, 
1999; Jazwinska et al., 1999a; Kirkpatrick et al., 2001; Minami et al., 1999; Muller et al., 2003; 
Pyrowolakis et al., 2004). 
 
1.11 Brk protein is a sequence specific transcription factor 
 The brk gene encodes a nuclear, sequence specific DNA binding protein of 704 amino 
acids, containing an N-terminal helix-turn-helix (HTH) DNA binding motif (Fig. 5) (Campbell 
and Tomlinson, 1999).  Studies have revealed that Brk binds to regulatory elements of numerous 
TGF-β regulated genes including omb in the wing, as well as zerknullt (zen), tolloid, labial and 
Ultrabithorax (Ubx) in the embryo (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and 
Bienz, 2001; Sivasankaran et al., 2000).  In vitro binding studies demonstrated that amino acids 
44-99 contain the DNA binding domain, which corresponds to the predicted helix-turn-helix 
motif and additional N-terminal region (Saller and Bienz, 2001).  DNA binding site selection and 
DNA footprinting identified a Brk consensus binding site of GGCGYY (Sivasankaran et al., 
2000; Zhang et al., 2001b).  In some enhancer regions, Brk binding sites overlap with activator 
sites (UbxB), while others do not (sal) (Guss et al., 2001; Kirkpatrick et al., 2001; Kuhnlein et 
al., 1997; Saller and Bienz, 2001).  For the embryo target gene zerknullt, mutation of putative  
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Figure 5.  Schematic Representation of Brinker (Brk) Protein. 
 
The brk gene encodes a 704 amino acid protein, and contains an N-terminal DNA binding 
domain.  The protein also contains sequence corresponding to interaction motifs for 
transcriptional co-repressors CtBP and Groucho, CiM and GiM, respectively.  Does Brk contain 
any additional repression domains besides the CiM and GiM?  What mechanism(s) does Brk use 
to repress target genes? 
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 Brk binding sites results in de-repression of reporter gene expression (Rushlow et al., 2001).  In 
contrast, mutation of Brk binding sites in an omb enhancer reduces the ability of this enhancer to 
activate reporter gene expression, indicating the Brk binding sites overlap with those of a 
transcriptional activator which also fail to bind when Brk sites are mutated (Sivasankaran et al., 
2000). 
 
1.12 Dpp indirectly regulates target genes via Brk repression 
 In the Drosophila wing, Brk functions to repress expression of Dpp target genes sal and 
omb.  In brk mutants, the sal, omb and vg-QE expression domains are expanded laterally (Fig 
6B, D, F), whereas ectopic brk expression in central regions of the wing disc where brk is not 
normally expressed, results in a loss of both sal and omb expression (Campbell and Tomlinson, 
1999; Jazwinska et al., 1999a; Minami et al., 1999; Muller et al., 2003).  Therefore, expression of 
sal and omb requires that Brk protein must be absent or reduced, which is the case in central 
portions of the wing disc corresponding to high levels of Dpp causing repression of brk.  
Consequently, does Dpp regulate target gene expression indirectly via repression of brk?  Double 
mutant studies demonstrated that if Dpp signaling and brk are eliminated, sal is expressed, 
supporting an indirect mechanism of target gene regulation by Dpp (Campbell and Tomlinson, 
1999; Jazwinska et al., 1999a; Marty et al., 2000).  However, brk mutant clones in lateral regions 
of the wing disc possess lower levels of sal expression compared to its endogenous central 
region, and loss of both brk and Mad in the central region produced a partial reduction in sal 
levels (Campbell and Tomlinson, 1999; Jazwinska et al., 1999a; Marty et al., 2000).  This 
indicates that even though Dpp signaling acting through Mad may not be needed for sal 
expression, direct Dpp signaling may be required to obtain maximal sal expression levels.  In  
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Figure 6. Phenotype of brkXA Mutant Wing Imaginal Discs. 
 
Third instar wing discs comparing wild-type to brkXA mutant discs.  brkXA mutant discs 
have an overgrowth phenotype showing expansion of the A-P axis in the wing pouch. 
(A & B) sal expression (anti-Sal). The arrow designates the sal expression domain that 
widens into the expanded wing pouch in the mutant disc.  (C & D) omb expression  
(UAS-GFP; Omb-Gal4).  The brkXA mutant disc shows misexpression of omb. (E & F) 
β-gal expression driven by vg-QE enhancer (x-gal).  vg-QE expression in the mutant disc is 
expanded into lateral regions of the wing disc.  Note: brkXA is also an enhancer trap, and 
staining in (F) reveals expression from both enhancer traps, but vg-QE is stronger than brkXA. 
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 comparison, brk mutant clones in lateral regions seem to contain similar levels of omb 
expression as central regions, suggesting Dpp may not be directly activating omb (Campbell and 
Tomlinson, 1999; Jazwinska et al., 1999a; Marty et al., 2000).  
 
1.13 Differential sensitivity of Dpp targets to Brk 
 Even though Brk represses both sal and omb, the sal expression domain is more narrow 
compared to the omb expression domain.  However, Brk forms a lateral to medial gradient and it 
appears that sal has a lower threshold than omb to repression by Brk, producing the difference in 
the width of the expression domains (Fig. 4) (Campbell and Tomlinson, 1999; Jazwinska et al., 
1999a; Minami et al., 1999).  Misexpression studies provide some support for these differences 
(Muller et al., 2003), but the mechanism of differential sensitivity between sal and omb is not 
known.  The ability of a single transcription factor to activate or repress a gene at one 
concentration, but the necessity for increased levels of the factor to have an effect on another 
gene remains unclear.  One of the most probable mechanisms explaining the differences in 
variability and sensitivity to threshold responses to a transcription factor relates to the number of 
binding sites or affinity to these sites in enhancers of target genes. The above mechanisms seem 
to be working in enhancers regulated by transcription factors Dorsal (Dl), Hunchback (Hb), 
Krüppel (Kr) and Knirps (Kni) (Clyde et al., 2003; Jiang et al., 1992; Langeland et al., 1994).  
On the other hand, other mechanisms may be used to regulate the sensitivity, for instance, the 
position of binding sites relative to a promoter can alter the sensitivity to repression by Giant 
(Hewitt et al., 1999). 
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 1.14 Mechanisms of Brk repression 
 
1.14.1 In vitro studies suggest Brk represses by simple competition with activators 
 Evidence that Brk represses by competition with activators comes from studies of the 
omb wing enhancer in which Brk binding sites appear to overlap with the binding sites of an 
unknown activator (Sivasankaran et al., 2000).  In the embryo, Brk targets zen and Ubx contain 
Brk binding sites which frequently overlap with activator (Mad) binding sites and in vitro 
binding studies showed direct competition between Brk and Mad for binding to the same region 
of DNA (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and Bienz, 2001). 
 
1.14.2 Brk may repress through recruitment of co-repressors, Gro and CtBP 
Sequence analysis of the Brk protein has identified interaction motifs for co-repressors, 
Groucho (Gro) and C-terminal binding protein (CtBP) and both of these proteins are capable of 
binding Brk in vitro (Hasson et al., 2001; Saller and Bienz, 2001; Zhang et al., 2001b).  In the 
absence of both CtBP and Gro, some Brk targets show ectopic expression such as brk itself, 
which negatively autoregulates, but other targets such as omb do not, suggesting Brk may recruit 
CtBP and Gro to repress some genes, but not others (Hasson et al., 2001).  Moreover, in the 
embryo, ectopic expression of modified/mutated brk transgenes suggest CtBP and Gro 
interaction motifs are required for maximal Brk activity. 
 
1.15 Brk target genes in the Drosophila wing 
Brk functions to repress expression of several target genes in the wing that were initially 
classified as Dpp target genes, including sal, omb and the vestigial quadrant enhancer (vg-QE) 
(Campbell and Tomlinson, 1999; Jazwinska et al., 1999a; Kim et al., 1996; Marty et al., 2000).  
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 The sal gene encodes a zinc-finger protein, containing three widely spaced, sequence related zinc 
finger groups (Kuhnlein et al., 1994).  The product of the sal gene participates in vein patterning 
and cell growth in the adult wing (de Celis et al., 1996).  Previous studies demonstrated that a 
10.2 kb Sal fragment could drive LacZ expression in the wing disc in an almost identical pattern 
to wild-type sal and a smaller 1.8 kb sub-fragment could also drive expression in the wing pouch 
(Kuhnlein et al., 1997).  Another study reported that a 328 bp subfragment of sal1.8 could drive 
expression in the wing pouch, but with wider expression and absence of expression in the central 
region (Guss et al., 2001).  In the developing wing disc, the sal domain is nested within the omb 
domain (Lecuit et al., 1996).  The omb gene encodes a member of the T-box family of 
transcription factors (Pflugfelder et al., 1992).  Brk has been shown to bind a minimal Dpp-
responsive omb wing enhancer region (Sivasankaran et al., 2000) and repress omb expression.  In 
addition, omb is one of the few genes that is positively regulated by Dpp in the wing disc and its 
expression along the A/P axis seems to be controlled by Brk (Sivasankaran et al., 2000).  
However, a recent study in the Campbell Lab revealed that upregulation of Mad levels 
antagonizes the ability of ectoptic Brk to repress omb, suggesting omb is directly activated by 
Mad (Moser and Campbell, 2005). 
 In addition to sal and omb, Dpp signaling activates expression of the vestigial gene.  The 
vestigial quadrant enhancer, (Vg-QE), is expressed in the developing wing disc and its 
expression domain extends to lateral regions of the wing pouch, overlapping the Brk domain.  
Dpp signaling activates expression of vg in the wing disc via the quadrant enhancer (QE), which 
is located within the fourth intron of vg and contains two Mad binding sites (Kim et al., 1996).  
The expression of vg-QE is de-repressed in brk mutant clones, indicating that vg-QE is a direct 
target of Brk repression (Campbell and Tomlinson, 1999; Jazwinska et al., 1999a; Minami et al., 
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 1999).  Studies also demonstrated activated Mad associates with Medea and directly regulates vg 
expression (Kim et al., 1997).  Moreover, Dpp response elements of vg are dependent on its Mad 
binding sites to drive Dpp dependent reporter gene expression (Kim et al., 1997).  In vitro studies 
revealed that Brk binds to a vg Dpp response element and represses reporter expression 
(Kirkpatrick et al., 2001).  Since vg is expressed throughout the wing pouch at a distance from 
the Dpp source, it appears that vg-QE has a low sensitivity to repression by Brk (Kirkpatrick et 
al., 2001). 
 
1.16 Brk target genes in the Drosophila embryo 
During embryonic development, Dpp regulates expression of Hox genes Ultrabithorax 
(Ubx) and labial (Hursh et al., 1993; Thuringer et al., 1993; Tremml and Bienz, 1992) involved 
in endoderm patterning.  Analysis of the Ubx and labial midgut enhancers revealed each contains 
binding sites for Mad (Kim et al., 1997) that mediate the response to Dpp stimulation (Szuts et 
al., 1998).  Dissection of the upstream regions of Ubx revealed a 260 bp fragment (UbxB) that 
drives reporter gene expression in a pattern similar to Ubx, but extends slightly wider than 
endogenous Ubx (Thuringer et al., 1993).  The minimal Ubx midgut enhancer (UbxB) is 
controlled by Brk, and brk mutant embryos showed de-repression in reporter gene expression in 
the anterior and posterior midgut (Saller and Bienz, 2001).  Further analysis of the UbxB 
enhancer revealed that Brk binding sites overlap activating Mad/Medea binding sites 
(GCCGNCGC) in this enhancer, and in vitro binding studies demonstrated that Brk competes 
with Mad for binding to these sites (Kirkpatrick et al., 2001; Saller and Bienz, 2001). 
In addition to Ubx expression in the embryo, zen is another gene that is regulated by Brk 
protein. During early to mid-cellularization, maintenance of the zen pattern becomes dependent 
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 on Dpp because zen transcript disappears in dpp mutant embryos (Ray et al., 1991; Rushlow and 
Levine, 1990).  The zen expression pattern is also dependent on Brk repression because zen 
transcripts expand into the ventral ectoderm in brk mutants (Jazwinska et al., 1999b).  The broad 
pattern of zen is maintained by Dpp in dorsal region and repressed by Brk in the ventral regions 
(Rushlow et al., 2001).  Analysis of a 1.6 kb zen promoter region revealed 6 putative Brk binding 
sites and 10 Mad binding sites.  Of the 6 Brk binding sites, 5 overlap with Mad binding sites 
(Rushlow et al., 2001).  Mutation or deletion of several combinations of two Brk sites did not 
effect reporter gene expression, but mutation of four Brk binding sites produced ectopic 
expression in the ventral ectoderm during late cellularization (Rushlow et al., 2001), reminiscent 
of expression pattern observed in brk mutant embryos (Jazwinska et al., 1999b).  These findings 
demonstrated that Brk binding to zen promoter sites are critical for Brk repressor activity and in 
this tissue it appears that a cumulative effect of Brk binding sites is required, not just the 
presence of any single site (Rushlow et al., 2001). 
 
1.17 Project Goals 
The preceding introduction illustrates the complex transcriptional control of gene 
expression in eukaryotes.  Although Brk represses both sal and omb, the omb expression domain 
is wider than sal, demonstrating that sal is more sensitive to Brk than omb.  This work 
investigates the mechanisms Brk uses to repress Dpp target gene expression to gain an 
understanding of why some targets are more sensitive to repression by Brk than others.  Does 
Brk function identically to repress each of its targets?  What mechanisms does Brk use to repress 
transcription?  Does Brk use the same mechanism to repress each of its target genes?  To answer 
these questions, several approaches were utilized:  1) Previous work in the Campbell lab 
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 analyzed endogenous brk mutants and EMS induced mutations in a brk transgene.  Due to the 
limited availability of brk mutants, I utilized another approach.  2) In vitro mutated UAS-brk 
transgenes were generated and ectopically expressed in the developing Drosophila wing or 
embryo.  Phenotypes of adult wings were analyzed following misexpression of modified/mutated 
forms of Brk using two Gal4 drivers (C765-ubiquitous expression in wing and en-Gal4-
expressed exclusively in the posterior).  Expression of Brk target genes sal, omb, Vg-QE and 
salE1 reporter (a sal enhancer fragment that drives expression in a pattern similar to sal) were 
analyzed following misexpression of UAS-brk transgenes in the posterior of the wing using en-
Gal4.  Expression of embryonic midgut mesoderm reporter, UbxB, was analyzed following 
misexpression of UAS-brk transgenes in the embryonic mesoderm.   
Analysis of endogenous brk mutants revealed the importance of a functional DNA 
binding domain for Brk function, as well as that CtBP and Groucho interaction motifs are not 
required for repression of some targets.  To determine whether Brk uses the same mechanism to 
repress each of its targets, it was necessary to analyze mutants with specific repression 
domains/motifs mutated or deleted.  Initially, I expected that Brk used the same mechanism to 
repress each of its targets, and the difference in sensitivity between sal and omb result from the 
number of Brk binding sites or affinity for the binding sites contained in enhancer/promoter 
regions.  However, analysis of modified/mutated forms of Brk protein revealed that Brk does not 
repress by simple binding site competition, but requires specific repression domains in 
combination with its DNA binding domain.  Interestingly, although sal and omb show 
quantitative differences in their response to Brk, there are qualitative differences in the 
mechanisms that Brk uses to repress each target.  
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 2 Chapter 2:  Repression of Dpp Targets in the Drosophila Wing by Brinker 
 
2.1 Introduction 
 
Decapentaplegic (Dpp), a TGF-β superfamily member, plays an important role in many 
developmental events in Drosophila including patterning of the wing imaginal disc, where it 
forms a medial to lateral morphogen gradient along the anterioposterior (A/P) axis of the wing 
(Blackman et al., 1991; Entchev et al., 2000; Masucci et al., 1990; Teleman and Cohen, 2000).  
Dpp signaling regulates gene expression in a dose dependent manner and does this in part, by 
downregulating the expression of the brinker (brk) gene, which encodes a transcriptional 
repressor; brk is consequently expressed in a lateral to medial gradient (Muller et al., 2003).  We 
have investigated the mechanisms Brk uses to repress gene expression to gain an understanding 
of why some targets such as spalt (sal) are more sensitive to Brk than others such as optomotor-
blind (omb) that in turn is more sensitive than the vestigial quadrant enhancer (vg-QE) (Kim et 
al., 1997; Lecuit et al., 1996; Nellen et al., 1996). 
It has been suggested that Brk may repress different target genes using different 
mechanisms.  First, Brk binding sites in the cis-regulatory regions of some embryonic Brk 
targets, including Ubx and zen overlap with activator sites for Mad, and in vitro studies 
demonstrate that Brk and Mad can compete for binding to the same region of DNA (Kirkpatrick 
et al., 2001; Rushlow et al., 2001; Saller and Bienz, 2001).  Second, Brk contains interaction 
motifs for the co-repressors CtBP (Chinnadurai, 2002) and Gro (Chen and Courey, 2000), 
indicating Brk may use more active mechanisms to repress target genes (Zhang et al., 2001b).  
The absence of Gro or CtBP does result in derepression of some Brk targets, such as the vg-QE, 
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 but not others, such as omb, suggesting Brk may use alternate mechanisms to repress different 
genes (Hasson et al., 2001).   
To characterize the importance of the DNA-Binding Domain, Groucho interaction motif 
(GiM), CtBP interaction motif (CiM) or other regions of Brk protein required for its repressor 
activity, modified/mutated forms of Brk protein were generated in which one or more of these 
domains/motifs were mutated or deleted.  The current study reveals that Brk requires its DNA-
binding domain (DBD) plus a repression domain to act as a transcriptional repressor.  Moreover, 
the DBD alone cannot repress target genes, even those shown to possess overlapping Brk and 
Mad binding sites, suggesting competition may not be a real mechanism in vivo.  Brk possesses 
four independent repression domains, Gro and CtBP interaction motifs and two other domains 
defined as 3R (Winter and Campbell, 2004) and 4R for third and fourth repression domain, 
respectively.  However, these domains are not equivalent: 3R can repress omb but not sal, and 
this difference may be related to the spacing of Brk-binding sites relative to activator sites.  
 
2.2 Comparison of Brk homologs in other insect species 
Brinker (Brk) is a sequence specific transcription factor that regulates Dpp responsive 
genes by binding to response elements and repressing expression of these genes.  In an attempt to 
identify the regions of Brk protein required to repress gene expression, a comparison of four 
insect species, Drosophila melanogaster, Drosophila pseudoobscura, the mosquito Anopheles 
gambiae and the distantly related silkworm Bombyx mori was completed.  A 60 amino acid 
segment corresponding to the helix-turn-helix (HTH) motif (residues 68-89), predicted from the 
original Brk sequence, plus additional N-terminal sequence (Campbell and Tomlinson, 1999) 
were similar in all four species (Fig. 7).  The region spanning amino acids 44-99 was identified 
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 as the DNA binding domain (DBD) by in vitro studies (Rushlow et al., 2001; Saller and Bienz, 
2001; Sivasankaran et al., 2000; Zhang et al., 2001b).  Based on the size of the Brk DNA binding 
domain and the positioning of the HTH motif, there are definite similarities between the Brk 
DNA binding domain and the homeodomain (Jazwinska et al., 1999a), a DNA binding domain 
found in many important transcription factors, which is composed of three helicies, with the last 
two forming a helix-turn-helix.  The Brk DNA binding domain has weak homology with other 
homeodomain proteins including Engrailed and Hox proteins (Jazwinska et al., 1999a).  Outside 
the DNA binding domain, only the regions centered on the Groucho Interaction Motif (GiM) and 
the CtBP Interaction Motif (CiM) are conserved among all four insect species (Fig. 7).  The two 
Drosophila species share some identical resides such as poly-glutamine stretches before and after 
the 3R region, and the region from amino acids 593-629 which are identical in both species, as 
well as several regions with 2-5 identical amino acids. 
 
2.3 Experimental Approaches 
The fact that the DNA binding domain, the CiM and GiM have been conserved through 
millions of years of evolution indicates these regions are essential for Brk activity, at least in 
some contexts.  However, questions that remain to be answered are as follows.  First, is the DNA 
binding domain required for repression of all Brk target genes?  Second, can Brk repress some 
target genes simply by competing with activators (such as Mad) for overlapping binding sites?  If 
so, this may only require the DBD and not the CiM, GiM or other repression domain.  Third, in 
addition to the functional domains/motifs already identified, does Brk possess additional regions 
that act as repressor domains? To determine the answers to the above questions, previous work in 
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Figure 7. Sequence comparison of Brk from Drosophila melanogaster and from three other 
insects, D. pseudoobscura, Anopheles gambiae and Bombyx mori. 
 
The DNA-binding domain (boxed in red) is strongly conserved in all four species. Outside of the 
DNA-binding domain there is only one other region of significant similarity, centered on the 
Groucho interaction motif (GiM, blue), although the short CtBP interaction motif (CiM, blue) is 
also conserved.  The third repression domain, 3R, of D. melanogaster, identified by functional 
studies described here, is outlined in pink. This domain shares some limited sequence identity 
with D. pseudoobscura, but this does not extend to the other two species, although it is rich in 
Ala and His residues in Anopheles, as in the two Drosophila species. 
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the Campbell lab utilized two approaches: 1) characterize three EMS mutations in the 
endogenous brk gene (Lammel et al., 2000; Lammel and Saumweber, 2000) and 2) generation of 
additional mutations in a brk transgene UAS-brkA438.  The second approach screened for EMS  
induced mutations in the transgene by driving ubiquitous expression of the UAS-brkA438 
transgene in the wing using Gal4 C765, resulting in an almost complete loss of the wing blade at 
25°.  An EMS induced lesion in the brk transgene would result in reversion of the wing 
phenotype, producing an increase in wing size.  Five point mutants in UAS-brkA438 were isolated 
and characterized.  3) The third approach was the basis of my thesis research, and involved 
generation of UAS-brk transgenes that produced HA-tagged proteins in which different regions 
were included, modified, mutated or fused to other domains, including nuclear localization 
sequences (NLS) and repression motifs.  Activity of the modified/mutated Brk proteins was 
compared to that of wild type Brk protein (Brk3PF3) by misexpression of transgenes in the 
developing wing and analysis of:  a) adult wings using two Gal4 drivers and b) expression of 
known Brk targets in the imaginal wing disc and embryo. 
  
2.4 Results 
2.4.1 Analysis of Brk target genes in the wing imaginal disc and embryo 
Previous studies have identified Dpp targets in the wing and embryo that are repressed by 
Brinker (Brk) protein including sal, omb, vg-QE, UbxB and salE1.  The normal expression 
pattern for each of these targets (Fig 8A, C, E, G, I) has been analyzed and will be compared to 
expression following misexpression of wild type Brk (Fig. 8B, D, F, H, J) and modified/mutated 
forms of Brk protein to determine the repressor activity of altered Brk proteins.  A majority of  
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Figure 8. Analysis of Brk targets in the wing imaginal disc and embryo. 
 
(A,C,E,G,I) Wild-type expression pattern of Brk targets analyzed in the wing imaginal disc and 
embryo.  (B,D,F,H)  Misexpression of wild-type Brk protein (Brk3PF3) in the posterior of wing 
imaginal discs represses expression of each of the targets tested in the wing (anterior-posterior 
interface is marked by the line; posterior is to the right).  (J) Misexpression of Brk3PF3 in the 
mesoderm of embryos represses expression of the UbxB reporter.   
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 the analysis was completed on the expression of sal and omb in developing wing discs, with 
secondary analysis on the expression of vg-QE in the wing and UbxB in the embryo.  In 
addition, the salE1 reporter was used to analyze the repressor activity of brk mutants and brk 
transgenes.  The following provides details on how each of the targets will be assessed 
throughout the studies as well as evidence that each is a Brk target.   
 Brk functions to repress the expression of sal, omb and vg-QE in the wing and these 
genes were originally classified as Dpp targets.  In the absence of Dpp and Brk, these genes are 
still expressed, indicating indirect regulation by Dpp, through repression by Brk.  In brk mutants, 
the expression domains of sal and omb expand laterally, and ectopic expression of brk in central 
regions of the wing disc results in loss of both sal and omb expression (Campbell and 
Tomlinson, 1999; Jazwinska et al., 1999a; Minami et al., 1999; Muller et al., 2003).  Moreover, 
other studies have demonstrated that Brk binds to cis-regulatory elements of omb (Sivasankaran 
et al., 2000) and vg (Kirkpatrick et al., 2001).   
A) spalt (sal)  the expression of sal will be detected using an anti-Sal antibody (Kuhnlein et al., 
1994) to stain wing imaginal discs. 
B) optomotor-blind (omb)  the expression of omb will be detected using omb-LacZ enhancer trap 
line and an anti-β-gal antibody to stain wing imaginal discs. 
C) vestigial quadrant enhancer (vg-QE, an enhancer recapitulating a portion of vestigial gene 
expression) the expression will be detected using a vg-QE (LacZ) line and an anti-β-gal antibody 
to stain wing imaginal discs. 
Brk was shown to repress Ubx in the embryonic midgut (Saller and Bienz, 2001), and to bind to 
Ubx response elements (Kirkpatrick et al., 2001; Saller and Bienz, 2001). 
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 D) UbxB an Ultrabithorax (Ubx) reporter construct, expressed in the embryonic midgut 
mesoderm (Thuringer et al., 1993), will be detected in embryos using X-gal staining 
E) salE1  an enhancer identified in our lab, and is the smallest region that drives GFP expression 
in a similar pattern as endogenous sal.  Additional studies, including Barrio and de Celis, (2004) 
show that activator sequences do not overlap with Brk binding sites (Fig. 9A). 
In an attempt to further understand the repressor activity of both endogenous brk mutants 
and UAS-brk transgenes, we have characterized a portion or the sal enhancer element, salE1.  
salE1 is a 471 bp fragment located 10 kb upstream of the salm gene, in which the sal locus 
contains two partially redundant genes, salm and salr (Fig 9A) (Barrio et al., 1996).  salE1 is a 
subfragment of sal1.8S/E enhancer (Kuhnlein et al., 1997) and was designed based on previous 
studies (Guss et al., 2001) (Fig. 9A).  The salE1 reporter drives expression in a slightly wider 
expression pattern compared to endogenous sal (Fig. 9C), but it is repressed in lateral regions of 
the wing pouch, presumably by the repressor activity of Brk. 
 It was shown that Brk is required for repression of salE1 expression in the lateral regions 
of the wing pouch in the following ways.  First salE1 reporter expression is upregulated in lateral 
regions (where it is not normally expressed) in brk null (brkM68) mutant clones (Fig. 10).  
Second, mutation of the three putative Brk binding sites in salE1 from GGCGYY (Kirkpatrick et 
al., 2001; Rushlow et al., 2001; Sivasankaran et al., 2000; Zhang et al., 2001b) (Fig. 9A) to 
GTCGYY, to generate salE1MB123, results in expansion of the expression domain to lateral 
regions of the wing pouch (Fig. 9E).  Therefore, these binding sites must be required to repress 
salE1 in lateral regions.  Deletion of the salE1 region encompassing the three Brk binding sites 
producing salGCNB (Fig 9A), a fragment similar to that analyzed previously (Guss et al., 2001), 
resulted in an expansion of expression into lateral regions of the wing pouch, but reporter  
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Figure 9. cis-regulatory elements at the salm locus. 
 
(A) The upstream region of the salm gene and constructs tested for enhancer activity (driving 
lacZ or GFP).  All putative Brk binding sites (GGCGYY) are marked along with conservation in 
D. pseudoobscura.  Below, the sal1.8 fragment is magnified and seven putative Mad binding 
sites (MA-MG) are labeled along with seven putative Brk binding sites (B1-B7) and 
Scalloped/Vestigial site (S). (B) The sal1.8 fragment drives expression in the wing pouch, but in 
a wider pattern than sal itself.  (C) salE1 fragment contains three Mad binding sites and three Brk 
binding sites and is the smallest fragment that drives reporter expression in a similar pattern as 
endogenous sal, but like sal1.8, expression is slightly wider (lateral limit marked by yellow 
dashed line).  (D) The salGCNB fragment lacks all Brk binding sites and drives reporter 
expression in the lateral regions of the wing pouch (lateral limit marked by the blue dashed line), 
although expression is missing from the central region.  (E) salE1MB123 has the three Brk 
binding sites mutated, and drives expression in the lateral-most region of the wing pouch, to the 
same width as salGCNB. 
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Figure 10. Expansion of salE1 reporter in brk mutant clones. 
 
(A) Third instar wing discs containing brk null mutant clones, marked by the loss of ubiquitous 
β-gal in red.  (B) salE1 expression is ectopically expressed in brk clones in the lateral wing 
pouch (arrow). (C) Merge of panels A and B. 
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 expression was lost in the central region (Fig.9D).  SalGCNB possesses a binding site for the 
activator Scalloped/Vestigial as well as two sites for activators Mad/Medea (Fig. 9A) (Barrio and 
de Celis, 2004).  These data indicate that the Brk binding sites located in salE1 are separated  
from these activator sites as well as other potential activators, and are consistent with the results 
obtained in another recent analysis of sal enhancer regions (Barrio and de Celis, 2004). 
 
2.4.2 SalE1 does not require omb to be activated  
 A recent study revealed that endogenous sal expression is dependent on Omb (del Alamo 
Rodriguez et al., 2004), so we wanted to test whether salE1 also requires omb for its expression.  
Clonal analysis of brk omb double mutant clones revealed ectopic salE1 expression in clones 
suggesting that salE1 does not require omb to be activated.  Consequently, salE1 is not behaving 
exactly like the endogenous sal gene, since sal does require omb for its expression (GC, 
unpublished results). 
 
2.4.3 Characterization of point mutations in the endogenous brk gene 
 Previously identified Brk mutations (Lammel et al., 2000; Lammel and Saumweber, 
2000) were sequenced and lesions are as follows: brkE427 introduces a stop codon at amino acid 
115, producing a truncation following the DNA binding domain (Fig 11A and 16B); brkF138 
produces a longer version of the protein truncated at amino acid 333 (Fig 11A and 16B) before 
the CtBP Interaction Motif and brkF124 contains an amino acid substitution (R82W) in the DNA 
binding domain recognition helix (Fig 11A and 16B).  Activity of brk endogenous mutants was 
assessed by analyzing expression of known Brk targets in the wing, sal, omb and Vg-QE, in 
marked homozygous mutant clones.  Previous work revealed that in null brk mutant clones 
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 (brkM68), Brk targets were misexpressed in lateral regions of the wing disc (Campbell and 
Tomlinson, 1999; Jazwinska et al., 1999a; Minami et al., 1999).  Homozygous mutant clones of 
brkE427 and brkF124 had no perceptible activity and were not able to repress sal, omb or Vg-QE 
expression (Fig 11A,B and 12A,B).   
Interestingly, Brk protein truncated just before the CiM and GiM, brkF138, had significant 
activity compared to brk null mutant clones.  BrkF138 was able to repress omb, but not sal 
completely or Vg-QE in mutant clones (Fig. 11A,B and 12C,D), as there was ectopic sal 
expression adjacent to the normal sal expression domain, but it does not expand beyond the omb 
expression domain.  However, sal expression is dependent upon Omb (del Alamo Rodriguez et 
al., 2004), and so the absence of ectopic sal expression in more lateral regions could be due to 
the lack of ectopic omb expression in brkF138 clones, rather than direct repression of sal by 
BrkF138 protein.  Consequently, BrkF138 can repress omb completely and sal either partially or 
possibly not at all in the absence of the CiM and GiM.  These results are consistent with the 
finding that omb is not ectopically expressed in CtBP, gro double mutant clones (Hasson et al., 
2001).  However, it was suggested that Vg-QE expression is also dependent on upon Omb (del 
Alamo Rodriguez et al., 2004), but Vg-QE expression is expanded into lateral brkF138 clones 
where omb is not expressed (Fig 12D).  Possible explanations for these discrepancies are that 
Vg-QE expression may not always be dependent on Omb, or there may be omb expression in the 
clones, but the low levels are not detectable with the omb enhancer trap used. 
 
2.4.4 CtBP or Gro is required for repression of sal 
BrkF138 protein product represses omb without recruiting either CtBP or Gro, but either 
one or both co-repressors could be required to repress other target genes in the wing such as sal  
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Figure 11. Schematic Representation of EMS point mutants in the endogenous brk gene 
and expression patterns of target genes. 
 
(A) Schematic of Brk proteins containing mutations in endogenous brk gene and corresponding 
activity level for each of the proteins compared to wild-type Brk protein.  brkE427, a protein 
truncated immediately after the DBD, has no activity, while a truncation producing a longer 
protein, but still does not include the CiM or GiM, brkF138, has significant activity.  An amino 
acid substitution within the DBD, brkF124, also has no activity.  (B) Schematic of wing imaginal 
discs showing expansion of sal and omb expression domains into lateral regions of the disc for 
brkF124 and brkE427.  The sal domain extends to the end of the omb domain, but does not extend 
beyond the omb expression domain in brkF138 mutant clones. 
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Figure 12. Phenotype of brk point mutants, brkF124 and brkF138. 
 
Third instar wing discs containing mutant clones, marked by the loss of a ubiquitous GFP 
transgene, and stained for omb (lac-Z, anti-βgal), Sal (antibody) and vg-QE (lacZ, anti-βgal) 
expression.  The anterior compartment is to the left and the posterior is to the right. (A) brkF124 
clones show ectopic expression of Sal and omb within the wing pouch, even in lateral postions.  
(B) brkF124 clones also show expansion of the vg-QE domain.  (Cii)  sal is ectopically expressed 
only in brkF138 clones next to the endogenous domain and does not extend to lateral regions. (Ciii) 
omb is not ectopically expressed (the upregulation of expressionin the clone is because omb-lacZ 
is on the X, as is brk, so the clone contains two copies of the enhancer trap).  (D) vg-QE 
expression is expanded laterally in some brkF138 clones. 
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 and Vg-QE.  These findings are consistent with previous studies demonstrating that neither CtBP 
nor Gro are required to repress omb and that Gro is required to repress Vg-QE (Hasson et al., 
2001).  These studies have been expanded and revealed that in contrast to omb, Gro is required 
for complete repression of sal, and CtBP can partially compensate for the loss of Gro.  
Therefore, these findings contradict previous studies that neither CtBP nor Gro are required for 
repression of sal (Hasson et al., 2001).  In the wing, CtBP/gro double mutant clones show the 
same phenotype for sal expression as brkF138 clones, i.e. ectopic expression, but only within the 
omb domain (Fig. 13A).  However, in CtBP single mutant clones, sal expression is normal (Fig. 
13B), showing the ectopic expression of sal present in CtBP/gro double mutant clones can be 
rescued by Gro alone.  In contrast, sal expression in gro single mutant clones is somewhat 
expanded (Fig. 13C), but not as severely as in the CtBP/gro double mutant clones.  Therefore, 
CtBP can supply some repressor activity to narrow the lateral limit of sal expression in the wing 
disc, but it is not as effective as Gro. 
 
2.4.5 BrkF138 cannot repress salE1 reporter expression 
It was previously demonstrated that brkF138 was able to repress expression of omb but not 
sal (Fig. 12C).  Based on this finding, it was logical to assume that BrkF138 would also not be 
able to repress the salE1 reporter.  As expected, clonal analysis revealed that BrkF138 was not able 
to repress salE1 leading to misexpression of the reporter in lateral brkF138 mutant cells (Fig. 
14Ai-ii).  Interestingly, in brkF138/+ heterozygous cells, salE1 was expanded compared to 
homozygous wild type (Fig. 14Aiii), suggesting that BrkF138 was interfering with the ability of 
wild type Brk to repress salE1.  Based on these data, it appears as if BrkF138 may be exhibiting a  
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Figure 13. Phenotype of CtBP and gro mutants. 
 
Third instar wing discs containing mutant clones, marked by the loss of a ubiquitous GFP 
transgene, andstained for Sal (antibody) expression.  (Aii) CtBP gro double mutant clones are 
similar to brkF138 clones (Fig.12C), only showing ectopic Sal expression (C, arrow) immediately 
adjacent to the endogenous domain (when located in the omb domain, not shown).  In contrast, 
Sal is not ectopically expressed in any CtBP single mutant clones (B), whereas there is an 
occasional, minor deregulation of Sal in gro clones (C, arrow). 
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 dominant negative activity, but analysis of misexpression of other truncated forms of Brk protein 
(presented later) contradict this finding. 
 
2.4.6 Requirement for CtBP and Gro for repression of salE1 
 To determine the role of co-repressors CtBP and Gro in repression of salE1, clonal 
analysis using CtBP and gro single and double mutants was completed.  In CtBP single mutant 
clones, expression of salE1 looks normal (Fig. 14, Bi-iii), whereas in gro single mutant clones 
there was possibly some de-repression of salE1 in the anterior compartment, but the salE1 
expression in the posterior looks normal (Fig14, Ci-iii).  In contrast, in CtBP/gro double mutant 
clones, salE1 was strongly misexpressed in the lateral wing pouch (Fig 14, Di-iii).  Based on 
these findings, repression of salE1 by CtBP and Gro is similar to endogenous sal, as the ectopic 
expression of salE1 observed in CtBP/gro mutant clones can be rescues by Gro alone.  
 
2.4.7 Characterization of UAS-brkA438 mutants 
 Of the 5 mutants isolated from the UAS-brkA438 screen, four of the lesions produced 
amino acid substitutions in the DNA binding domain, D44 (L57F), S4 (A72V), C(H80L) and F2 
(R81C) (Fig. 15D-G and Fig 16C).  The mutations isolated were located at different regions of 
the DNA binding domain, and had varying effects on the activity of the resulting protein, 
assessed by ubiquitous expression using Gal4 driver C765, although no mutation completely 
abolished activity.  In contrast, UAS-brkA438-53 contained a stop codon immediately following the 
DNA binding domain (residue 102) and had no detectible activity in vivo (Fig. 15H and 16C).  
However, if Brk represses simply by binding-site competition, UAS-brkA438-53 should be able to 
repress in vivo, assuming it is localized to the nucleus and is stable, because it contains the entire  
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Figure 14. Expression of salE1 reporter in brkF138 clones and CtBP and gro mutant clones. 
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 Figure 14. Expression of salE1 reporter in brkF138 clones and CtBP and gro mutant clones. 
 
Third instar wing discs containing mutant clones are marked by the loss of ubiquitous β-gal  
expression (red for F138 and green for CtBP and gro single and double mutant clones).(Ai-iv) 
salE1 (green) is ectopically expressed in brkF138 clones.  In fact, expression is expanded in 
brkF138/+ heterozygous tissue (most of the wing, weak red) compared to homozygous wild-type 
tissue (twin spot, dark red) (iv, yellow arrow; salE1, white arrow).  (Bi-iii) salE1 expression is 
not affected in CtBP mutant clones.  (Ci-iii) gro mutant clones show some de-repression of salE1 
expression in the anterior compartment (ii).  (Di-iii) In CtBP gro double mutant clones (i) there 
is misexpression of salE1 in lateral regions of the wing pouch (ii, arrows). 
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Figure 15. Mutations in UAS-brkA438, which originally contained a wild-type brk transgene. 
 
(A) Ubiquitous expression of brkA438 transgene produces a smaller wing, and mutation of the 
transgene results in reversion to a larger wing blade.  (B) Wild-type adult wing.  (C) 
Misexpression of wild-type A438 results in a dramatically reduced wing size.  (D-H) 
Misexpression of mutated forms of A438, results in larger wings; from completely wild-type in 
the case of A438-53, indicating a complete loss of activity, to small wings in the case of A438-
S4 and A438-C, indicating significant, but less than wild-type activity of Brk protein.  Wings 
produced with A438-D44 and A438-F2 are almost wild type in size, but have venation defects 
indicating some activity still remains. 
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DNA binding domain.  In vitro studies have demonstrated Brk residues 44-99 are sufficient to 
bind DNA and compete with activators (e.g. Mad) (Saller and Bienz, 2001).   
 Taken together, analysis of endogenous brk mutants and mutations in the UAS-brkA438 
transgene have provided a preliminary understanding of the regions required for Brk to function 
as a repressor and begin to answer some of the questions previously posed.  However, to 
completely understand which regions of Brk protein are required for its repressor activity, an 
additional approach was utilized, in which mutated/modified forms of Brk protein were 
generated and misexpressed in the developing Drosophila wing and embryo and the results were 
compared to misexpression of wild type Brk. 
 
2.4.8 Misexpression Studies 
 To gain a further understanding of how Brk functions to repress Dpp target genes, a 
series of transgenic flies have been generated that carry mutated or modified forms of the Brk 
protein (Fig. 16D).  Brk is a 704 amino acid protein containing an N-terminal DNA binding 
domain (residues 44-99), a poly-glutamine region (residues 102-120), a histine rich region 
(residues 151-172) and a poly-alanine tract (resides 173-189) (Fig. 16Ai).  Brk also contains 
interaction motifs for two transcriptional co-repressors, CtBP (CiM) and Gro (GiM).  Previous 
analysis revealed the Brk DNA binding domain is required for its function (Fig.12A,B (section 
2.5) and Fig. 15D-G (section 2.9)), and so each of the brk transgenes contain the DNA binding 
domain alone or in combination with other portions of the protein. 
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Figure 16. Mutated/modified Brk proteins and activity. 
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 Figure 16. Mutated/modified Brk proteins and activity. 
 
(A, Part i) Domains/motifs in the Brk protein. DBD, DNA binding domain; Q, poly-glutamine; 
H, histidine rich; A, poly-alanine; 3R, 4R independent repression domains.  CiM and GiM,  
interaction motifs for the co-repressors CtBP and Groucho, respectively.  (A, parts ii-v) 
Properties and effects of modified/mutated Brk proteins shown in B-D. (A, part ii) Domains 
present: present (+), deleted (-), mutated (M), or partially missing (/).  (A, part iii) Nuclear (N) or 
cytoplasmic (C) localization (blank spaces, here and in other columns indicates that they were 
not tested).  (A, part iv) Activity level assessed by the effect on the phenotype of adult wings (‘-’, 
no repressor activity;  ‘++++’, maximal activity; ‘D’, dominant negative; ‘E’, neomorphic).  (A, 
part v) The ability of each protein to repress the endogenous sal gene, an omb-LacZ line and 
three reporters, salE1, vg-QE and UbxB.  Y, repressed; N, not repressed; A. activated; U, we 
were unable to detect reliable differences in UbxB expression between wild-type and mutant 
embryos of any genotype.  (B) EMS point mutants in the endogenous brk gene.  A protein 
truncated within the DBD, brkM68, or immediately after it, brkE427, have no activity, whereas a 
truncation producing a longer protein, but which still does not include the CiM or GiM, brkF138, 
has significant activity and can repress omb, but not the other targets.  An amino acid substitution 
within the DBD, brkF124, also abolishes activity.  (C) Point mutants in a UAS-brk transgene, 
A438.  Four result in amino acid substitutions in the DBD and reduce activity.  The fifth 
mutation, A438-53, results in a truncation immediately after the DBD and has no activity.  (D) In 
vitro mutated/modified UAS-brk transgenes.  There are two basic requirements for these 
transgenes to repress gene expression: the DBD and a repression domain/motif.  In addition to 
the CiM and GiM, there are two other independent repressor domains, 3R and 4R.  The DBD 
plus any one of the four repression domains/motifs is sufficient to repress some Brk targets, 
although there is some variability in the ability of individual repressor domains to repress 
different targets.  The response of salE1 reporter is unusual in that many proteins activate rather 
than repress its expression. 
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2.4.8.1 Generation and testing of Wild Type and modified/mutated forms of UAS-brk 
transgenes 
 
 Different portions of Brk coding regions were modified, mutated or fused to other 
domains, including Nuclear Localization Sequences (NLS) and repression motifs, and cloned 
into the pUAST plasmid (Brand and Perrimon, 1993) containing the yeast Upstream Activating 
Sequence.  In addition, each of the constructs contains an HA epitope tag sequence to visualize 
localization of the proteins in wing imaginal discs.  The function of the mutated/modified Brk 
proteins was assessed by misexpression in the developing wing and observing the effects in two 
different ways, first by analyzing the phenotypes of adult wings and second by looking at 
expression of known Brk targets in the wing.  In addition, the expression of a target (Ubx) in the 
embryo was also analyzed.  The modified/mutated Brk transgenes were misexpressed in the wing 
using two different Gal4 drivers, en-Gal4 which drives expression in the posterior of the wing 
(Fig. 17C) and C765 which drives ubiquitous expression in the wing (Fig. 17B), but is weaker 
than en-Gal4.  In comparison, endogenous Brk is expressed in a lateral to medial gradient in the 
wing disc (Fig. 17A). 
The activity of the modified/mutated Brk proteins was compared to the wild type protein 
by analysis of Brk target genes sal, omb, Vg-QE and salE1 in wing discs and UbxB, an 
Ultrabithorax reporter in embryos (this enhancer is known to contain overlapping Brk and Mad 
binding sites) (Kirkpatrick et al., 2001; Saller and Bienz, 2001).  To analyze the expression of 
known Brk target genes in the wing (omb, sal and Vg-QE, salE1), brk transgenes were 
misexpressed in the posterior of wing discs using the en-Gal4 driver and the expression of target 
genes in the posterior were compared to normal expression in the anterior of the disc.  Animals  
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Figure 17. Misexpression of UAS-brk transgenes using two different Gal4 drivers. 
 
(A) Expression of wild type brk in wing imaginal disc and how expression would project onto 
the adult wing.  The activity of UAS-brk transgenes was assessed in adult wings using two Gal4 
drivers, C765 and enGal4.  Wing imaginal disc and adult wing showing ubiquitous expression 
using the C765 driver (B), and expression exclusively in the posterior compartment using enGal4 
(C). 
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 were raised at different temperatures to vary the amount of protein produced, as Gal4 is cold 
sensitive, so more protein is produced at higher temperatures.  The modified/mutated forms of 
Brk protein generated a wide range of repressor activity based on the corresponding wing adult 
phenotype (Fig. 18).  The assignment of activity levels observed in adult wings was based on the 
following criteria: 
(++++) Wild-type level (no modified/mutated protein achieved this level).  No adults’ eclosed 
with en-Gal4 even when reared at 17°C.  With C765 at 20°C, there was an almost complete loss 
of wing blade. 
(+++) Some adults were obtained with en-Gal4 at 20-25°C, with substantial loss of posterior 
wing tissue and veins.  With C765 at 25°C, there was almost a complete loss of the wing blade. 
(++) Adult flies were obtained with en-Gal4 at 25-30°C, their wings had loss of tissue or fusion 
of veins IV and V and loss of the posterior cross vein.  With C765 at 30°C, the wings were 
slightly smaller and had vein defects including extra cross veins. 
(+) Adult flies obtained with en-Gal4 at 25-30°C with loss of the posterior cross vein.  With 
C765 at 30°C there was little or no effect on the wings. 
(D) Dominant negative: Adult flies obtained with en-Gal4 and C765 at 25-30°C and have excess 
posterior wing tissue and veins, sometimes producing a ‘blistered’ phenotype in the posterior. 
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 (E) Neomorphic: Adult flies obtained with en-Gal4 and C765 at 25-30°C, wings have ectopic 
veins, particularly near vein V.  The Brk protein in these animals may have a different function 
compared to wild-type protein. 
(-) No activity.  No abnormal phenotype under 25°C; at 30°C there was often some disruptions to 
wing venation such as extra small veins around the posterior cross vein and vein V.  This was 
distinct from the other phenotypes above and may be caused by an extremely weak dominant 
negative activity. 
At least three lines of each construct were tested apart from BrkF124 (one line).  Although there 
was some variability in the level of activity from line to line, in general, most lines from any one 
construct fell into the same category of activity level.  To be assigned to one of the above 
categories, at least two lines from a construct had to have a similar level of activity, with most 
constructs having at least three lines with similar levels of activity. 
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Figure 18. Phenotype of adult wings following misexpression of modified/mutated forms of 
brk. 
 
UAS-brk transgenes were driven by en-Gal4 in the posterior compartment and C765 
ubiquitously (C765 is weaker than en-Gal4).  (A) Wild-type wings shaded to indicate the 
expression domains of the Gal4 drivers.  (B-F) The activity level of different Brk proteins was 
classified into five categories from ‘++++’ (full, wild-type level) to ‘-’ (no repressor activity); 
examples of each category are shown, for comparison, the temperature must be taken into 
account (Gal4 is cold sensitive).  (B) Full activity of 3PF3 (wild-type).  With en-Gal4, no 
animals survived to adult; with C765 the wing size is drastically reduced at 20°C.  (C-F) 
Mutated/modified Brk proteins have weaker activity than wild-type.  (C) Stop1, 20°C (top); CM, 
20°C (bottom).  (D) 3M, 25°C (top); 3M, 30°C (bottom).  (E) A2, 30°C.  (F) NLS, 30°C (top); 
F124, 30°C (bottom).  At high temperatures, ectopic veins are produced with F124, which we 
attribute to gain of function, as it has no effect on Brk target gene expression. 
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2.4.8.2 Activity of Wild Type Brk 
 As stated above, the activity of modified/mutated forms of Brk was compared to wild 
type Brk protein, Brk3PF3. UAS-brk3PF3; en-Gal4 flies do not survive to adults, even at low 
temperatures (17°C), whereas ubiquitous expression of the full-length brk transgene using C765 
allows the animals to emerge at 20°C, but they have an almost complete loss of the wing blade 
(Fig 19B).  However, UAS-brk3PF3; en-Gal4 animals survive to the late larval or early pupal 
stages at 20°C, allowing analysis of brk target gene expression at this temperature.  Wing 
imaginal discs stained for sal, omb and Vg-QE revealed that sal and omb are completely 
repressed in the posterior and Vg-QE was almost completely repressed (Fig. 19D,E).  In 
comparison, analysis of larvae reared at 17°C revealed that sal is completely repressed (Fig. 
19Cii), but some omb expression can be detected (Fig 19Ci), demonstrating that wild type Brk 
represses sal better than omb.  
Analysis of brk null mutant clones revealed ectopic salE1 expression in lateral regions of 
the wing pouch (Fig. 10, section 2.4), and we tested to see if wild type Brk was able to repress 
salE1 reporter expression.  UAS-brk3PF3 was misexpressed in the posterior of the wing disc using 
en-Gal4 and showed that salE1 expression was repressed in the posterior (Fig. 19F), providing 
further evidence for the role of Brk in repressing the salE1 reporter in lateral regions of the disc. 
Furthermore, misexpression of UAS-brk3PF3 in the posterior of salE1MB123 (salE1 with 3 Brk 
binding sites mutated) discs did not repress reporter gene expression in the posterior, but rather 
had no effect (Fig. 19G).  Therefore, as expected Brk binding sites in salE1 are critical for Brk to 
repress salE1 reporter expression. 
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Figure 19. Misexpression of wild-type Brk (3PF3) in the developing wing and embryo. 
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Figure 19. Misexpression of wild-type Brk (3PF3) in the developing wing and embryo. 
 
(A) Schematic of Brk and HA-tagged wild-type Brk (3PF3) protein containing DBD, interaction 
motifs CiM and GiM, and independent repressor domains, 3R and 4R.  In Figures 19-35, the 
construct is shown below the Brk protein  (B) Adult wings. Color overlays of wild-type wing 
showing the regions where Brk3PF3, and other modified proteins throughout the study were 
misexpressed; enGal4 is expressed in the posterior, while C765 is ubiquitous, but weaker than 
enGal4.  Brk3PF3, a wild-type form of Brk protein, induces early pupal lethality with enGal4, 
and an almost complete loss of the wing blade with C765.  (C-F) Repression of sal, omb, vg-QE 
and salE1 following misexpression of 3PF3 in the posterior of wing discs using enGal4 
(posterior is to the right in this and other figures and is compared to anterior expression on the 
left).  Expression of Sal is visualized with anti-Sal antibody; omb and vg-QE are visualized using 
lacZ (anti-βgal antibody).  salE1 and salE1MB123 are  GFP reporter constructs.  Transgene 
expression is indicated by HA panel (anti-HA antibody).  This methodology will be used for 
Figures 19-35.  (Ci-iv) At 17°C, sal is completely repressed (red), but some omb (blue) 
expression is present.  (Di-iv) At higher temperatures (20°C) (results in higher levels of 
transgene expression), both sal (green) and omb (red) are completely repressed.  (Ei-iii) 3PF3 
substantially reduces the level and width of vg-QE expression in the posterior.  (Fi-iii) 3PF3 
almost completely represses salE1 reporter expression in the posterior (20°C).  But mutation of 
the three Brk binding sites in salE1 results in the inability of Brk to repress salE1 expression (Gi-
iii).  (H) UbxB drives reporter gene (lacZ, visualized using X-gal) expression in the visceral 
mesoderm of embryos.  (Hii) Misexpression of 3PF3 throughout the mesoderm completely 
represses UbxB reporter gene expression. 
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Previous studies demonstrated ectopic wild type Brk completely repressed expression of 
an Ultrabithorax reporter, UbxB, in the visceral mesoderm of the embryo (Saller and Bienz, 
2001).  We repeated the experiments completed in the Bienz Lab to confirm that our wild type 
Brk transgene also repressed UbxB reporter expression in the visceral mesoderm in the embryo.  
Misexpression of UAS-brk3PF3 in the mesoderm with the 24B Gal4 driver results in complete 
repression of UbxB reporter gene expression compared to control embryos with no transgene 
(Fig 19H).  Taken together, these studies revealed that full-length, wild type Brk is capable of 
repressing all five Brk targets in the wing and embryo. 
Misexpression of wild-type Brk in wing discs (UAS-brkB459) (25°C) results in a dramatic 
alteration of the wing disc morphology from a relatively flat morphology, to a deep invagination 
at the interface between cells ectopically expressing brk in the posterior and normal cells in the 
anterior (Moser and Campbell, 2005).  Recent studies demonstrated that loss of Dpp signaling in 
cells in the wing pouch results in extrusion from the epithelium (Gibson and Perrimon, 2005; 
Shen and Dahmann, 2005).  Cells in the invagination move basally relative to the apical/basal 
polarity of the epithelium (Moser and Campbell, 2005).  As a result of the alteration in disc 
shape, analysis of gene expression patterns required both the basal and apical XY confocal 
sections.  Analysis revealed that at lower temperatures (20°C), sal was completely repressed and 
omb was detected in the posterior of discs (Moser and Campbell, 2005).  These results are 
similar to those obtained using UAS-brk3PF3, showing more Brk is required to repress omb than 
sal.  However, analysis of gene expression in this study predominantly focused on apical to 
medial confocal sections.   
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 2.4.8.3 Analysis of modified/mutated forms of Brk protein 
 
2.4.8.3.1 Requirement for a functional DNA binding domain 
 As indicated previously, clonal analysis of endogenous mutant brkF124, containing an 
amino acid substitution in the recognition helix (R82W) of the DNA binding domain, revealed a 
protein with little or no activity, as brkF124 mutant clones were reminiscent of brk null alleles 
with misexpression of sal, omb and vg-QE in lateral regions of the wing pouch (Fig. 12A,B).  In 
addition, four mutations isolated from the UAS-brkA438 EMS screen, corresponding to lesions in 
the DNA binding domain, reduced activity of the protein, but these mutations did not abolish 
activity (Fig 16C).  An HA tagged version of the brkF124 mutant (Fig 16D, 20A), UAS-brkF124, 
containing the same amino acid substitution in the DNA binding domain, was produced and it 
also did not possess repressor activity as shown by normal sal and omb expression (Fig. 20C).   
Misexpression of UAS-brkF124 in the posterior of wing discs revealed that Brk protein 
with a non-functional DNA binding domain was not capable of repressing salE1 (Fig 16D), as 
salE1 expression is identical in the anterior and posterior compartments.  Since BrkF124 could not 
repress salE1, it argues that this protein may be compromised in its ability to bind DNA.  
However, when BrkF124 was misexpressed at high levels using C765 (30°C), ectopic veins were 
present in adult wings (Fig 20B), possibly due to aberrant activity of the protein, indicating the 
protein has some activity but it is not equivalent to wild type protein.  This protein may have a 
novel activity possibly due to titrating out factors such as Gro or CtBP, e.g. reduction of Gro may 
result in ectopic wing veins.  Overall, mutations in the DNA binding domain of brk either 
reduces or completely abolishes the repressor activity of the protein, indicating Brk requires a 
functional DNA binding domain for repressor activity.   
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Figure 20. Misexpression of UAS-brkF124 in the developing wing. 
 
(A) Schematic of HA-tagged BrkF124 protein containing an amino acid substitution in the DBD, 
but with functional interaction motifs CiM and GiM, and independent repressor domains, 3R and 
4R.  (B) Adult wing phenotype.  Misexpression of BrkF124 at high levels (30°C) with enGal4 and 
C765 produced ectopic veins in adult wings, indicating the protein has some activity, but it is not 
equivalent to wild type protein.  (Ci-iv) Misexpression of BrkF124 in the posterior of wing discs 
did not repress either sal (green) or omb (red) expression. 
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2.4.8.3.2 Brk proteins containing only a DNA binding domain or DBD plus ‘Q’ region 
have no repressor activity 
 
 If Brk can repress simply by binding-site competition, then a protein possessing only the 
DNA binding domain and which is localized to the nucleus should be able to repress target 
genes.  Previous in vitro studies have demonstrated that Brk residues 44-99 are sufficient to bind 
DNA and compete with activators such as Mad (Saller and Bienz, 2001).  Endogenous mutant  
brkE427, truncated at residue 115, and UAS-brkA438-53, truncated at residue 102, produce proteins 
primarily containing the DNA binding domain (Fig. 16B,C).  However, neither of these proteins 
possessed repressor activity in vivo (Fig. 16B,C).  One possible reason for the inactivity of these 
proteins could be the lack of a Nuclear Localization Sequence (NLS), thereby making the 
proteins predominately cytoplasmic.  Characterization of the localization of these proteins was 
not possible using available antibodies, so an equivalent HA tagged version of UAS-brkA438-53, 
Brk53, was produced (Fig. 16D, 21A).  Misexpression of UAS-brk53 produced a wild type wing 
indicating the protein does not possess activity (Fig. 21B).  Brk53 was not able to repress 
expression of sal or omb in the posterior of wing discs (Fig. 21D).  Subsequent analysis of the 
localization of this protein in wing discs using an anti-HA antibody revealed that Brk53 protein 
was not restricted to the nucleus (Fig. 21E), which could explain its lack of activity.  Moreover, 
extension of the protein to include the poly-glutamine region ‘Q region’ to generate BrkS (Fig. 
16D, 21A), truncated at residue 123, also produced a protein with no repressor activity (Fig. 
16D).  In fact, BrkS seemed to be functioning as a dominant negative form of the protein shown 
by the excess wing tissue producing a “blistered” wing (Fig. 21B).  The truncated form of the 
protein may be interfering with the ability of endogenous Brk to repress target genes, resulting in 
excess wing vein and tissue formation.  Overexpression of BrkS with a deletion brk-Gal4 line  
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Figure 21. Misexpression of truncated forms of Brk (53 and S) in the developing wing. 
 
(A) Schematic of HA-tagged Brk53 and BrkS proteins, truncated immediately following the DBD, 
and after the poly-glutamine region, respectively.  Both of these proteins lack interaction motifs 
for CiM and GiM, as well as independent repressor domains 3R and 4R.  (B) Misexpression of 
Brk53 or BrkS produced predominantly wild type adult wings with enGal4 and C765.  BrkS may 
be functioning as a dominant negative, shown by the excess wing tissue in the posterior portion 
of the wing.  (C) Overexpression of BrkS with brk-Gal4 deletion line (G4M132), results in 
excess tissue and veins in the posterior and an expansion of the posterior similar to a weak loss 
of function brk mutant (XGXM2).  (Di-v) Brk53 cannot repress expression of sal (green) or omb 
(red) in the posterior of wing discs, but analysis revealed that Brk53 was not restricted to the 
nucleus. (i, ii) expression of sal and omb, respectively.  (iii, iv,v) expression of HA-53 and omb.  
(E) Higher magnification image focused on the large peripodial membrane cells showing 
expression of 53 is not restricted to the nucleus. 
 69
  
 (G4M132) produced adult wings with a similar phenotype to a weak loss of function brk mutant 
(XGXM2) (Fig. 21C).  Brk53 and BrkS were not able to repress salE1 reporter expression when 
misexpressed in the posterior of wing discs, but surprisingly, they were able to activate 
expression indicating that some Brk53 does get into the nucleus (Fig. 16D).  These data suggest 
that salE1 is not acting the same as the endogenous sal gene. 
 
2.4.8.3.3 Addition of a Nuclear Localization Sequence does not change the repressor 
activity of truncated Brk 
 
 Since Brk53 did not possess activity and was predominantly cytoplasmic, an SV40 T 
Antigen Nuclear Localization Sequence (Kalderon et al., 1984) was added to Brk53, making 
BrkNLS protein (Fig. 16D, 22A).  In contrast to Brk53, BrkNLS was localized in the nucleus (Fig. 
22Dv, 16D) where it could potentially bind DNA and repress target genes.  However, BrkNLS 
also did not have detectible repressor activity, as shown by the presence of wild type wings in 
adults following misexpression using both en-Gal4 and C765 (Fig 22B).  Furthermore, BrkNLS 
was not able to repress either sal or omb when misexpressed in wing discs (Fig 22Di-iv). 
Misexpression of UAS-brkNLS in the posterior of wing discs did not repress salE1 reporter gene 
expression.  Similar to Brk53, BrkNLS also activated salE1 reporter expression, providing strong 
evidence that BrkNLS can bind DNA in vivo (Fig. 22E).  Surprisingly, these findings suggest that 
the N-terminal region of Brk protein may possess a cryptic activation domain.  In contrast, 
misexpression of UAS-brkNLS, in the posterior of wing discs did not have any effect on 
salE1MB123 expression, either activating or repressing the reporter (Fig. 22F). 
 70
  
 
Figure 22. Misexpression of UAS-brkNLS in the developing wing and embryo. 
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 Figure 22. Misexpression of UAS-brkNLS in the developing wing and embryo. 
(A) Schematic of HA-tagged BrkNLS, a protein truncated immediately after the DNA binding 
domain that contains a nuclear localization sequence.  (B) Phenotype of adult wings.  BrkNLS 
does not have any detectable repressor activity, shown by wild-type wings following 
misexpression with either Gal4 driver.  (C) Misexpression of NLS in the mesoderm has no effect 
on UbxB reporter gene expression in the embryo.  (D-F) Analysis of sal, omb, salE1 expression 
in wing discs.  (Di-iv) At 30°C, NLS has no effect on the expression of sal (green) or omb (red) 
when misexpressed in the posterior of wing discs.  (Dv) Higher magnification image focused on 
the large peripodial membrane cells showing expression of NLS is exclusively nuclear (HA 
staining).  (Ei-iii)  Misexpression of NLS in the posterior of wing discs results in activation of 
salE1 reporter expression.  (Fi-iii) NLS does not activate salE1MB123 (salE1 with three Brk 
binding sites mutated) reporter expression (compare posterior to anterior expression). 
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2.4.8.3.3.1 BrkNLS can bind DNA in vitro 
 
 To confirm whether or not BrkNLS is capable of binding DNA in vitro, DNA binding 
assays were completed using the UbxB enhancer signal responsive sequence as the probe.  Brk 
residues 44-99 were previously shown to bind the UbxB enhancer, (Saller and Bienz, 2001).  The 
UbxB enhancer is a 260 bp fragment that can drive reporter gene expression in a pattern similar 
to endogenous Ubx (Thuringer et al., 1993), but its expression is slightly wider.  In addition, the 
signal responsive sequences contained within the UbxB midgut enhancer contains three Brk 
binding sites as well as three Mad binding sites which are overlapping (Fig. 23A) (Saller and 
Bienz, 2001). 
 In vitro translated BrkNLS was incubated in the presence of radiolabeled UbxB probe (36 
bp in length and centered around the overlapping Mad/Brk sites shown in Fig. 23A), and run on 
a 4% PAGE Gel (Ausubel et al., 1993).  Analysis revealed a shift of the labeled UbxB probe to 
two slower migrating bands, the lower migrating band possibly corresponds to one BrkNLS bound 
and the higher migrating band corresponds to two BrkNLS molecules bound (Fig. 23B, Lanes 
3,4,5,6,11,12).  In addition, incubation of the BrkNLS-UbxB complex with anti-HA antibody 
produced a supershift of the complex (Fig. 23B, Lane 9), confirming that BrkNLS is indeed 
binding to the UbxB probe and that the antibody recognizes the HA tagged in vitro translated 
protein.  Furthermore, experiments adding either 10X or 100X of unlabeled UbxB self 
competitor probe resulted in a predominant loss of the higher migrating species with 10X (Fig. 
23B, Lane 12) and complete loss of the higher migrating species and partial loss of the lower 
migrating species in the presence of 100X unlabeled probe (Fig. 23B, Lane 13) compared to the 
absence of competitor probe control (Fig. 23B, Lane 11).  In addition, there is an increase in the  
 73
  
 
Figure 23. Gel Mobility shift assay using HA-BrkNLS rabbit reticulocyte lysate and UbxB 
probe demonstrating BrkNLS  binds to DNA in vitro. 
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 Figure 23. Gel Mobility shift assay using HA-BrkNLS rabbit reticulocyte lysate and UbxB 
probe demonstrating BrkNLS  binds to DNA in vitro. 
 
(A) Relevant portion of UbxB DNA probe showing overlapping Brk (Red boxes) and Mad 
(activator) binding sites (Green boxes)(adapted from Saller & Bienz, 2001).  (B) Gel shift assays 
demonstrating BrkNLS binds to DNA in vitro. (Lanes 1,10) 32P labeled UbxB probe, no lysate.  
(Lane 2) Control lysate with no BrkNLS expression plasmid added.  (Lane 3) Addition of NLS 
lysate to UbxB probe results in a slower migration of the UbxB probe.  We hypothesize that the 
higher migrating band corresponds to binding of two BrkNLS molecules and the lower band to 
one molecule.  (Lanes 4,5,6,7)  Addition of decreasing amounts of NLS lysate.  (Lane 8) Same as 
lane 3, but with addition of green dye.  The same amount of UbxB probe was added to each lane.  
(Lane 9) Addition of anti-HA antibody to a similar reaction as in lane 3, results in a supershift of 
the protein-DNA complex.  (Lanes 11,12,13)  NLS lysate plus 0X, 10X and 100X unlabeled  
competitor UbxB probe.  Increasing amounts of competitor DNA first results in a loss of the 
higher migrating band suggesting that the second Brk may be more weakly bound. 
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 amount of radiolabeled probe not being shifted in the presence of the 10X and 100X unlabeled 
probe compared to the control, demonstrating the unlabeled probe is in fact competing for 
binding to BrkNLS.  Taken together, these data suggest that BrkNLS is capable of binding DNA in 
vitro and indicates that this protein is probably capable of binding DNA in vivo, thereby arguing 
against simple binding-site competition as the mechanism Brk uses for repression of target 
genes.  
 
2.4.8.3.3.2 Brk does not use competition as a mechanism for repression of target genes 
BrkNLS contains the region previously shown to bind DNA in vitro (residues 44-99) 
(Saller and Bienz, 2001), binds DNA in vitro (Fig. 23) and is localized in the nucleus (Fig. 
22Dv); therefore, BrkNLS should be able to bind DNA in vivo and argues against Brk using 
binding-site competition as a mechanism for repression.  However, the in vitro studies 
suggesting Brk uses binding-site competition as a mechanism for competition were completed 
using genes expressed in the embryo (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and 
Bienz, 2001), and it is possible that Brk does not use this mechanism in the wing.  Subsequently, 
we tested one of the embryonic targets, UbxB, a Ubx reporter construct expressed in the 
embryonic midgut mesoderm (Thuringer et al., 1993) and found that BrkNLS was not able to 
repress this target either (Fig. 22C).  Consequently, these data argue against Brk competing with 
activators, even with enhancers where Brk and activator (Mad) binding sites overlap. 
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 2.4.8.3.4 Addition of a minimal repression domain/motif to Brk DBD restores repressor 
activity 
 
Although BrkNLS was shown to bind DNA in vitro, possible reasons for the lack of 
BrkNLS activity are that it cannot bind DNA in vivo or it cannot fold properly.  To test these 
possibilities, another construct was generated by inserting 4 amino acids corresponding to a 
minimal Gro Interaction Motif, WRPW, between the Nuclear Localization Sequence and the HA 
tag of BrkNLS to produce BrkNLSW (Fig 24A, 16D).  The WRPW motif has been shown to 
function as a repression motif via recruitment of the co-represssor Groucho (Aronson et al., 
1997; Fisher et al., 1996).  Addition of the WRPW repression motif confers considerable activity 
to BrkNLSW, although not as strong as that of wild type Brk.  UAS-brkNLSW; C765 flies have a 
significant reduction in the size of the wing blade (Fig. 24B) and there is loss of posterior wing 
tissue in en-Gal4 animals (Fig. 24B).  Furthermore, analysis of UAS-brkNLSW; en-Gal4 wing 
discs revealed that sal is completely repressed and omb partially repressed (Fig. 24D).  The 
ability of BrkNLSW to repress sal more effectively than omb is similar to the repression profile 
observed with wild type Brk protein.  In contrast, BrkNLSW cannot repress Vg-QE expression 
(Fig. 24E), but can strongly repress UbxB expression in the embryonic midgut mesoderm (Fig. 
24C).  Moreover, BrkNLSW, a protein possessing only the GiM was also not able to repress salE1 
but rather activated this reporter, similar to other truncated proteins (Fig. 24F).  
 
2.4.8.3.5 Brk protein possesses an additional repression domain/motif, 3R, between the 
DNA binding domain and the CiM 
 
 As shown previously, BrkNLS does not possess repressor activity in this assay, but BrkF138 
has considerable activity (Section 2.5, Fig. 12C,D), suggesting that the region lying between the 
DNA binding domain and the CtBP Interaction Motif (CiM) must contain an additional  
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Figure 24. Misexpression of UAS-brkNLSW in the developing wing and embryo. 
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 Figure 24. Misexpression of UAS-brkNLSW in the developing wing and embryo. 
 
(A) Schematic of HA-tagged BrkNLSW, a protein truncated immediately after the DNA binding  
domain that contains a nuclear localization sequence and a Groucho interaction motif (GiM), 
WRPW.  (B) Adult wing phenotype.  NLSW, a protein identical to NLS, but has the GiM added, 
has significant activity resulting in loss of wing tissue and veins.  (C) NLSW represses UbxB 
reporter gene expression in embryos.  (D-F) Analysis of sal, omb, vg-QE and salE1 expression.  
(Di-iv) Misexpression of NLSW in the posterior of wings discs using en-Gal4 results in complete 
repression of sal (green) and almost complete repression of omb (red, arrow).  (Ei-iii) NLSW has 
no effect on vg-QE expression when misexpressed in the posterior.  (Fi-iii) NLSW activates 
salE1 reporter gene expression in the posterior of wing discs, similar to NLS. 
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 repression domain.  To test this possibility, BrkStop1 a protein similar to BrkF138, being truncated 
immediately before the CiM and lacking the GiM (residue 377) (Fig. 25A, 16D), was produced 
to verify that any activity from BrkF138 was not due to read through of the stop codon.  At 20°C, 
UAS-brkStop1; C765 animals have significantly reduced wing size and misexpression in the 
posterior compartment with en-Gal4 reduces the amount of posterior wing tissue (Fig. 25B).  
Furthermore, misexpression of BrkStop1 in the posterior of wing discs at 25°C results in complete 
repression of target genes omb, sal and Vg-QE (Fig. 25E,F).  When larvae were reared at 20°C to 
reduce the expression of the transgene, omb was still almost completely repressed with some 
weak expression present in the posterior (Fig. 25Di).  However, at 20°C, sal was strongly 
expressed in the posterior adjacent to the A/P boundary, but did not extend laterally compared to 
its endogenous expression domain (Fig. 25Dii).  These findings show that BrkStop1 represses omb 
more effectively than sal and therefore is the opposite of wild type Brk repression of these target 
genes.  In addition to repression of omb and sal, BrkStop1 also represses UbxB and vg-QE 
reporters (Fig. 25C,F).  In fact, BrkStop1 can repress UbxB more efficiently than BrkNLSW (Fig. 
24D) and vg-QE better than wild type.  Misexpression of BrkStop1 in the posterior of wing discs 
activated expression of salE1 throughout the posterior wing pouch as well as in the hinge and 
notum (body wall) (Fig. 25G).  
 
2.4.8.3.5.1 Identification of the 3R repression domain 
 To identify the specific region between the DNA binding domain and the CiM required 
for repressor activity, a series of progressively smaller Brk truncations were generated (Fig. 26A, 
16D).  Truncations of the region between the DNA binding domain and the CiM revealed BrkA 
as the shortest protein with repressor activity.  BrkA is truncated at residue 206 (Fig 26A) and has  
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Figure 25. Misexpression of UAS-brkStop1 in the developing wing and embryo. 
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Figure 25. Misexpression of UAS-brkStop1 in the developing wing and embryo. 
 
(A) Schematic of HA-tagged BrkStop1, a protein truncated before the CiM and GiM.  (B) Adult 
wing phenotype.  Stop1 has significant activity, resulting in loss of wing tissue and veins with 
both Gal4 drivers.  (C) Misexpression of Stop1 in the embryonic mesoderm completely represses  
UbxB reporter expression.  (D-G) Analysis of sal, omb, vg-QE and salE1 expression in wing 
discs.  (Di-iv) Misexpression of Stop1 in the posterior of wing discs at 20°C results in an almost 
complete loss of omb (red)  (there is some residual expression, arrow in i), whereas sal is still 
expressed at high levels in the posterior (green-arrow in ii).  (Ei-iv)  At 25°C, Stop1 represses sal 
and omb completely.  (Fi-iii)  Stop1 almost completely represses vg-QE expression in the 
posterior at 25°C.  (Gi-iii) Misexpression of Stop1 in the posterior of wing discs results in 
activation of salE1 reporter rather than repression. 
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 repressor activity similar to BrkStop1 (Fig 16D).  At 25°C, UAS-brkA ; C765 adults have smaller 
wings compared to wild type and there is a significant loss of posterior wing tissue using en-Gal4 
(Fig. 26B).  BrkA contains three distinct sequences: a poly-glutamine stretch, a histidine rich 
region and a poly-alanine stretch (Fig. 26A).  All of these sequences may be important for this 
region to act as a repressor domain, but no single region alone is capable of repressor activity. 
Similar to BrkStop1, misexpression of UAS-brkA in the posterior of wing discs activated 
expression of salE1 throughout the posterior wing pouch as well as in the hinge and notum (Fig. 
16D) 
 Truncation of Brk at residue 173 (BrkA2), eliminating the poly-alanine region and some 
unique sequence at the C-terminus, produces a protein with minimal repressor activity (Fig. 16D) 
as shown by the nearly wild type wings following misexpression with both C765 and en-Gal4 
drivers at 30°C (Fig 26B).  The wings have a few excess veins surrounding vein V and some 
excess tissue with en-Gal4.  In addition, sal and omb expression are not repressed by BrkA2 (Fig 
16D).  UAS-brkC produces a protein truncated at residue 140, to eliminate the histidine rich 
region, and renders a nearly inactive form of the protein with excess veins and tissue, when 
misexpressed in the wing using C765 and en-Gal4 (Fig 26B).  In fact, BrkC seems to be acting as  
a dominant negative demonstrated by the excess wing tissue and blistery appearance present in 
the posterior of the wing.  Interestingly, both BrkA2 and BrkC were able to activate salE1 reporter 
gene expression, not repress its expression (Fig. 16D).  
 
2.4.8.3.5.2 Dissection of the region between the DNA binding domain and the CiM 
To further dissect the region between the DNA binding domain and the CiM required for 
repressor activity, a series of additional constructs were generated containing portions of this  
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Figure 26. Misexpression of UAS-brkA, UAS-brkA2 and UAS-brkC in the developing wing. 
 
(A) Schematic of HA-tagged proteins, BrkA, BrkA2 and BrkC containing progressively smaller 
truncations that includes the 3R repressor domain, includes a portion of 3R or does not include 
3R, respectively.  (B) Phenotype of adult wings following misexpression with enGal4 and C765.  
BrkA has significant repressor activity resulting in a reduction of wing tissue and/or loss of wing 
veins.  In contrast, BrkA2 has minimal repressor activity, whereas BrkC expression results in 
excess wing tissue formation, and thus appears to be acting as a dominant negative. 
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 region attached to the DBD + NLS.  UAS-brkEA contains the DBD/NLS plus residues 152 to 377 
(Fig. 27A, 16D) and produced a protein with intermediate to high levels of activity demonstrated 
by misexpression at 20°C with en-Gal4 and C765.  UAS-brkEA; en-Gal4 adult wings are notched 
at the distal posterior portion of the wing (Fig 27B), and at 25°C, many of the animals died as 
pharate adults.  In addition, UAS-brkEA; C765 animals have smaller wings when reared at 25°C 
and fusion of veins II and III and IV and V when reared at 20°C (Fig. 27B). Another protein 
BrkEC, contains the DBD/NLS plus residues 151 to 228 (Fig. 27A, 16D) with no poly-glutamine 
region and this protein had considerable activity, suggesting the poly-glutamine region is not 
required for repressor activity.  At 25°C, UAS-brkEC; en-Gal4 produced wings with missing 
posterior tissue (Fig. 27B). However, misexpression with C765 produced predominantly wild 
type wings at 25°C (Fig. 27B).  Misexpression of UAS-brkEC (30°C) in the posterior of wing 
discs revealed that both omb and sal are repressed in the posterior compartment, with low levels 
of omb and sal detected near the A/P border (Fig. 27C).  In common with BrkStop1, BrkEC 
activated salE1 reporter gene expression rather than repressing its expression (Fig. 16D).  In 
contrast, two additional transgenes UAS-brkED and UAS-brkEF containing the DBD/NLS plus 
residues 200 to 377 and 253 to 377, respectively produced proteins with no significant repressor 
activity.  In fact, misexpression of UAS-brkED and UAS-brkEF using the en-Gal driver (25°C) 
produced adult wings with excess posterior tissue (blistery) indicative of a dominant negative 
effect (Fig. 27B) rather than any true repressor activity. 
 Several transcriptional repressors have poly-alanine tracts, some of which reside in 
regions known to act as repression domains (Gerwin et al., 1994; Han and Manley, 1993a; Han 
and Manley, 1993b; Licht et al., 1994).  To determine the importance of the poly-alanine tract, 
the 17 alanine residues (173-189) from BrkStop1were deleted, producing BrkStop1∆A17 (Fig. 28A, 
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Figure 27. Misexpression of UAS-brkEC, UAS-brkEA, UAS-brkED, UAS-brkEF in the 
developing wing. 
 
(A) Schematic of HA-tagged proteins, BrkEC, BrkEA, BrkED, and BrkEF containing the DBD, NLS 
plus different portions of the region between the DBD and CiM.  (B) Phenotype of adult wings 
following misexpression with enGal4 and C765.  BrkEC has moderate repressor activity and 
results in a reduction of wing tissue and/or loss of wing veins with enGal4.  BrkEA, contains 
almost the entire region between the DBD and CiM has significant activity, and results in loss of 
wing tissue and fusion of veins with en-Gal4 and C765, respectively.  BrkED and BrkEF do not 
possess repressor activity, but rather possess a dominant negative activity.  (Ci-iii) BrkEC 
partially represses both sal (green, arrow) and omb (red, arrow) when misexpressed in the 
posterior of wing discs with en-Gal4. 
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 16D) that still had considerable repressor activity (Fig. 16D).  In fact, BrkStop1∆A17 repressed both 
sal and omb in the posterior of wing discs (Fig. 16D).  On the other hand, deletion of the poly-
alanine stretch along with additional sequence on either side (residues 148-200) to make 
BrkStop1NA results in the loss of repressor activity (Fig. 16D, 28B).  Analysis of UAS-brkStop1NA; 
en-Gal4 wing discs revealed that neither sal nor omb were repressed in the posterior (Fig 28C) 
suggesting that the deleted region confers repressor activity.  Misexpression of both BrkStop1∆A17 
and BrkStop1NA in the posterior of wing discs resulted in activation of salE1 reporter gene 
expression rather than repression (Fig. 16D). 
 Based on the above analysis, the region of Brk protein corresponding to residues 151-206 
is the minimal region sufficient to confer repressor activity and has been named 3R (Winter and 
Campbell, 2004) for the third repression domain in addition to the CiM and GiM (Fig. 16Ai).  
The 3R region consists of a histidine rich region, a stretch of poly-alanine residues and additional 
unique sequence at the C-terminal end.  Further analysis of this region is necessary to determine 
essential sequences in this region, as it appears the poly-alanine stretch may not be absolutely 
required for repressor activity as demonstrated with BrkStop1∆A17 (Fig. 28B).  Additional support 
that the poly-alanine region in 3R is not acting as an autonomous repressor region comes from 
analysis of another construct UAS-brkNLSA17 (fusion of 17 alanines to BrkNLS)(Fig. 28A, 16D). 
BrkNLSA17 also did not possess repressor activity as shown by predominantly wild type wings 
upon misexpression with either en-Gal4 or C765 (Fig. 28B).   
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Figure 28. Misexpression of UAS-brkStop1∆A17, UAS-brkStop1NA and UAS-brkNLSA17 in the 
developing wing. 
 
(A) Schematic of HA-tagged Brk proteins. BrkStop1∆A17, BrkStop1NA and BrkNLSA17 containing a 
deletion of poly-alanine region, deletion of 3R region and addition of poly-alanine region to 
NLS, respectively.  (B) Phenotype of adult wings following misexpression with enGal4 and 
C765.  Stop1∆A17 has significant activity resulting in loss of wing tissue and veins, whereas 
Stop1NA and NLSA17 do not have detectable repressor activity.  (Ci-v) Analysis of sal and omb 
expression.  Misexpression of Stop1NA in the posterior of wing discs does not repress sal or 
omb expression. 
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 2.4.8.3.6 Brk containing only the CiM has significant activity 
BrkStop1NA, a protein truncated immediately before the CiM and deletion of the 3R region, 
did not possess repressor activity. However, addition of 10 amino acids to include the CiM to 
BrkStop1NA, produced BrkStop1NAC (Fig. 29A, 16D) that had considerable activity following 
misexpression with en-Gal4 and C765 at 25°C (Fig 29B), with posterior wing tissue missing and 
additional cross veins, respectively.  Moreover, BrkStop1NAC almost completely repressed sal, 
whereas omb is somewhat repressed in wing discs (Fig. 29C).  Therefore, BrkStop1NAC behaves in 
a similar manner to wild type Brk, as it was more effective at repressing sal compared to omb.  
In contrast, BrkStop1NAC was not capable of repressing salE1.  In fact, this truncated protein like 
other truncated forms of Brk actually activated salE1 reporter gene expression (Fig. 16D). 
 
2.4.8.3.7 Inactivation of a single repression domain/motif decreases Brk activity 
 To determine if the loss of a single repression domain/motif of Brk reduced its activity in 
comparison to wild type, a series of constructs mutating or deleting repression domains were 
generated.  Mutation of the CiM from residues PMDLSLG to AMAAALA produced BrkCM (Fig. 
30A, 16D) that possessed significant repressor activity demonstrated by misexpression in the 
wing.  UAS-brkCM; en-Gal4 animals have almost a complete loss of posterior wing tissue at 25°C 
and loss of wing veins IV and V at 20°C (Fig. 30B).  At 25°C UAS-brkCM; C765 flies have very 
small wings and at 20°C wing are somewhat smaller with fusion of wing veins II and III as well 
as IV and V (Fig. 30B). 
Mutation of the GiM from FKPY to FAAA or deletion of the GiM to produce BrkGM and 
BrkGD, respectively also rendered proteins with significant repressor activity, having similar 
adult wing phenotypes as those described for BrkCM, but slightly more severe (Fig. 30B).  In   
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Figure 29. Misexpression of UAS-brkStop1NAC in the developing wing. 
 
(A) Schematic of HA-tagged BrkStop1NAC, a protein truncated immediately after the CiM, but has 
the 3R repression domain region deleted.  (B) Phenotype of adult wings.  BrkStop1NAC has 
significant repressor activity resulting in a loss of wing tissue and veins when misexpressed 
withenGal4 and C765.  (Ci-iv)  At 25°C, Stop1NAC, which possesses only a CiM, completely 
represses sal (green) and almost completely represses omb (red, arrow). 
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Figure 30. Misexpression of UAS-brkCM, UAS-brkGD and UAS-brkNA in the developing 
wing. 
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 Figure 30. Misexpression of UAS-brkCM, UAS-brkGD and UAS-brkNA in the developing 
wing. 
 
(A) Schematic of HA-tagged proteins BrkCM, BrkGD, and BrkNA which contain a mutated CiM, 
deleted GiM and deleted 3R, respectively.  (B) Phenotype of adult wings.  CM and GD, 
containing mutation of the CiM or deletion of the GiM, produce proteins with significant 
repressor activity resulting in loss of wing tissue and veins when misexpressed using enGal4 or 
C765, even at lower temperatures (17°C or 20°C).  BrkNA also has significant activity resulting 
in a reduction of wing tissue and fusion of wing veins.  (C-D) Analysis of salE1 reporter 
expression.  Misexpression of CM and GD in the posterior of wing discs results in almost 
complete repression of salE1 reporter expression at 20°C. 
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 addition, deletion of the 3R region (residues 148-200) forming BrkNA also produced a protein 
with comparable activity to the other proteins having mutations/deletions to a single repression 
motif (Fig 30B).  However, in contrast to the activity of wild type Brk3PF3 (Fig. 19B), flies did 
survive to adults following misexpression of each of these single mutant transgenes with en-Gal4 
at 20°C, demonstrating each protein was less active than wild type Brk protein.  Additional 
analysis revealed each of the above mentioned proteins could repress sal and omb, but 
expression levels of each target gene were too similar to each other and to that seen in the 
presence of wild type protein to make any distinctions (data not shown).  Analysis of BrkCM, a 
full-length protein with the CiM mutated, revealed that it could repress salE1 reporter expression 
in the posterior of wing discs (Fig.30C).  In addition, BrkGD, a full-length Brk protein with the 
GiM deleted, was also capable of repressing salE1 (Fig 30D). Mutations similar to those 
generated in CM and GM result in the loss of Gro and CtBP binding in other studies (Hasson et 
al., 2001; Zhang and Levine, 1999) 
 
2.4.8.3.8 Inactivation of multiple repression domains/motifs also decreases the activity of 
Brk 
 
 Subsequent analysis of the effect of mutation and/or deletion of multiple repression 
domains/motifs revealed that each protein had reduced activity compared to wild type Brk, but 
had similar activity levels as the single mutations/deletions.  The following constructs were 
generated: UAS-brkCMGM, with mutations of the CiM and GiM listed previously; UAS-brkNACM, 
containing a deletion of the 3R region (residues 148-200) and mutation of the CiM; and UAS-
brkNAGM, with a deletion of the 3R region and mutation of the GiM (Fig. 31A, 16D).  When each 
of these transgenes was misexpressed using en-Gal4, adults survived only with BrkCMGM at 25°C  
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Figure 31. Misexpression of UAS-brkCMGM, UAS-brkNACM and UAS-brkNAGM in the 
developing wing. 
 
(A) Schematic of HA-tagged proteins BrkCMGM, BrkNACM, and BrkNAGM containing mutated CiM 
and GiM, deleted 3R and mutated CiM, and deleted 3R and mutated GiM, respectively.  (B) 
Phenotype of adult wings.  Misexpression of these modified Brk proteins using enGal4 and C765 
results in significant loss of wing tissue and veins demonstrating that each of the proteins still has 
significant repressor activity.  (Ci-iii) Analysis of salE1 reporter expression.  Misexpression of 
CMGM in the posterior of wing discs results in activation of salE1 reporter expression rather 
than repression.  
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 and the flies contained wings with significant, almost complete loss of posterior wing tissue (Fig. 
31B).  At 20°C, adults survived following misexpression of all three transgenes, but once again 
the posterior portion of the wing tissue was missing (Fig. 31B).  On the other hand, 
misexpression of transgenes using C765 produced animals with small wings at 25°C for all three 
double mutations/deletions (Fig. 31B).  These results confirm that Brk protein containing 
multiple mutations/deletions of repression domains/motifs still have significant repressor 
activity, indistinguishable from proteins with a single mutation or deletion.  Interestingly, 
mutation of both the CiM and GiM significantly reduced the ability of BrkCMGM to repress salE1, 
suggesting that either an intact CiM or GiM are required for repression of this reporter (Fig. 
31C). 
 
2.4.8.3.9 Brk must possess a fourth repression domain/motif 
 The experimental data discussed thus far demonstrate that Brk requires a functional DNA 
binding domain, plus at least one repression domain/motif to confer repressor activity.  
Furthermore, if 3R, the CiM and GiM are the only repression domains/motifs present in the Brk 
protein, then mutation or deletion of all three simultaneously should render the protein inactive.  
To test this hypothesis, UAS-brk3M was generated that contains previously mentioned mutations 
in the CiM and GiM as well as a deletion of the 3R region (residues 148-200) (Fig 32A, 16D).  
Misexpression of UAS-brk3M using both en-Gal4 and C765 produced adults at 25°C containing 
missing posterior wing tissue and smaller wing size (Fig. 32B), respectively, not the anticipated 
wild type wing observed with an inactive form of the protein.  In addition, Brk3M repressed sal, 
omb and Vg-QE in wing discs (Fig. 32C,D). Consequently, since Brk3M still possessed 
significant repressor activity, there must be at least one additional repression domain/motif in  
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     Figure 32. Misexpression of UAS-brk3M in the developing wing.  
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Figure 32. Misexpression of UAS-brk3M in the developing wing. 
 
(A) Schematic of HA-tagged protein, Brk3M containing mutations in the CiM and GiM, and 
deleteion of the 3R region.  (B) Phenotype of adult wings.  Although the 3R region is deleted and 
the CiM and GiM are mutated, 3M still had significant activity resulting in a loss of wing tissue 
and veins.  (C-E) Analysis of sal, omb, vg-QE and salE1 expression.  (Ci-iv) Misexpression of 
3M in the posterior of wing discs with enGal4 (30°C) results in complete repression of sal 
(green) and omb (red).  (Di-iii) Brk3M can almost completely repress vg-QE expression in the 
posterior of wing discs.  (Ei-iii) In contrast, 3M cannot repress salE1 reporter expression; but 
rather it activates salE1. 
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 Brk.  Further analysis of the ability of Brk3M to repress salE1 revealed a predominantly full-
length form of Brk protein that activated salE1 reporter rather than repressed its expression (Fig. 
32E).  These data suggest either the CiM or GiM may be required to repress salE1, since 
BrkCMGM was also not able to repress this reporter. 
 
2.4.8.3.9.1 Identification of putative fourth repression domain/motif 
 In an attempt to identify the fourth repression domain/motif, successive truncations of 
Brk3M revealed UAS-brkStop2NACM (Fig. 33A, 16D) as the shortest protein with repressor activity 
even though it was truncated before the GiM, the CiM was mutated and 3R region was deleted.  
UAS-brkStop2NACM; en-Gal4 (25°C) animals have wings with posterior tissue missing (Fig 33B), 
whereas UAS-brkStop2NACM; C765 (25°C) flies have extra cross veins or fusions between veins II 
and III, IV and V; or complete loss of veins III and V. (Fig. 33B).  Analysis of gene expression 
in wing discs stained for sal and omb revealed complete repression of both sal and omb (Fig. 
33C).  In contrast, BrkStop2NACM was not able to repress salE1, but similar to other truncated Brk 
proteins activated this reporter (Fig. 16D).  BrkStop2NACM is truncated immediately before the 
GiM and is identical to BrkStop1NA with the exception of the region between the CiM and the 
GIM.  Therefore, additional constructs were generated to confirm if this region between the CiM 
and GiM was in fact the fourth repression domain.  BrkNLS4R has the region between the CiM and 
the GiM (residues 383-453) fused to the DNA binding domain plus an NLS (Fig. 33A, 16D).  
This protein has an intermediate level of activity shown by adult wings having the distal 
posterior wing tissue missing (en-Gal4) and fusion of wing veins II and III (C765) at 25°C.  
Misexpression of UAS-brkNLS4R in the posterior of wing discs revealed that sal was more 
repressed than omb (Fig. 33D).  However, BrkNLS4R was not able to repress salE1 but rather  
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Figure 33. Misexpression of UAS-brkStop2NACM, UAS-brkNLS4R and UAS-brk∆4R in the 
developing wing. 
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 Figure 33. Misexpression of UAS-brkStop2NACM, UAS-brkNLS4R and UAS-brk∆4R in the 
developing wing. 
 
(A) Schematic of HA-tagged proteins, BrkStop2NACM, BrkNLS4R and Brk∆4R.  Stop2NACM is 
truncated immediately before the GiM and has a mutated CiM and deleted 3R region.  NLS4R 
contains N-terminal 104 aa, NLS plus the region between the CiM and GiM, and ∆4R has a 
deletion of the region between the CiM and GiM.  (B) Phenotype of adult wings.  At 25°C, 
Stop2NACM has significant activity resulting in a loss of wing tissue and veins when 
misexpressed with both enGal4 and C765.  NLS4R also has considerable activity resulting in a 
loss of wing tissue with enGal4.  Brk∆4R, like other single mutations/deletions, has significant 
activity shown by a reduction of wing tissue and loss of veins.  (C-D) Analysis of sal and omb 
expression.  (Ci-iv) Misexpression of Stop2NACM in the posterior of wing discs (iii) at 30°C 
results in a complete loss of sal (green) and omb (red) expression.  (Di-iv)  NLS4R can partially 
repress expression of sal (green) and omb (red) in the posterior. 
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 activated reporter expression (Fig. 16D). Previously mentioned experiments revealed that 
mutation or deletion of a single repression domain/motif reduced the activity of the protein 
compared to that of wild type Brk.  When the region between the CiM and GiM is deleted 
(Brk∆4R), the protein still possesses significant activity as demonstrated by misexpression using 
en-Gal4 and C765, with the posterior wing tissue missing and smaller wing size, respectively 
(Fig. 33B).   
In an attempt to identify the residues between the CiM and GiM responsible for the 
repressor activity, a series of truncations of BrkStop2NACM were generated producing the following 
transgenes: UAS-brkS2NACM1 (truncated at residue 390); UAS-brkS2NACM2 (truncated at residue 
424) and UAS-brkS2NACM3 (truncated at residue 445) (Fig. 34A, 16D).  Each of the transgenes 
was misexpressed in the wing using en-Gal4 resulting in wings with posterior tissue missing as 
well as a blistery appearance near vein V for BrkS2NACM1; a loss of posterior tissue at the distal tip 
for BrkS2NACM2 and a severe loss of posterior tissue and fusion of veins IV and V for BrkS2NACM3 
at 25°C (Fig 34B).  In addition, ubiquitous expression of the transgene (C765) in the wing 
produced a slightly smaller wing and partial loss of vein II for BrkS2NACM1; extra veins near vein 
V for BrkS2NACM2 and extra veins near vein V as well as a very slight excess portion of vein II for 
BrkS2NACM3 (Fig 34B).   
If this region is the fourth repression domain, then the protein should no longer possess 
repressor activity if the 3R region as well as the region including the CiM through the GiM were 
deleted (residues 377-464).  Brk4M (Fig. 35A, 16D) contains both of these deletions and renders 
an inactive form of the Brk protein based on predominantly wild type appearance of adult wings 
(Fig. 35B).  There are, however, some ectopic wing veins in the proximity of vein V (en-Gal4) 
that could be due to a dominant negative effect of this protein.  Initial attempts to determine the  
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Figure 34. Misexpression of UAS-brkS2NACM1, UAS-brkS2NACM2 and UAS-brkS2NACM3 in the 
developing wing. 
 
(A) Schematic of HA-tagged proteins, BrkS2NACM1, BrkS2NACM2 and BrkS2NACM3 containing 
progressively larger truncations within the putative 4R region.  (B) Phenotype of adult wings.  
Misexpression of the truncated Brk proteins in the posterior (enGal4) or ubiquitously (C765) 
results in varying phenotypes; S2NACM1 has a dominant negative activity, S2NACM2 has 
moderate activity with loss of distal most posterior tissue with enGal4, and S2NACM3 has 
significant activity, with almost complete loss of posterior tissue with enGal4. 
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Figure 35. Misexpression of UAS-brk4M in the developing wing and overexpression in 
larval salivary glands. 
 
(A) Schematic of HA-tagged protein, Brk4M with a deletion of the 3R region and deletion of the 
region including the CiM through the GiM.  (B) Adult wing phenotype.  Misexpression of 4M 
with enGal4 and C765 results in predominantly wild-type wings, suggesting the 4R region is the 
4th repressor domain of Brk.  (C-D)  Overexpression of wild-type Brk (3PF3) and 4M in salivary 
glands using a brk-Gal4 driver (3SB).  (Ci, Di) Expression of HA tagged proteins showing 
nuclear and membrane localization.  (Cii, Dii) Expression of endogenous Brk protein (Brk 
antibody). 
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 gene expression of sal and omb revealed that both sal and omb were not repressed by Brk4M (data 
not shown).  However, subsequent triple staining experiments for sal, omb and the HA tagged 
protein did not detect the HA epitope in wing discs.  Further analysis of Brk4M in larval salivary 
glands, where endogenous Brk is highly expressed, using a brk-Gal4 line to drive UAS-brk4M 
revealed expression of the HA epitope on Brk4M (Fig. 35Di) compared to staining using anti-
BrkR3 antibody which showed high gene expression of sal and omb revealed that both sal and 
omb were not repressed by Brk4M (data not shown).  However, subsequent triple staining 
experiments for sal, omb and the HA tagged protein did not detect the HA epitope in wing discs.  
Further analysis of Brk4M in larval salivary glands, where endogenous Brk is highly expressed, 
using a brk-Gal4 line to drive UAS-brk4M levels of endogenous Brk expression (Fig. 35Dii).  In 
contrast to Brk4M, wild type Brk3PF3, or any other modified Brk protein, showed high levels of 
expression using either the anti-HA antibody or the anti-BrkR3 antibody (Fig. 35Ci-ii).  These 
findings suggest that Brk4M is being expressed, but at low levels (multiple lines tested), and the 
HA antibody is not detecting this protein in wing discs.  The above data suggest that the region 
between the CiM and GiM serves as the fourth repression domain of Brk and has been named 
4R. 
 
2.5 Discussion 
 Dpp acts as a morphogen in the Drosophila wing and it is distributed in a medial to 
lateral gradient that in turn produces the lateral to medial Brk expression gradient, 
complementary to Dpp itself.  Dpp target genes sal and omb are repressed by Brk, and the lateral 
limits of their expression domain are determined by their sensitivity to Brk (Campbell and 
Tomlinson, 1999; Entchev et al., 2000; Jazwinska et al., 1999a; Minami et al., 1999; Muller et 
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 al., 2003; Teleman and Cohen, 2000).  Therefore, omb, which is less sensitive to Brk, is 
expressed in a wider domain compared to sal.  One of the key questions that the above study 
tries to address is: Why are some genes, such as sal, repressed by lower levels of Brk protein 
than others such as omb? The mechanism Brk uses to repress gene expression has been 
investigated to determine if it is the same for different Dpp target genes.  If the mechanism is the 
same for each gene, then the sensitivity observed between genes is simply quantitative and Brk 
would operate the same, but just more effectively at the more sensitive target genes and this 
could be achieved, for example, by sal having more binding sites or sites with higher affinity.  
On the other hand, if the mechanism is not the same for each gene, then the difference in the 
genes sensitivity may result from the ability of Brk to use different mechanisms to repress target 
genes.  Here we demonstrate Brk can in fact utilize different mechanisms to repress sal and omb. 
 
2.5.1 Brk does not appear to repress by simple competition 
 One of the most basic modes of transcriptional repression involves competition between a 
repressor and an activator for binding to DNA, when the repressor and activator have the same or 
overlapping binding sites in an enhancer common in prokaryotes.  It is reasonable to assume that 
a transcription factor, localized in the nucleus, should only require a DNA binding domain to 
bind DNA and compete for overlapping binding sites in an enhancer.  Possibly, the affinity of 
each protein could play a role in its ability to bind and “out compete” the other protein.  It has 
been shown that Brk contains an N-terminal sequence specific DNA binding domain (Fig. 16A) 
(Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller et al., 2002; Sivasankaran et al., 2000; 
Zhang et al., 2001b) and mutations in the DNA binding domain completely abolish repressor 
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 activity (Fig. 12A,B; 16B,C,D; 20) or reduce the activity demonstrating the DNA binding 
domain is absolutely required for Brk function. 
 Previous studies suggested Brk functions by simple competition with activators (Mad) for 
overlapping binding sites in vitro (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and 
Bienz, 2001).  The data presented herein argue against Brk functioning by simple competition.  
BrkNLS, a nuclear protein containing only the DNA binding domain cannot repress any of the Brk 
target genes tested in vivo in the wing (Fig. 22), as well as the UbxB reporter in embryos that 
possesses overlapping Brk and Mad binding sites which Brk and Mad can compete for in vitro 
(Kirkpatrick et al., 2001; Saller and Bienz, 2001).  BrkNLS can bind the UbxB enhancer in vitro 
(Fig. 23B), but one concern may be that BrkNLS cannot bind DNA in vivo.  However, BrkNLS 
actually activated salE1 (Fig. 22E), which was repressed by wild type Brk, providing strong 
evidence that this protein can bind DNA in vivo.  salE1 is activated in cells that are not 
expressing endogenous Brk, indicating BrkNLS is not acting as a dominant negative.  
Furthermore, misexpression of UAS-brkNLS in salE1MB123 wing discs did not activate 
expression (Fig. 22F), demonstrating the three Brk sites are required for repression or activation 
of the reporter, and providing even more evidence that brkNLS can bind DNA in vivo.  Therefore, 
it seems Brk cannot repress by competition, but requires additional repression domains/motifs.  
In addition, a variation of BrkNLS, BrkNLSW which is the same as BrkNLS except for the addition of 
four amino acids WRPW (Fig. 16D, 24A), shown to recruit the co-repressor Gro (Aronson et al., 
1997; Fisher et al., 1996), can repress the Dpp targets, sal and omb (Fig. 24D).  These data 
suggest that BrkNLS should also be able to bind DNA and repress target genes in vivo by 
competition, but this was not the case, so it argues against simple binding site competition as a 
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 mechanism for Brk repression.  Other studies just assume that overlapping binding sites alone 
are sufficient for simple competition. 
The N-terminal 104 amino acids are sufficient to allow Brk to bind to its normal targets, 
but the protein is unable to repress genes without an active repression domain such as that 
provided by the GiM and recruited by the WRPW motif.  An active repression domain may be 
required for the protein to access DNA in chromatin.  Therefore, Brk requires the DNA binding 
domain plus an active repression domain for its activity, and based on these data it appears that 
BrkNLS does fold properly. 
Although many repressors are thought to use competition as a mechanism based on in 
vitro binding studies, there is little direct support in eukaryotes that this occurs in vivo.  The 
present study provides in vivo evidence that a Brk protein consisting of a functional DNA 
binding domain and which is localized in the nucleus does not repress target genes in vivo, even 
those shown to contain overlapping binding sites for repressor and activator in vitro (UbxB) (Fig. 
23A).  One of the only in vivo studies providing evidence for competition showed that 
Drosophila embryonic repressor Krüppel (Kr) could repress a synthetic enhancer possessing 
overlapping binding sites with activators Dorsal and Bicoid (Nibu et al., 2003).  Kr uses CtBP as 
a co-repressor for repression, but repression in the Nibu study (2003) was CtBP independent. 
However, additional studies of Kr are necessary to determine if additional regions outside the 
DNA binding domain and CtBP interaction motif function as repressor domains (Licht et al., 
1990), similar to that of the 3R domain in Brk.  A region of Kr spanning amino acids 62-92 has 
been identified as a putative repressor domain (Nibu et al., 2003).  Overall, in prokaryotes, 
binding site competition in vivo has been demonstrated (Ptashne and Gann, 2001), but strong 
support is lacking in eukaryotic organisms for this phenomenon in vivo.  In vivo, multiple 
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 proteins form complexes that can activate or repress transcription, and so there is not just 
competition with a single transcription factor as in vitro.  Therefore, my studies question whether 
or not binding-site competition is really a mechanism of repression in eukaryotic organisms.  
 
2.5.2 Brk protein possesses at least three repression domains/motifs 
My in vivo studies argue strongly against Brk repressing target genes by simple 
competition for binding sites.  Therefore, Brk must contain repression domains/motifs that confer 
Brk with its repressor activity.  Previous studies have identified regions of Brk protein serving as 
interaction motifs for co-repressors CtBP and Groucho (referred to as the CiM and GiM) 
(Hasson et al., 2001; Saller and Bienz, 2001; Zhang et al., 2001b).  Interestingly, neither CtBP 
nor Gro is required for repression of a Brk target gene omb (Hasson et al., 2001).  Such a finding 
is consistent with data showing that brkF138, encoding a protein truncated before the CiM and 
GiM, is capable of repressing omb (Fig. 12Ciii).  Further support that the CiM and GiM are not 
required for repression of omb comes from analysis of truncated Brk proteins BrkStop1, BrkEC and 
BrkA which all repress omb even though they lack a CiM or GiM (Fig. 25D,E, 16D, 27C).  
However, other truncated Brk proteins that do not contain the 3R region of Brk or the other three 
repression domains (BrkA2, BrkStop1NA) (Winter and Campbell, 2004) cannot repress omb 
expression (Fig. 16D, 28C).  Furthermore, it is not known whether 3R can function as an 
autonomous repression domain outside of Brk or the positioning requirement for Brk sites and 
activator/promoter sites for the functioning of 3R.  Additional studies are necessary to answer 
these questions. 
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 2.5.3 Differential activity of Brk repression domains/motifs 
Brk contains three (probably four) repression domains/motifs, and this poses the question 
of why multiple repression domains are needed? Analysis revealed that the three Brk repression 
domains/motifs are not equivalent, as some domains are more effective at repressing some target 
genes, but not others.  In fact, wild type Brk protein, as well as those possessing only the CiM 
(BrkStop1NAC) and GiM (BrkNLSW), can repress both sal and omb, but they can repress sal more 
effectively than omb (Fig. 29C, 24D).  However, salE1 is repressed by wild type Brk (Brk3PF3), 
but salE1 cannot be repressed by truncated forms of Brk containing only the CiM (BrkStop1NAC) 
or the GiM (BrkNLSW) (Fig. 16D, 24F), showing this sal enhancer does not behave like the 
endogenous sal gene.  Each of the above mentioned truncated forms of Brk were able to repress 
endogenous sal.  The co-repressor CtBP can only function over short distances (Arnosti et al., 
1996; Gray and Levine, 1996; Gray et al., 1994), suggesting Brk and activator binding sites in 
salE1 may be located too far apart to be repressed by BrkStop1NAC.  In contrast, Gro is known as a 
long-range repressor (Barolo and Levine, 1997; Cai et al., 1996; Dubnicoff et al., 1997; Paroush 
et al., 1994), therefore, BrkNLSW should be able to repress salE1.  However, BrkNLSW was not able 
to repress salE1 either.  The inability of BrkNLSW to repress salE1 may be due to the artificial 
nature of this protein, where the GiM is situated very close to the DNA binding domain thereby 
causing a steric hindrance that interferes with long-range repression.  Many transcriptional 
repressors (e.g. Hairy family members) containing a GiM have the interaction motif located at a 
distance from the DNA binding domain (Fisher et al., 1996; Rushlow et al., 1989). 
Studies of CtBP and gro single mutant clones or double mutant clones revealed that Gro 
is required for repression of sal, and that CtBP can provide some activity for repression of sal in 
gro mutant clones, but the repression is limited (Fig. 13C).  However, neither CtBP nor Gro are 
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 required for repression of omb (Hasson et al., 2001).  Further analysis of CtBP and gro single 
and double mutant clones showed that in the absence of gro, there was some de-repression of 
salE1 reporter gene expression in the anterior, but the not in the posterior (Fig. 14C).  salE1 
expression was not affected in CtBP single mutant clones, but CtBP gro double mutant clones 
showed strong misexpression of salE1 in the wing pouch (Fig. 14D).  These findings suggest that 
Gro is required to repress the salE1 reporter due to the positioning of Brk sites and activator sites 
that are over 150 bp apart.  However, CtBP can partially repress in the absence of Gro. 
The third repression domain of Brk, 3R (Winter and Campbell, 2004), is sufficient for 
repression of omb (Fig. 12Ciii, 25D,E), as well as the UbxB enhancer in embryos (Fig. 25Cii),  
and to repress sal also.  However, this may be indirect (see below).  In fact, proteins containing 
only the DNA binding domain plus the 3R domain can repress omb better than sal, which is the 
opposite of wild type Brk or those proteins containing only the CiM or GiM (Fig. 29C, 24D).  
Even though 3R may appear to repress sal (Fig. 25D,E), the repression may be indirect because 
previous studies show that sal requires Omb to be expressed (del Alamo Rodriguez et al., 2004) 
and if omb is directly repressed by 3R, then sal expression would be eliminated as well.  For 
example, although sal is repressed by BrkStop1 at 25°C, it may be indirect because sal requires 
Omb and omb is completely repressed at this temperature (Fig. 25Eii) (del Alamo Rodriguez et 
al., 2004).  In contrast, most other proteins such as wild-type Brk and BrkNLSW, do appear to 
repress sal directly because for these proteins, sal expression is lost at lower Brk transgene 
protein concentration than omb, i.e. loss of omb cannot account for loss of sal.  Surprisingly, at 
20°C (BrkStop1) omb expression cannot be detected in some cells where sal is being expressed.  
Previous studies (del Alamo Rodriguez et al., 2004) as well as our own studies demonstrate that 
sal expression is completely dependent upon Omb, so the most plausible explanation for these 
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 findings is that omb is actually expressed in these cells, but the levels may be too low for 
detection with the omb-LacZ line used for the studies. 
 Analysis of the ability of 3R to repress Vg-QE produced confusing, contradictory results.  
In brkF138 mutant clones, there was expansion of Vg-QE expression suggesting that the 3R 
repression domain cannot repress this enhancer.  In contrast, BrkStop1 (a similar truncated protein) 
could effectively repress Vg-QE upon misexpression using the UAS/Gal4 system (Fig. 25F).  
One possible explanation for this discrepancy could be the high levels of expression achieved 
with the UAS/Gal4 system may have enabled repression of this target, compared to more 
physiological levels of brkF138 protein produced in the mutant clones which did not allow 3R to 
repress Vg-QE.  A previous study demonstrated ectopic expression of UAS-engrailed in the 
posterior of wing discs reduced expression of En protein (Tabata et al., 1995), similar to the 
reduction of Vg-QE expression when UAS-brkStop1 was misexpressed in the current study. 
 The ability of a single repression domain to be sufficient to repress a given target gene 
may rely on the positioning of Brk binding sites relative to activator sites (or promoter sites) of 
the target.  For example, the UbxB reporter contains overlapping Brk and Mad (activator) 
binding sites (Kirkpatrick et al., 2001; Saller and Bienz, 2001).  Moreover, an important Brk 
binding site may overlap with an activator site in the omb enhancer (Sivasankaran et al., 2000).  
In contrast, activator and Brk binding sites are separated in the cis-regulatory elements of the sal 
gene (Barrio and de Celis, 2004) and the salE1 enhancer (Fig. 9A).  Brk proteins containing only 
the 3R domain can repress omb and UbxB, but not sal or salE1. Clonal analysis of brkF138 mutant 
cells revealed BrkF138 was not able to repress salE1 reporter gene expression and there was 
ectopic salE1 expression in lateral clones (Fig. 14A).  In addition, truncated forms of Brk protein 
containing the 3R region (BrkStop1, BrkA, BrkEC) were also not able to repress salE1 reporter 
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 expression when misexpressed in the posterior of wing discs; rather they activated expression 
(Fig. 16D).  These results suggest that 3R can only repress over short distances rather than long 
range (over 150 bp) and that activator and Brk binding sites must overlap or be in close 
proximity for the 3R region to repress.  
 
2.5.4 Multiple repression domains of Brk protein 
 The current study has identified two additional regions of Brk protein that act as 
repression domains along with the previously identified CiM and GiM.  Why does Brk possess at 
least three, possibly four independent repression domains/motifs? There are two probable 
answers: qualitative, where different repression domains/motifs are required to repress different 
target genes and quantitative, where more domains/motifs confer increased repressor activity.  
There are several known transcription factors containing multiple repression domains, and they 
have multiple domains for either qualitative and quantitative reasons or both.  A prime example 
comes from the pair rule protein Runt in the Drosophila embryo that requires Gro to repress one 
stripe of the pair rule genes, even skipped (eve) and hairy but not to repress engrailed (Aronson 
et al., 1997).  In addition, the gap protein Knirps represses different stripes of eve, and requires 
CtBP to repress stripes 4 + 6, but not to repress stripes 3 + 7.  However, increasing the levels of 
Knirps enables it to repress stripes 4 + 6 without CtBP suggesting a quantitative rather than 
qualitative difference (Struffi et al., 2004).  Furthermore, the repressor activity of Eve protein is 
increased in the presence of Gro (Kobayashi et al., 2001). 
 As stated above, there are differences in the ability of the three repression domains/motifs 
of Brk to repress different target genes.  For instance, 3R is sufficient for repression of omb but 
not sal or SalE1.  But, either CiM or GiM seem to be able to repress both sal and omb (Fig. 29C, 
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 24D), so why does Brk need the 3R domain as well?  Brk seems to be completely active in its 
ability to repress omb in the absence of CtBP and Gro, and recruitment of both CtBP and Gro 
does not appear to increase Brk activity in terms of increased repression of omb.  If this was not 
the case, then the width of the omb expression domain should shift in brkF138 mutant cells, which 
do not have a CiM or GiM, or in CtBP/gro double mutant clones, but this does not happen 
(Hasson et al., 2001).  Therefore, the 3R domain may be more efficient than either CiM or GiM 
in repressing omb, thereby providing Brk with an appropriate level of activity to set up the omb 
domain in the correct position.   
 Brk must recruit either CtBP or Gro to repress some target genes such as sal (Fig. 13) and 
brk itself (Hasson et al., 2001), or just Gro for others such as Vg-QE (Hasson et al., 2001).  So, 
why does Brk even need to recruit CtBP?  Misexpression of Brk proteins with a mutation of CiM 
alone or in combination with a mutation or deletion of GiM and 3R show reduced activity 
compared to wild type (Fig. 16D).  However, there is no evidence for the specific role of CtBP 
for repression of any Brk target gene in the wing, as CtBP mutant clones do not have any effect 
on expression of known Brk targets in the wing (Fig. 13B) (Hasson et al., 2001).  Analysis of 
Brk sequences from four diverse insect species reveal that CtBP and Gro interaction motifs have 
been conserved for millions of years (Fig. 7) suggesting recruitment of CtBP must be important 
for Brk function.  Therefore, it is possible that CtBP is required for Brk function in other tissues 
outside the wing such as the embryo (Hasson et al., 2001) or for other unidentified Brk targets in 
the wing. 
 Transcriptional repression can act over either long or short distances with Gro acting via 
the former and CtBP the latter.  Consequently, it seems odd that Brk would recruit both co-
repressors based on these properties.  Presumably transcription factors would recruit either CtBP 
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 or Gro (Zhang and Levine, 1999), and it appears that recruitment of CtBP would provide the 
advantage of enabling a transcription factor to repress at a single enhancer without interfering 
with the activity of another closely positioned enhancer.  On the other hand, recruitment of Gro 
by a transcription factor at one enhancer may in fact interfere with the activity of a more distant 
enhancer, but such a simple model is not always the case (Nibu et al., 2001).  Experiments using 
chimeric repressors, containing the DNA binding domain from short-range repressors and Gro 
interaction sequences from the long-range repressor Hairy, revealed that long-range repression 
mediated by Gro (via Hairy) did not always produce the dominant inactivation of linked 
enhancers, suggesting that repressors need activators present to bind DNA (Nibu et al., 2001).  
Therefore, almost all transcription factors only recruit one co-repressor.  In addition to Brk, two 
other transcription factors, Hairy and Hairless, have been shown to recruit both CtBP and Gro.  
Surprisingly, CtBP seems to function as an antagonist of Gro when recruited by Hairy as 
compared to its standard function as a co-repressor (Phippen et al., 2000; Zhang and Levine, 
1999).  For Brk, all experimental evidence suggests that CtBP contributes to the repressor 
activity of Brk, not an antagonistic role.  In the case of Hairless, genetic evidence suggests that 
CtBP and Gro both confer repressor activity to the transcription factor (Barolo and Posakony, 
2002), but it is not known whether CtBP is required to increase the activity of Hairless, or if it is 
required for some targets that Gro is not able to completely repress. 
 Extensive analysis of the 3R region of Brk revealed that it is sufficient for normal 
repression of omb and UbxB, but not for complete repression of sal, suggesting this region is 
only sufficient when Brk sites are in close proximity to activation sites.  Further studies need to 
be completed to determine the binding site proximity requirements for the 4R region.  BrkNLS4R 
 114
 can repress both sal and omb partially, but has not been tested for its ability to repress the UbxB 
enhancer. 
 As stated previously, the best way to fully understand the function of each repression 
domain would be to replace endogenous brk with transgenes having one or two repression 
domains that have been mutated or deleted.  The current study analyzed the effects of 
misexpression of modified/mutated forms of Brk protein in regions where endogenous brk is 
normally not expressed.  Although this was not the ideal approach to use, great strides have been 
made in beginning to understand what regions of the protein are important for Brk repressor 
activity and more importantly, how each of these regions serve to act differentially on target 
genes. 
 
2.5.5 Requirement of CiM and/or GiM for repression of salE1  
Full-length forms of Brk protein containing mutation or deletion of the CiM or GiM 
(BrkCM and BrkGD) were capable of repressing salE1 expression (Fig. 30C,D).  On the other 
hand, mutation of both the CiM and GiM (BrkCMGM, Brk3M) produced proteins that were not able 
to repress salE1 expression (Fig. 31C, 32E), and Brk3M actually activated salE1 expression (Fig. 
32E).  Therefore, either the CiM or GiM are required for repression of salE1.  Based on the 
analysis of CtBP gro single and double mutant clones as well as the misexpression of mutated 
forms of Brk protein, it appears as if salE1 enhancer requires the recruitment of co-repressor Gro 
and possibly CtBP.  However, BrkStop1NAC was also not able to repress salE1, possibly due to the 
fact that CtBP cannot mediate long-range repression, and Gro recruitment is required for 
repression of this reporter.  If this were the case, BrkGD should not have repressed salE1 
expression, but it did (Fig. 30D).  Possible explanations for the inability of BrkStop1NAC to repress 
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 salE1 include: 1) artificial nature of the reporter construct or 2) there may be sequences in the C-
terminal region that work in conjunction with Gro/CtBP to repress this reporter.  Additional 
evidence to support the requirement for GiM (Gro) and/or CiM (CtBP) for repression of salE1 
comes from BrkCMGM, Brk3M and CtBP gro double mutant clones.  In each of these cases, CtBP 
and Gro are either not available for recruitment, or cannot bind to a mutated interaction motif, 
and salE1 cannot be repressed.  Similar to endogenous sal, repression of the salE1 reporter 
requires recruitment of a co-repressor to assist Brk.   
 
2.5.6 Importance of putative Brk binding sites in salE1 enhancer 
 Although wild type Brk (Brk3PF3) repressed salE1 expression and BrkStop1 and BrkNLS 
activated salE1, mutation of the three putative Brk binding sites present in salE1 (salE1MB123) 
have a different effect.  Mutation of the three binding sites results in expansion of expression into 
lateral regions of the wing pouch, and misexpression of each of the above mentioned transgenes 
in the posterior of the wing does not change the expression of salE1MB123 either by repressing 
or activating (Fig. 19Gi, 22Fi).  Therefore, one or more of the Brk binding sites contained in 
salE1 are important for the repressor activity of wild type Brk and activation by BrkStop1 and 
BrkNLS.  Additional analysis of the effect of mutation of each of these sites individually or in 
combination revealed that binding sites 1 and 2 are important for repression, but binding site 3 is 
a lower affinity site.   It is interesting to note that binding site 3 is the site not conserved between 
D.  melanogaster and D.  pseudoobscura (Fig. 9A). 
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 2.6 Conclusions 
In order for Brk to possess repressor activity in vivo, the protein must contain a functional 
DNA binding domain.  Moreover, Brk does not repress target genes simply by binding site 
competition, but rather it requires specific repression domains/motifs for its activity.  In addition 
to the CiM and GiM, Brk possesses two other independent repression domains/motifs designated 
3R and 4R, for third and fourth repression domains, respectively (Fig 36).  The 3R repression 
domain is sufficient for normal repression of omb and UbxB, but not sal.  The co-repressor, Gro 
is required for normal repression of sal and is sufficient even in the absence of CtBP.  However, 
in the absence of Gro, CtBP can provide partial activity for repression of sal, but it is not 
completely effective.  Whether a single repression domain is sufficient for Brk to repress a 
particular target gene may depend upon the positioning of Brk binding sites relative to activator 
sites.  For example, the UbxB reporter has overlapping Brk and activator (Mad) sites 
(Kirkpatrick et al., 2001).  In contrast, the cis-regulatory elements of sal suggest that Brk and 
activator binding sites are separated (Barrio and de Celis, 2004). 
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Figure 36. Repression of Dpp targets by Brinker. 
 
Brk does not repress genes simply by competition, but requires repression domains/motifs in 
combination with its DNA binding domain (DBD). Brk possesses four independent repression 
domains/motifs: the CtPB interaction motif (CiM), Groucho interaction motif (GiM), 3R and 4R.  
3R represses omb and UbxB, but not sal.  The CiM and GiM can repress sal, omb and UbxB. 
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2.7 Future Studies 
 Based on the above analysis, the 3R region of Brk seems to require Brk and activator 
sites to be located in close proximity for repression of target genes such as UbxB and omb.  In 
contrast, further analysis needs to be completed to determine the requirements for the 4R region 
of Brk and whether Brk and activator sites need to be in close proximity or if they can be 
separated. 
 Other experiments will attempt to answer some of the following questions.  To begin 
with, which repression domains are truly required by endogenous Brk for its repressor activity 
and why are these domains required?  Analysis of the functional domains of Brk relied on 
misexpression of the modified/mutated forms of the protein, in regions where Brk is not 
normally expressed, and comparison to wild type Brk.  To gain a more complete understanding 
of the role each of the repression domains plays in Brk function, the endogenous brk gene will be 
replaced with the modified/mutated forms of the protein allowing the requirements of each 
domain to be assessed.  The easiest way to replace endogenous brk, with the brk transgenes, 
would be to drive the transgenes with a brk-Gal4 line in a brk mutant background.  My attempts 
to replace endogenous brk in this manner were unsuccessful, and so another approach will have 
to be utilized.  The initial approach utilized deletion lines of the brk-Gal4 line, but none of the 
seven deletion lines isolated were able to rescue when crossed with wild-type (3PF3).  The 
deletion lines may have important enhancer/promoter elements missing/disrupted and do not 
drive brk expression enough to resuce the phenotype.  An alternate approach is to drive brk 
transgenes with a B14 genomic fragment, plus 320 bp of endogenous promoter region, plus brk 
coding region, shown to rescue a brk mutant (brkXA) (completed by M. Moser), but not brk null 
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 mutant, brkM68.  B14 is a 4.7 kb enhancer fragment, containing a 53 bp silencer region and 
enhancer region plus additional sequence, that drives brk expression in a pattern similar to 
endogenous brk (Muller et al., 2003).  Flies containing modified/mutated forms of Brk will be 
examined to see if they can rescue brkXA mutants (a hypomorphic allele). 
Analysis of BrkA and BrkEC narrowed the 3R region to include residue 151-206 and 
BrkA2 truncated at residue 173, indicating that 3R could be included in residues 173 to 206, or 
these residues work in combination with more N-terminal residues.  In contrast, the 4R domain 
has been narrowed down to only the region lying between the CiM and GiM (residues 383-452).  
To further analyze this region, smaller regions will be fused to DBD+NLS and their activity 
assayed in vivo as previously described.  To overcome the potential problems of the repressor 
domain being located too close to the DNA binding domain, it may be necessary to fuse smaller 
regions to BrkStop1NA (no repressor activity), i.e. a linker region between the DNA binding 
domain and repression domain might be necessary.  Moreover, do these regions contain short 
motifs for recruitment of co-repressors such as CtBP or Gro, or are they composed of larger 
regions that constitute autonomous repression domains or act as antagonists of activator 
proteins?  To evaluate the ability of 3R and 4R to function as autonomous repressor domains, 
each of the regions will be fused to heterologous DNA binding domains (e.g. Gal4) and assayed 
for their ability to repress reporter genes driven by enhancer or promoter regions with inserted 
UAS sites.  Spacing between the UAS sites and activator sites or the promoter (driving LacZ) is 
different for each reporter, enabling a determination of whether a particular region of a protein 
can act as a repression domain.  Moreover, this method may be able to distinguish whether the 
region acts by quenching activators or directly repressing the transcriptional machinery, as well 
as the distance over which it will act.  In addition, to assess whether the repression domains act 
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 as antagonists of activators, UAS sites can be introduced into enhancers that contain Mad 
binding sites.  Additional experiments will be completed to determine whether or not the 3R 
region can only repress targets when Brk and activator sites are in close proximity. 
 Since BrkNLSW was not able to repress salE1, it may be a result of the lack of spacing 
between the DNA binding domain and the GiM creating a smaller “artificial” protein.  Clonal 
analysis revealed that Gro was needed to repress the salE1 enhancer so it was thought that 
BrkNLSW should be able to repress salE1, but it did not.  However, would the addition of the 
WRPW motif to BrkStop1NA enable the truncated protein to repress salE1? Addition of the GiM to 
BrkStop1NA would allow for spacing between the DNA binding domain and the GiM.  However, 
this approach may not work either because BrkStop1NAC was not able to repress salE1. 
 In addition, larger enhancer regions may behave more like the endogenous sal gene, 
therefore the ability of brk mutants and modified/mutated forms of the Brk protein to repress 
could be tested using larger enhancer regions such as sal1.8 or even sal10.2.  Once the 
importance of different sites within the enhancer are determined, additional constructs can be 
generated that change the spacing between Brk sites and analyzed for the ability of wild type and 
modified/mutated forms of Brk to repress reporter gene expression.  Furthermore, additional Brk 
binding sites can be added to determine if these increase the ability of wild type and 
modified/mutated forms of Brk to repress expression.  Finally, a determination of the 
requirements for each Brk repression motif/domain (CiM, GiM, 3R and 4R) can be made in 
terms of the distance Brk and activator sites need to be for repression by each of the domains. 
Overall, this study revealed that Brk does not function identically to repress each of its 
targets.  The DNA binding domain is essential for Brk to repress target genes and the DNA 
binding domain alone is insufficient for repressor activity.  Contrary to previous suggestions, I 
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 demonstrated that Brk cannot repress simply by competing with activators, but requires specific 
repression domains (active repression) in combination with its DNA binding domain.  Brk 
possesses four independent repression domains, but these domains are not equivalent.  Thus, 
although sal and omb show quantitative differences in their response to Brk, this may actually be 
based more on qualitative differences in the mechanisms that Brk uses to repress them. 
Although the current study answered the question whether or not Brk functions 
identically to repress each of its targets, the analysis relied on ectopic expression of 
modified/mutated form of the Brk protein in regions where Brk is not normally expressed.  A 
better approach would be to replace the endogenous brk gene with modified/mutated forms of 
Brk to fully understand the role of each repression domain/motif in Brk function.  However, this 
approach requires a brk rescue construct that was not available when these studies were 
implemented.  Ectopic expression of modified/mutated brk transgenes using the Gal4/UAS 
system enabled me to identify two additional regions of Brk protein that function as independent 
repression domains.  
As mentioned, there are numerous experiments that need completed to determine how 
each repression domains/motifs of Brk functions to repress target genes.  However, the most 
important experiments would include those replacing endogenous brk with modified/mutated 
proteins forms of the protein and further analysis of the 4R region similar to that completed for 
the 3R region.  In addition, experiments to verify whether or not the 3R and 4R regions function 
as autonomous repression domains are extremely important. 
 
 
 
 122
 2.8 Materials and Methods 
2.8.1 Comparison of brinker sequences from insect species 
 
brinker sequences from Anopheles gambiae (accession number AY57899), Drosophila 
pseudoobscura (included in AADE01000981) and Bombyx mori (combination of AU004448 and 
AV402267) were obtained through BLAST searches of NCBI databases and compared to 
Drosophila melanogaster. 
 
2.8.2 Fly strains utilized for studies 
 The following alleles or transgenes were used: brkF124, brkF138, brkM68, CtBP87De-10, 
groE48, Vg-QE (P3-lacZ), hs-GFP (Avic\GFPhsT:Hsap\MYC), hs-flp (P{hsFLP}22), FRT18A 
(P{ry[+t7.2]=neoFRT}18A), FRT82B (P{neoFRT}82B, Ubi-GFP (P{Ubi-GFP(S65T)nls}3R), 
omb-lacZ (P{lacW}biPol-1), C765 (Scer\Gal4C-765), en-Gal4 (P{en2.4-Gal4}e16E), W1118, W1118 
P{ey-FLP.N}2; P{bossT:Arus/HRP}2, P{neoFRT}82B P{arm –LacZ.V}83B. 
 
2.8.3 Generation of in vitro mutated/modified UAS-brk transgenes 
Constructs containing modified/mutated forms of brk were generated by PCR 
amplification from brk cDNA (tmbNB14-2) and cloned into appropriate sites of pBluescript 
containing two copies of the HA epitope sequence to the C-terminus (pFlu3PRX).  The sequence 
is (GS/EF/RS)MAGNIYPYDVPDYA GYPYDVPDYAG and HA sequence is underlined.   Brk 
wild type and modified/mutated transgenes were cloned into pUAST vector (Brand and 
Perrimon, 1993) as KpnI/XbaI fragments for misexpression studies. 
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 Location of mutations, modifications or deletions are indicated in Figure 16.  To generate 
wild type brk, brk3PF3 , a HindIII/HindIII fragment from brk cDNA (Campbell and Tomlinson, 
1999; Jazwinska et al., 1999a) was cloned into HindIII cut pBluescript.  An EcoRI site was 
introduced at the end of the coding region by PCR, and a KpnI/EcoRI fragment (nt 1-2643) was 
cloned into pFlu3PRX to add the HA tag at the C-terminus.  An HA tagged version of 
endogenous brk mutant, brkF124, (containing an R82W substitution in the DNA binding domain), 
was generated by cloning a BsiWI/SpeI  (nt 67-1762) cut PCR product derived from brkF124 
genomic DNA into BsiWI/SpeI cut brk3PF3.  Primer pairs used to generate each of the 
modified/mutated forms of Brk protein can be found in Appendix 1.  C-terminal truncations of 
brk to produce Brk53, BrkS, BrkStop1, BrkA, BrkA2 and BrkC were generated by PCR using an 
external primer M13 forward (pBluescript) and internal primers flanked by EcoRI, BamHI or 
BglII restriction sites.  BrkStop1NA was generated by inverse PCR to remove the 3R region 
(deletion of residues 148-200 to a BglII site (RS)) using brkStop1 as template.  BrkStop1∆A17, and 
BrkStop1NAC were generated as indicated above, but template DNA was brkStop1NA or brkNA, 
respectively.  BrkStop2NACM, BrkS2NACM1, BrkS2NACM2 and BrkS2NACM3 were generated by PCR as 
indicated above using brk3M as template DNA that has the 3R region deleted and mutation of the 
CtBP interaction motif (CiM) from PMDLSLG to AMAAALA as a NotI site.  BrkNLS and 
BrkNLSW were generated by PCR using an internal primer flanked by the sequence of the Nuclear 
Localization Sequence (NLS) from SV40 T Antigen (Kalderon et al., 1984), PPKKKRKV, plus 
WRPW for BrkNLSW.  Constructs with regions of Brk protein attached to the BrkNLS were 
generated by cloning residues 151-228 for BrkEC, residues 152-377 for BrkEA, residues 200-377 
for BrkED, residues 253-377 for BrkEF and residues 383-453 for BrkNLS4R as BglII cut fragments 
into BamHI cut BrkNLS.  Mutations of CtBP and Groucho Interaction Motifs and deletions of 
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 internal regions (3R and 4R) were generated by inverse PCR using two internal primers flanked 
by restriction sites to change the sequence as indicated and religation of the PCR product.  BrkCM 
was designed to mutate the CiM from PMDLSLG to AMAAALA and create a NotI site, whereas 
BrkGM mutated the GiM from FKPY to FAAA and created a NotI site.  Mutations similar to 
those generated result in a loss of CtBP and Gro binding to Brk (Hasson et al., 2001; Zhang and 
Levine, 1999).  Cloning a SpeI/XbaI fragment from brkGM into SpeI/XbaI cut brkCM, to mutate 
the CiM and GiM, generated BrkCMGM.  BrkNA was generated by inverse PCR to remove amino 
acids 148-200 and replace with a BglII site (RS).  Brk3M was generated by inverse PCR using 
brkCMGM as template DNA to remove the 3R region in addition to mutation of CiM and GiM.  
BrkNACM and BrkNAGM were generated by inverse PCR to delete the 3R region using brkCM and 
brkGM as template DNA, respectively.  Brk∆4R was generated by inverse PCR to remove the 
region lying between the CiM and the GiM (residues 383-453) and replace with a BglII site (RS).  
Lastly, Brk4M was generated by inverse PCR to remove the CiM, GiM and the region lying in 
between (residues 377-464), using by brkNA as the template DNA for removal of the 3R region. 
 Transgenic flies were generated by injection of pUAST plasmid DNA (final conc. 
0.8µg/µl) containing each of the transgenes plus Turbo wingsclipped helper plasmid at a 
concentration of 1µg/µl into posterior of W1118 syncytial blastoderm embryos.  Injected embryos 
were incubated at 18°C, then room temperature in a humidity chamber until larvae emerged from 
vitelline membrane.  Larvae were collected and placed in food vials at 25°C until adults 
emerged.  Each individual Go fly was mated to 3 W1118 flies of the opposite sex, and the F1 
generation from each vial was screened for flies containing colored eyes indicative of 
transformation.   
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2.8.4 Clonal analysis and ectopic expression studies 
Homozygous mutant clones were generated in wing imaginal discs by hs-flp/FRT-
induced mitotic recombination (Golic and Lindquist, 1989).  Clones were generated in the 
second or early third instar of larvae by heat shock for 1 hour at temperatures ranging from 33°C 
to 37°C. 
hs-flp; FRT82B CtBPl(3)87De-10 groE48/FRT82B Ubiq-GFP (and the same for single mutant 
clones) Clones in discs were identified by loss of GFP. 
hs-flp: FRT82B CtBPl(3)87De-10 groE48/FRT82B arm-LacZ (and the same for single mutant clones) 
Clones in discs were identified by loss of lacZ staining.  
 Ectopic expression of UAS-transgenes was achieved by independently crossing 
transformant lines to two Gal-4 expressing lines; en-Gal4 (expressed in the posterior of the wing) 
and C765 (ubiquitous expression in the wing) (See section 2.4.8.1 for criteria). 
 
2.8.5 Reporter constructs 
salE1 is a 471 bp fragment at the 3′end of the sal1.8S/E fragment of Kuhnlein et al.  
salGCNB is a 285 bp fragment comprising the 5′ half of salE1.  salE1MB123 had the three 
putative Brk sites mutated from GGCGYY to GTCGYY using the Stratagene QuickChange Site-
Directed Mutagenesis Kit.  These fragments were cloned into the GFP reporter vector, pHSB, 
which is a modified version of the pH-Stinger vector (Barolo et al., 2000) in which two Brk 
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 binding sites in the hsp70 promoter have been mutated by inverse PCR.  UbxB is an 
ultrabithorax reporter construct, expressed in the embryonic midgut mesoderm (Thuringer et al., 
1993). 
 
2.8.6 Electrophoretic mobility shift assays (EMSAs) 
 brkNLS PCR fragment was cut with BglII/NotI and cloned into BamHI/NotI pET21a 
expression vector (Novagen).  Plasmid DNA was obtained using Qiagen QIAprep spin Mini Prep 
(Catalog #27104) Kit.  Protein was produced using Promega TNT quick Coupled 
Transcription/Translation System according to manufacturers instructions.   
 
2.8.6.1 Probe Preparation 
Equal molar ratios of UbxB oligos (25 pmol each) were mixed and annealed under the 
following conditions:  95°C 10 minutes; 65°C 15 minutes; 37°C 15 minutes, 23°C 15 minutes 
and 4°C for 1 hour to a final concentration of 50 pmol/µl.  UbxB probe was radiolabeled by 
Klenow extension of 3′ ends using α-32P CTP and unincorporated nucleotides were removed 
using BioRad P-30 gel spin columnsProbe sequences are as follows: 
5′  GACTCTGGACTGGCGTCAGCGCCGGCGCTTCCAGCT  3′ 
5′  GGCAGCTGGAAGCGCCGGCGCTGACGCCAGTCCAGA  3′ 
The following buffer (Mad buffer) was used in binding reactions (Xu et al., 1998): 
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 50 mM KCl, 20 mM HEPES, 1 mM DTT, 1 mM EDTA, 5 µg/ml poly[d(A-T)] , 10 0.25 mg/ml 
BSA, 4% Ficoll (To optimize BrkNLS binding, final concentration of 100 mM KCl was added for 
some experiments). 
2.8.6.2 EMSA reactions 
Briefly, EMSAs were performed by incubating in vitro translated BrkNLS with 1 µl 32P-labeled 
(10,000 cpm/µl) UbxB probe in 10 µl reactions.  For competition experiments, 10X or 100X of 
unlabeled probe was added to reaction.  Reactions were incubated for 20 min at Room Temp.  
The entire reaction was separated on a non-denaturing 4% polyacrylamide gel following standard 
protocol (Ausubel et al., 1993).  For supershift experiment, 0.5 µl of anti-HA antibody was 
added to the reaction and allowed to incubate for an additional 10 minutes.  The gels were dried 
and exposed to autoradiographic film. 
 
2.8.7 Immunostaining, X-gal staining and analysis of adult wings. 
Dissection and staining of wing imaginal discs was carried out by standard techniques.  Omb 
expression was detected using a lac-Z enhancer trap.  The following primary antibodies were 
used: anti-Sal (rabbit, 1:50) (Kuhnlein et al., 1994); anti-βgal (rabbit, 1:2000 Cappell) and 
chicken, 1:2000; Abcam); anti-HA (mouse, 1:1000; Covance). Secondary Antibodies included 
Alexa 488 (mouse, rabbit, rat) and Alexa 568 (minX) (rabbit) (Molecular Probes); and Cy2 
(chicken) Cy5 (mouse) (Jackson).  Embryos carrying the UbxB reporter were stained with X-gal 
by standard protocol; all embryos were fixed and stained along side each other.  Wings from 
adult flies were mounted in GMM. 
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3 Chapter 3:  Genome wide analysis of Drosophila protein kinases involved in nervous 
system development 
 
3.1 Abstract 
Protein kinases play important roles in many eukaryotic cellular processes including 
nervous system development.  Nervous system development in Drosophila progresses through a 
series of events including neuroblast specification, neuroblast formation, neurogenesis, 
development of nerve cells/glia, axon outgrowth and pathfinding and formation of precise 
connections with target cells.  The Drosophila genome contains approximately 13,000 genes and 
of these, there are approximately 229 protein kinase genes.  The availability of the sequenced 
genome makes it possible to conduct a focused search for kinases involved in nervous system 
development.  RNA interference (RNAi) was used to systematically knockdown the function of 
individual kinase genes and analyze the effect of each gene on the developing nervous system.  
Sequence specific primers were designed for 54 kinase genes and dsRNA corresponding to each 
of these genes synthesized.  Flies expressing neuronal specific GFP were injected with dsRNA 
and screened for kinase genes causing aberrant CNS and PNS development.  Of the 54 kinase 
dsRNA injected, 36 did not produce a nervous system phenotype, 13 produced a non-specific 
phenotype and 5 produced nervous system specific phenotypes.  The five candidate genes 
included Epidermal Growth Factor Receptor (CG10079), Mushroom Bodies Tiny (CG18582), 
Cyclin dependent kinase 2 (CG5363), C-terminal Src kinase (CG17309) and p21 activated 
kinase3 (CG14895). 
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 3.2 Introduction 
 
The fruit fly, Drosophila melanogaster has been a valuable model organism for genetic 
studies for close to a century.  Traditionally, the power of Drosophila genetics relied on forward 
genetic screens to identify genes that affect a given biological process (St Johnston, 2002).  
Forward genetic screens uncover many genes required for specific processes, but other genes can 
be missed due to limitations of the screening process.  For example, embryonic screens may not 
uncover some mutations because the genes are expressed during oogenesis by the mother and 
mask a mutation in the zygotic gene (St Johnston, 2002).  Patterning of the early embryo body 
axes is directed by mRNAs that are deposited in the oocyte by the mother and localized at the 
specific positions within the embryo (St Johnston and Nusslein-Volhard, 1992).  The genes 
providing the mRNA are known as the maternal effect genes as they are expressed in the mother 
rather than the embryo.  Recently, the availability of Drosophila genome sequences enables a 
reverse genetic approach to be utilized to determine the function of predicted classes of gene 
products.  Since many developmental processes as well as known human disease genes are 
conserved between flies and vertebrates (St Johnston, 2002), studies in the fly may provide 
useful insights into understanding disease in humans. 
I am interested in looking at how one class of proteins, the protein kinases, control 
development of the nervous system in Drosophila.  First, I am going to briefly review the 
function of protein kinases and then provide a brief review of nervous system development in 
flies.   
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 3.2.1 Protein Kinases 
  
Protein kinases are enzymes that catalyze the transfer of a phosphate group from the 
nucleotides ATP or GTP onto serine, threonine or tyrosine residues of their substrate proteins 
(Morrison et al., 2000).  Protein kinases play instrumental roles in controlling many eukaryotic 
cellular processes including cell cycle regulation, DNA replication, metabolism, growth and 
differentiation and signal transduction (Morrison et al., 2000).  Kinases, whether receptor or 
cytoplasmic, control these processes by covalent attachment of a phosphate group to an amino 
acid side chain of their substrates (Johnson and Barford, 1993).  Addition of the phosphate group 
containing two negative charges can induce a conformational change in the substrate protein, 
resulting in a modification of its activity (Johnson and Barford, 1993). This conformational 
change can be reversed by another class of enzymes, the protein phosphatases, which remove the 
phosphate (Morrison et al., 2000).  Reversible protein phosphorylation is a key strategy used to 
control activity of proteins in complex networks of signaling pathways in eukaryotic cells 
(Morrison et al., 2000). 
Based on sequence similarity, kinases from species as diverse as Saccharomyces 
cerevisiae, Caenorhabditis elegans, Drosophila melanogaster and humans all share homology in 
the catalytic kinase domain (Manning et al., 2002).  Moreover, protein kinases and their 
signaling pathways are evolutionarily conserved, further emphasizing their importance in 
eukaryotic organisms (Manning et al., 2002).  There are numerous classes of kinases including 
AGC, Atypical, CAMK, CK1, CMGC, Ste, TK, TKL, RGC, PTK, OPK, and ‘Other’ based on 
kinase domain similarity (Manning et al., 2002; Morrison et al., 2000).  Overall, kinase function 
serves critical roles in the regulation of enzymatic activity as well as signal transduction 
pathways in diverse organisms from yeast to man. 
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3.2.2 Drosophila Nervous System Development 
 Nervous system development in Drosophila progresses through a series of events 
including neuroblast specification, neuroblast formation, neurogenesis, development of nerve 
cells/glia, outgrowth and pathfinding of axons, and the formation of precise connections with 
target cells (Goodman and Doe, 1993).  I am going to provide a brief review nervous system 
development in flies.  First, central nervous system development in the early embryo will be 
discussed, followed by peripheral nervous system development and then axon pathfinding. 
 
3.2.2.1 Central Nervous System Development 
Signaling pathways provide cues for cells at all stages of neuronal cell differentiation.  
The central nervous system is derived from two regions that lie on either side of the ventral 
midline of the cellular blastoderm embryo, known as the neuroectoderm (Fig. 37Ai) (Goodman 
and Doe, 1993).  The neuroectoderm is a region of the embryo within which cells have the 
ability to produce neuroblasts or progenitors of the epidermis, epidermoblasts (Campos-Ortega, 
1993).  Cells in the neuroectodermal region can take on either a neural or ectodermal fate 
depending on the cues obtained from their surrounding environment (Goodman and Doe, 1993).  
At the onset of gastrulation, the ventral-most mesoderm region invaginates into the interior of the 
embryo allowing the two lateral neuroectodermal regions to join at the ventral midline of the 
embryo (Fig. 37Aii).  Neural specification in Drosophila occurs during the initial phase of germ 
band elongation (stage 8) (Fig 37Aiii), prior to the onset of mitotic activity in the ectodermal 
layer (Foe, 1989; Foe and Alberts, 1983; Hartenstein, 1985).  
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Figure 37. Formation of the neurogenic-midline region and neuroblasts in Drosophila 
embryos. 
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 Figure 37. Formation of the neurogenic-midline region and neuroblasts in Drosophila 
embryos. 
 
(Ai-iv) Schematic representation of cross sections from embryos at successive developmental 
stages, with dorsal side up and ventral down.  (Ai) During cellular blastoderm stage, the 
presumptive neurogenic region lies on either side of the future mesoderm, with the midline 
precursor cells (mesectoderm) lying in between these regions.  (Aii) During gastrulation, 
mesodermal cells invaginate into the embryo, bringing the presumptive midline cells and 
neurogenic region to the ventral side of the embryo.  (Aiii) During germ band elongation, the 
midline precursors intermix, forming eight midline precursors per segment.  (Aiv) Midline 
precursor cells and neuroblast cells delaminate and move inward.  (Bi-v) Neuroblast formation.  
(Bi)  Cells in the neuroectoderm receive positional cues from segmentation and dorsal/ventral 
genes.  (Bii)  Four to six cells are specified as neuroblasts.  (Biii)  Each of the neuroectodermal 
cells express one or more of the proneural genes that allow cells to be competent to differentiate 
as neuroblasts.  (Biv) Only one cell in the cluster will enlarge and delaminate as a neuroblast, 
and will express some neurogenic genes that inhibit other cells in the cluster from becoming 
neuroblasts.  Figures taken from (Goodman and Doe, 1993). 
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 Positional cues from segmentation and dorsal/ventral axis specification genes produce a 
cluster of 4-6 cells which all have the potential to become neuronal precursors, but only one cell 
of each cluster takes on the neuronal fate (Fig. 37Bi) (Goodman and Doe, 1993).  Individual 
clusters express one or more of the proneural genes (including genes of the achaete-scute 
complex) that give the neuroectodermal cell the potential to become neural precursors (Fig. 
37Bii).  The achaete (ac) and scute (sc) genes encode transcription factors that bind to target 
genes to initiate neural specification.  Within the neuroectoderm, cells expressing these genes 
form groups known as proneural clusters, and one cell in each cluster, the neuroblast, expresses 
achaete at higher levels compared to neighboring cells (Campos-Ortega, 1993).  All the cells in 
the cluster ubiquitously express Notch (a transmembrane receptor protein), but the cell that gives 
rise to the neuroblast express Delta (a transmembrane ligand) at higher levels compared to the 
other cells (Artavanis-Tsakonas et al., 1995; Campos-Ortega, 1993).  Binding of Delta to its 
receptor Notch, leads to inhibition of the proneural genes and the concomitant loss of the cells 
ability to become a neuroblast, and these cells instead become epidermal cells (Goodman and 
Doe, 1993).  Notch signaling activates expression of the E(spl)-Complex (Enhancer of split 
complex), and these gene products in combination with the transcriptional co-repressor Groucho, 
repress the expression of proneural genes ac/sc (Goodman and Doe, 1993).  The levels of Delta 
and Notch signaling may be regulated by a feedback mechanism where high levels of Delta 
produce high levels of Notch signaling, and activated Notch protein can downregulate Delta 
expression (Artavanis-Tsakonas et al., 1999).  Delta expression is negatively regulated by Notch 
signaling (Delta can only signal to adjacent cells).  If one cell has a slightly higher level of Delta, 
it will activate higher levels of Notch signaling in surrounding cells that will then lower Delta 
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 expression.  Delta expression in the signaling cell will then go up because Notch signaling is 
down (Artavanis-Tsakonas et al., 1999). 
Within the proneural cluster, only a single cell will enlarge and leave the 
neuroectodermal surface (delaminate) by moving to the interior of the embryo as a neuroblast 
(Fig. 37Biv) (Goodman and Doe, 1993).  The neuroblast will continue to divide asymmetrically 
to form one neuron and three glial cells (Fig. 37Bv).  In the absence of Notch signaling, all of the 
neuroectodermal cells develop as neuroblasts at the expense of epidermis (Campos-Ortega, 
1993).  In contrast, loss of function of any proneural genes results in loss of neuroblasts and 
increased numbers of epidermoblasts (Campos-Ortega, 1993). Therefore, the neural and 
epidermal progenitor cells are controlled by neurogenic and proneural genes, and these gene 
products are involved in a complex network enabling both neural and epidermal progenitors to 
be produced (Campos-Ortega, 1993). 
 
3.2.2.2 Peripheral Nervous System Development 
The Peripheral Nervous System (PNS) is composed of sensory and motor components.  
Sensory neuron cell bodies are present in the periphery and their axons extend toward the CNS, 
whereas the motor neuron cell bodies are located in the CNS and extend axons to the periphery 
(Jan and Jan, 1993).  There are three types of sensory organs: a) external sensory organs 
containing external sensory structures designed to detect mechanical or chemical signals b) 
chordontonal organs located internally and c) multiple dendritic neurons, internal sensory organs 
functioning as touch receptors or proprioceptors (Jan and Jan, 1993).  During embryonic 
development, formation of the external sensory organs and multiple dendritic neurons require 
expression of two proneural genes achaete and asense (Dambly-Chaudiere, 1987).  Similar to 
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 CNS development, the PNS also requires proneural and neurogenic gene expression for cells to 
take on the neuronal fate (Dambly-Chaudiere, 1987).  In addition to the action of Delta and 
Notch in lateral inhibition, two other genes shaggy and scabrous are also involved. The shaggy 
gene product, a serine-threonine kinase, is required for cells of the proneural cluster to take on 
the epidermal fate (Heitzler and Simpson, 1991), whereas loss of scarbrous results in duplication 
of sensory bristles (Mlodzik et al., 1990).  Neuronal precursors express genes of the Pan-
neuronal precursor class that enable the neurons to acquire specific characteristics including the 
ability to extend axons and dendrites, act as transmitters, and develop receptors for intercellular 
communication (Jan and Jan, 1993).  Ultimately, the specific sensory organ a neuronal precursor 
produces is controlled by the neuron type selector gene class (Jan and Jan, 1993).  Overall, many 
of the genes required for CNS development also play roles in larval PNS as well as adult PNS 
development.  
 
3.2.2.3 Axon Pathfinding 
At the onset of axon outgrowth, sensory and motor axons must find the way to their 
targets in the CNS and muscles without any preexisting neuronal landmarks, but upon 
encountering each other they may use the other as a guide to their destination (Jan and Jan, 
1993).  Interestingly, axons extending to the distal periphery will begin to extend axons before 
those extending to more proximal targets, an order inverse to the distance they extend (Johansen 
et al., 1989).  During axon outgrowth, the leading edge of the axon or growth cone detects 
environmental signals and converts the signals into movement towards a specific target (Lin and 
Forscher, 1993; Tanaka and Sabry, 1995).  The signals guiding axon outgrowth may be secreted 
or membrane-bound and serve to either attract or repel the migrating growth cones (Culotti and 
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 Merz, 1998; Guthrie, 1999; Tessier-Lavigne and Goodman, 1996).  The ability of a growth cone 
to receive signals relies on receptors on its surface, and these signals are transduced via signaling 
pathways within the growth cone (Bashaw and Goodman, 1999; Hong et al., 1999; Ming et al., 
1997).  Precise connections with targets require growth cones via receptors to interpret different 
concentrations of signals as well as combinations of signals and to translate the information to 
control motility of the growth cone (Suter and Forscher, 1998).  One important receptor in 
Drosophila is Dscam, involved in the Dock signal transduction pathway (Schmucker et al., 
2000).  Dscam detects axon guidance signals and transfers the signals into changes in the actin 
cytoskeleton via Dock and the protein kinase, Pak1 (Schmucker et al., 2000). 
 
3.2.3 Role of Protein Kinases in Nervous System Development 
 Complete understanding of nervous system development requires the identification of all 
the molecules involved in this complex process.  Although many genes involved in nervous 
system development have been identified, there are still many genes to be uncovered.  Classical 
genetics in Drosophila has identified several kinases involved in nervous system development, 
but the availability of genomic sequences will reveal the entire spectrum of kinases present in the 
fly and enable determination of the roles of these kinases in nervous system development.   
 Protein kinases play instrumental roles in various processes of nervous system 
development in Drosophila as well as in vertebrates.  For example, the cytoplasmic kinase, 
Shaggy is required in a cell autonomous manner for cells in the proneural cluster to become 
epidermal rather the neural progenitors (Heitzler and Simpson, 1991).  In addition, other kinases 
such as Cdk5 and Pak1 are required for different aspects of axonal pathfinding (Connell-Crowley 
et al., 2000; Hing et al., 1999). 
 138
 Cyclin-dependent kinase-5 (CDK5) plays a role in neuronal differentiation (Nikolic et al., 
1996), axon guidance (Kwon et al., 1999), and possibly synaptic plasticity (Li et al., 2001) as 
well as neurodegeneration (Patrick et al., 1999).  In Drosophila, Cdk5 and its activating partner 
p35 are involved in axon pathfinding, as disruption of Cdk5 function results in aberrant axon 
pathfinding (Connell-Crowley et al., 2000).  In vertebrates, CDK5 is predominantly localized to 
mammalian post-mitotic neurons where it works in conjunction with nervous system specific 
activators p35 and p39 (Tsai et al., 1993).  The CDK5/p35 complex is localized at the leading 
edges of growth cones and is involved in phosphorylation of neuronal microtubule-associated 
proteins (MAPs), thereby providing evidence for the role of CDK5 in regulation of axon 
extension in developing neurons (Maccioni et al., 2001).  On the other hand, CDK5 has been 
implicated in neurodegeneration via tau hyperphosphorylation promoted by β-amyloid proteins 
(Maccioni et al., 2001).  Therefore, changes in regulation of the CDK5/p35 complex may trigger 
neurodegeneration as seen in Alzheimers disease (Maccioni et al., 2001).   
 Another kinase, Drosophila Pak1 serine-threonine kinase (p21-activated kinase), is a 
downstream effector in the Dock pathway and regulates R-cell axon guidance in the ommatidia 
by controlling the actin cytoskeleton in growth cones (Hing et al., 1999; Newsome et al., 2000). 
The Drosophila compound eye is composed of approximately 800 identical photoreceptor organs 
known as ommatidia.  Each ommatidia consists of 8 photoreceptor neurons (R1-R8), four cones 
cells and additional pigment cells (Bonini and Choi, 1995; Halder et al., 1995). 
Studies by Allen et al. reveal that critical neuronal connections required for human 
cognitive function involve signal transduction via Pak3 and a mutation in Pak3 is present in 
patients with nonsyndromic X-linked mental retardation (Allen et al., 1998).  Therefore, 
transduction of signals via Pak3 appears to be required for human cognitive functioning (Allen et 
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 al., 1998).  In general, Pak proteins seem to be effecter proteins linking Rho GTPases, Rac and 
Cdc42, to the actin cytoskeleton (Sells et al., 1997) and thus are integral components of the Rho 
GTPase/Rac signaling pathway controlling neuronal development. 
 Receptor tyrosine kinases have also been shown to be involved in various stages of 
nervous system development.  In mice, Eph receptor tyrosine kinases and their ligands function 
in many aspects of nervous system development (Holder et al., 1998).  More recently, it has been 
determined that receptor tyrosine kinases (RTK), including the Trk RTK, the Src family of non-
receptor tyrosine kinases and the Eph RTK are involved in signaling cascades implicated in 
synaptic plasticity and long term memory (Purcell and Carew, 2003).  Furthermore, invertebrate 
studies provide evidence that RTKs may be involved in memory (Dura et al., 1995).   
Clearly, kinases have been shown to play key roles in many stages of neuronal 
development, thus the use of reverse genetics is likely to effectively uncover new roles for other 
kinases in the genome.  It is plausible to hypothesize that kinases most likely function at all 
stages of neuronal development.  Therefore, screening Drosophila kinases using a recently 
discovered reverse genetic tool, RNA interference, may prove to be an effective way to uncover 
additional kinases involved in nervous system development.   
 
3.2.4 RNA interference (RNAi) 
RNA interference (RNAi) is a mechanism for directly knocking down gene expression of 
genes with known sequence and has proven to be a powerful reverse genetic approach.  RNAi 
was originally discovered in Caenorhabditis elegans when injection of double-stranded RNA 
(dsRNA) into the worm was shown to result in degradation of the corresponding mRNA and 
silencing of the gene product (Fire et al., 1998).  Injection with dsRNA proved to be much more 
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 potent in knocking down mRNA levels than injection with either sense or anti-sense RNA alone.  
In addition to injection of dsRNA, RNAi has been demonstrated in C. elegans by feeding on E. 
coli engineered to express dsRNA of a nematode gene (Timmons and Fire, 1998) and soaking 
the worms in a solution of dsRNA (Tabara et al., 1998).  RNAi was also shown to be an effective 
and potent means of silencing genes in early Drosophila embryos (Kennerdell and Carthew, 
1998).  Subsequent studies have shown that RNAi is also effective in Drosophila cell culture 
enabling high throughput screening using RNAi to silence a plethora of genes (Clemens et al., 
2000). 
RNA interference refers to the use of double-stranded RNA (dsRNA) to target mRNAs 
for degradation leading to silencing of gene expression.  The dsRNA sequence is utilized by 
RNA machinery to produce a protein-RNA complex that degrades the corresponding mRNA, 
thereby producing an extremely specific means of silencing genes, as other non-specific mRNAs 
are not affected (Zamore et al., 2000).  It has been proposed that the biological roles of RNAi 
may be to maintain the integrity of the genome by suppressing mobilization of transposons or to 
prevent an accumulation of repetitive sequences in the germline (Aravin et al., 2001; Ketting et 
al., 1999; Ketting and Plasterk, 2000; Wu-Scharf et al., 2000).  In addition, RNAi may be a 
defense against viral infections as well as a regulator of gene expression (Zamore, 2001).  
 
3.2.4.1 Mechanism of RNA interference 
 RNAi is a two-step process (Fig. 38).  The RNAi pathway is initiated by the processive, 
ATP-dependent cleavage of the dsRNA into small interfering RNAs (siRNAs) 21-25 nt in length  
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Figure 38. Mechanism of RNAi. 
 
An ATP-dependent cleavage of the double-stranded RNA substrate into 21-23 nt siRNAs by 
Dicer, initiates the RNAi pathway.  The siRNAs interact with a multi-protein complex that 
unwinds the siRNA in an ATP-dependent manner.  Duplex unwinding produces a 
conformational change in the RNA-induced silencing complex (RISC), allowing recognition of 
target mRNA by the anti-sense strand of siRNA and subsequent cleavage of the mRNA. Figure 
taken from (Zamore, 2001). 
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 by Dicer, a Ribonuclease (RNaseIII), (Bernstein et al., 2001; Elbashir et al., 2001; Hamilton and 
Baulcombe, 1999; Hammond et al., 2000; Zamore et al., 2000).  Dicer is a member of the 
RNaseIII family of dsRNA specific endonucleases (Bernstein et al., 2001), and similar to other 
family members produces a siRNA product consisting of a 5′ phosphate and 3′ hydroxyl with 
two unpaired nucleotides at each end (Elbashir et al., 2001).  The siRNAs then interacts with a 
multi-protein complex that is not able to mediate RNAi until the ATP-dependent unwinding of 
the siRNA duplex is initiated (Nykanen et al., 2001).  Upon duplex unwinding, the complex 
undergoes a conformational change producing an active RNA induced silencing complex (RISC) 
(Hammond et al., 2000; Nykanen et al., 2001).  The siRNA antisense strand of the activated 
RISC complex can recognize and hybridize with corresponding target mRNA leading to 
cleavage of the mRNA by the RISC complex (Hammond et al., 2001; Nykanen et al., 2001).   
 
3.2.5 Utility of RNAi to silence gene function  
The availability of genomic sequences from C. elegans, Drosophila, mouse and humans 
have provided a source of target sequences against which RNAi can be utilized as a reverse 
genetic tool to begin understanding the function of many genes with previously unknown 
function.  RNAi has been effectively used as a tool to perform multiple screens in C. elegans 
(Gonczy et al., 2000), Drosophila embryos (Ivanov et al., 2004; Kim et al., 2004), and 
Drosophila cell culture (Bettencourt-Dias et al., 2004; Boutros et al., 2004; Goshima and Vale, 
2003; Kiger et al., 2003; Lum et al., 2003; Somma et al., 2002) to identify genes involved in 
numerous biological processes, including cell cycle regulators, cell morphology, growth and 
viability and signaling pathways. 
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 In the past, classical genetics identified mutations in many genes including those 
involved in nervous system development.  Availability of cell type specific markers for many 
sensory organs has also enabled detailed study of the embryonic sensory nervous system.  
Furthermore, many genes are used at multiple developmental stages enabling phenotypes of 
lethal mutations to be analyzed in embryos, but there are drawbacks to analyzing embryonic 
phenotypes.  For instance, some genes are expressed during oogenesis and the gene products 
contributed by the mother may be enough to mask a possible phenotype in the embryo even 
when the zygotic gene is non-functional (St Johnston, 2002).  Therefore, classical genetics may 
be limited by its inability to identify zygotic and maternal effects mutations simultaneously, and 
many mutations were not uncovered.  RNAi has been shown to reduce levels of both maternal 
and zygotic mRNA enabling further analysis of these previously uncharacterized gene products 
(Adams and Sekelsky, 2002).  RNAi provides a powerful reverse genetic tool to silence gene 
function in Drosophila and we are particularly interested in those genes involved in central and 
peripheral nervous system development.  We are interested in the protein kinase family because 
of their importance in signal transduction and regulation of cellular activity.  In the present study, 
an RNAi screen of Drosophila kinases was completed to identify kinases involved in nervous 
system development. 
 
3.3 Results 
The Drosophila genome contains approximately 13,000 predicted genes and of these 
there are approximately 229 protein kinase genes (Kiger et al., 2003).  Previous studies have 
identified kinase genes involved in nervous system development (Connell-Crowley et al., 2000; 
Heitzler and Simpson, 1991; Hing et al., 1999).  The availability of the sequenced genome makes 
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 it possible to conduct a focused search for kinases involved in nervous system development.  In 
the present study RNA interference was used to systematically knock down the function of 
individual kinase genes and analyze the effect of each gene on the developing nervous system.   
Upon release of the sequenced Drosophila genome in 2000 (Adams et al., 2000) it was 
possible to identify all of the kinases in the genome based on homology with the protein kinase 
catalytic core.  A FlyBlast search using the kinase domain of serine/threonine kinase dPar1 (a 
kinase being studied in the lab) initially identified 165 Drosophila kinases to be silenced using 
RNAi.  A subset of 60 kinases were chosen for testing due to availability of cDNAs, as 
Expressed Sequence Tags (ESTs), to use as template DNA.  However, if a particular EST could 
not be used, then Drosophila genomic DNA (BAC clone) was used.  Sense and antisense PCR 
primers were designed for each kinase gene with a 5′ T7 promoter sequence 
TAATACGACTCACTATAGGGAGACCAC for binding of T7 RNA polymerase in in vitro 
transcription reactions (Refer to Appendix B for a complete list of primer pairs).  In order to 
ensure specificity, primers were designed to amplify exon regions adjacent to the kinase domain 
and if this was not possible, alternate exons were used.  A Blast search was completed with each 
primer to determine that the sequence was indeed specific for that gene and would not also 
hybridize with other genes.  PCR fragments were produced from cDNA (ESTs) or genomic 
DNA (BAC clones), and then used as template DNA in in vitro transcription reactions to 
synthesize both strands simultaneously for dsRNA production.  The dsRNA products, ranging 
from 200 to 859 bp, were purified and injected into syncytial blastoderm embryos (Fig. 39A). 
Initially, screening to identify kinases involved in nervous system development utilized a 
fly line expressing GFP under the control of a nervous system specific promoter (ELAV) 
allowing GFP expression exclusively in the CNS and PNS to be visualized in live embryos  
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Figure 39. RNAi screening protocol. 
 
(A)  PCR primers specific for each protein kinase were designed with T7 promoter sequences, 
and used to produce PCR products from Drosophila genomic DNA ( BAC clones) or cDNA 
(EST).PCR fragments served as template DNA for in vitro transcription reactions using T7 
polymerase, to produce sense and anti-sense strands simultaneously.  dsRNA products were 
purified and injected into embryos that expressed GFP under the control of an ELAV promoter. 
(B)  Representative stage17 embryo showing GFP expression in the ventral nerve cord. 
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 (Fig. 39B) (Lee and Luo, 1999).  Embryos were injected with dsRNA, allowed to develop to 
embryonic stage 16-17, just prior to hatching, and visualized using epifluorescence to detect the 
presence of defects in the CNS or PNS.  Moreover, viewing live embryos enabled assessment of 
lethality or the inability of embryos to progress beyond a particular stage of development that 
would have been impossible if embryos were fixed and stained.  In order for a kinase gene to be 
considered a candidate, the injected embryos had to show disruption of the commissures or 
longitudinals of the ventral nerve cord or irregular patterning of the PNS such as an axon 
guidance defect or missing segmental neurons (Fig. 40A,B).  In addition, the embryos had to 
have developed beyond dorsal closure (stage 15). 
For actual phenotypes to be determined following injection with dsRNAs, it was 
necessary to complete injection buffer controls to ensure any observed phenotype was real and 
not an artifact of the injection procedure.  At least 50% of the injection buffer control embryos 
had to look wild type to make any judgment on phenotypes observed in the experimental kinase 
dsRNA injections.  A wild type CNS contains a distinct ‘ladder-like’ ventral nerve cord 
containing anterior and posterior commissures for each segment and longitudinal connectives on 
either side of the commissures along the A/P axis (Fig. 43C,D).  The PNS contains axons that 
extend from the CNS towards the muscles and sensory axons extending from the sensory organ 
cell bodies to the CNS.  Each individual segment has nerves and cell bodies confined within the 
segment and not crossing to adjacent segments.   
Overall, an average of 62% of injection buffer controls survived and did not exhibit any 
phenotypes.  In comparison, an average of 59% of the injected experimental embryos survived 
and showed no phenotype, an indirect, non-specific phenotype or a specific nervous system 
phenotype.  Approximately 170-200 embryos were injected with each of the kinase dsRNAs and  
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Figure 40. GFP and antibody stained control embryos. 
 
(A and B)  Embryos expressing GFP under the control of the ELAV promoter.  An ELAV-GFP 
line of flies was utilized for initial screening of CNS and PNS defects, following injection of 
dsRNA corresponding to Drosophila kinase genes.  (A) ventral view of stage 17 embryo 
showing ventral nerve cord and (B) lateral view showing PNS.  (C and D)  Embryos stained with 
BP104 antibody that recognizes a nervous system specific splice variant of neuroglian.  (C) 
Ventral view of CNS (ventral nerve cord).  (D) Lateral view of embryo showing continuous 
pattern of segmental neurons of the PNS within each segmental boundary. 
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 ~50% of the surviving embryos had to exhibit a nervous system phenotype to be considered as a 
candidate.  Of the 54 kinase genes analyzed, 36 of the dsRNAs did not produce any nervous 
system phenotype upon visualization of injected embryos using epifluorescence (Tables 1,2). 
 
 
Table 1. Overview of Drosophila Kinase RNAi Screen Results 
Class of Phenotype Number of kinase genes 
Specific Nervous System Phenotype 
 
5 
Non Specific Nervous System Phenotype 13 
No Nervous System Phenotype 
 
36 
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 Table 2. Kinase genes not producing a phenotype following injection 
 
Gene Number Gene Name 
CG1362 Cdc2rk 
CG1388 tak 
CG2615 ik2 
CG2621 sgg 
CG2829 BcDNA:GH07910  
CG2899 ksr 
CG3051 SNF1A 
CG3068 aur 
CG3086 MAPk-2-Ak2 
CG4224 CG4224 
CG4268 Pitslre 
CG4379 Pka-C1 
CG4551 Smi35A 
CG5125 ninaC 
CG5179 Cdk9 
CG5475 Mpk2 
CG5680 bsk 
CG6114 CG6114 
CG6518 inaC 
CG6551 fused 
CG6620 ial 
CG7001 Pkl17E 
CG7177 CG7177 
CG7719 greatwall 
CG7826 mnb 
CG9222 CG9222 
CG9774 rok 
CG11228 hippo 
CG12306 polo 
CG14992 Ack 
CG15793 Dsor1 
CG17161 grapes 
CG17342 LK6 
CG17998 Gprk 
CG18069 CamKII 
CG18247 shark 
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 Injection of 13 kinase dsRNAs produced non-specific phenotypes (Table 3).  For most of 
the kinase genes producing a non-specific phenotype, approximately 30% of the embryos 
exhibited a disorganized Central Nervous System (CNS), and in some cases a disorganized 
Peripheral Nervous System (PNS).  However, these embryos also exhibited other developmental 
defects such as inability to complete germ band retraction or a failure to undergo dorsal closure, 
which did not allow them to progress to later stages of development.  In some cases, the embryos 
had a disorganized CNS, but were also lethal (CG2049 and CG5072).  These embryos did not 
develop beyond germ band extension, and were not considered as candidates.  In addition, 
CG10033 showed a severe neurogenic phenotype (a majority of the epidermis was transformed 
into neuronal tissue) but the embryos also exhibited other morphological defects including the 
inability to progress past germ band retraction and this kinase was also not considered as a 
candidate.  If earlier developmental stages were affected by knocking down levels of the kinase 
using RNAi, these kinases were not considered as candidates because any observed phenotype 
might have resulted from a defect in another developmental process that did not allow the 
embryos to progress beyond dorsal closure.  In addition, we allowed these embryos to incubate 
longer to determine whether they would develop beyond dorsal closure, but they did not, so we 
classified these genes as producing an indirect, non-specific nervous system phenotype (Table 3). 
Screening for kinases producing specific nervous system phenotypes resulted in five 
candidate genes including: Epidermal Growth Factor Receptor (Egfr, CG10079), Mushroom 
Bodies Tiny (mbt, CG18582), Cyclin-dependent kinase 2 (Cdc2, CG5363), C-terminal Src 
Kinase (Csk, 17309) and p21-activated kinase 3 (Pak3, CG14895) (Tables 1 and 3).  Each of 
these candidate genes were further analyzed by re-injection of each dsRNA into W1118 embryos  
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 Table 3. Kinase Genes producing Specific and Non-Specific Phenotypes following injection 
of dsRNA into embryos.  
Gene Number Gene Name Phenotype Phenotype Description 
CG5363         Cdc2 Specific CNS disorganized, PNS 
disorganized 
CG10079 Egfr Specific  Compressed CNS, PNS 
disorganized 
CG14895 Pak3 Specific  PNS axon guidance defect 
 
CG17309 Csk Specific Abnormal CNS, PNS defects 
 
CG18582 Mbt Specific CNS somewhat abnormal, 
axon guidance defect 
CG1210 Pk61C Non-specific Disorganized CNS, other 
developmental defects 
CG1227 CG1227 Non-specific Disorganized CNS, other 
developmental defects 
CG1495 CamKI Non-specific Disorganized CNS, other 
developmental defects 
CG2049 CG2049 Non-specific Disorganized CNS, lethal 
 
CG5072 Cdk4 Non-specific Disorganized CNS, lethal 
 
CG7186 SAK Non-specific Disorganized CNS, other 
developmental defects 
CG8173 CG8173 Non-specific CNS somewhat disorganized 
 
CG8485 CG8485 Non-specific Disorganized CNS, other 
developmental defects 
CG8866 CG8866 Non-specific Disorganized CNS, other 
developmental defects 
CG10033 foraging Non-specific Neurogenic phenotype, other 
developmental defects 
CG10579 Eip63E Non-specific Disorganized CNS, other 
developmental defects 
CG14217 CG14217 Non-specific Disorganized CNS, other 
developmental defects 
CG16973 misshapen Non-specific Disorganized CNS,  
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 and staining with monoclonal antibody (mAb) BP104 that recognizes a nervous system specific 
splice variant of neuroglian.  Embryos were fixed at stages 15-17 post injection, stained and 
evaluated for phenotypes corresponding to those observed in live embryos using epifluorescence.  
In addition to injections with dsRNA to each of the five candidate genes, control embryos were 
injected with injection buffer and stained alongside the experimental embryos.  Buffer control 
embryos had a distinct ventral nerve cord (CNS) with longitudinal connectives running from the 
anterior to the posterior of embryos and commissures situated perpendicular to the connectives 
forming the normal “ladder-like” structure of the ventral nerve cord.  The PNS of each 
embryonic segment possessed continuous axons confined to their individual segments (Fig. 
40C,D).   
 
3.3.1 Epidermal Growth Factor Receptor (Egfr) 
Injection of dsRNA corresponding to Egfr (CG10079) revealed a range of neuronal 
phenotypes of differing severity.  Some embryos displayed a fusion of the longitudinal 
connectives into the midline resulting in a loss of distinct commissures between the longitudinal 
connectives and no clear midline (Fig. 41A,B,C).  Other embryos contained a fusion of the 
longitudinal connectives as well as expansion of the CNS more laterally beyond the normal 
ventral nerve cord region (hyperplastic), encompassing a greater surface area of the embryo (Fig. 
41C).  Furthermore, some embryos contained a PNS that lost the clearly segmented nerves 
confined within an individual segment, being replaced by disorganized clumps of nerves (Fig. 
41C).  In addition, a few embryos that did not show a hyperplastic CNS contained axon guidance 
defects in the PNS, with an axon extending from segment 2-3 that was almost parallel with the 
ventral nerve cord (Fig. 41A). 
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Figure 41. Phenotype of embryos injected with Epidermal growth factor receptor (Egfr) 
dsRNA. 
 
Embryos were injected with Egfr dsRNA and stained with BP104 mAb.  Embryos exhibit a 
range of phenotypes of differing severity.  (A) Embryo has fusion of longitudinal connectives 
into the midline and loss of distinct commissures between the connectives.  There is also an axon 
guidance defect between segmental neurons 2 and 3 (arrow).  (B) Partial fusion of longitudinal 
connectives, but not as severe as in embryo (A).  (C) Expansion of the ventral nerve cord into 
lateral regions of the embryo.  Peripheral neurons are not continuous and form ‘clumps’ along 
each segment. 
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3.3.2 C-terminal Src Kinase (Csk) 
C-terminal Src Kinase (Csk, CG17309), produced a phenotype with an abnormal CNS 
and PNS.  The CNS appeared to have a gap along the midline and it has lost the commissures 
lying between the longitudinal connectives, thereby losing its “ladder-like” appearance (Fig. 42).  
In some embryos, the CNS appears segmented and almost continuous with the PNS, with breaks 
in the longitudinal connectives as well as loss of commissures positioned between the 
longitudinal connectives (Fig. 42).  These embryos did not have distinct longitudinals extending 
continuously from the anterior to the posterior.  Moreover, the axons of the PNS were confined  
within their individual segments, but they were not continuous along the segment with clumps of 
axons, then a space with no axons, then additional axons beyond the space (Fig. 42). 
  
3.3.3 Cyclin-dependent kinase 2 (Cdc2) 
Embryos injected with dsCdc2 (CG5363) lacked a clear “ladder-like” structure of the 
CNS and disorganized PNS.  The ventral nerve cord had a wavy appearance compared to the 
wild type embryos (Fig.43A,B)  In some embryos, the ventral nerve cord was pinched together in 
some regions, but other sections contained a space between the midline (Fig. 43B).  In addition, 
the PNS was severely disorganized with several of the segments missing neurons completely or 
fusion of neurons from adjacent segments (Fig. 43A).  For a majority of the embryos, it was not 
possible to distinguish the 10 distinct segments of peripheral nerves due to loss of segmental 
nerves or hypoplasia of the PNS neurons.   
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Figure 42. Phenotype of embryo injected with C-terminal Src Kinase (Csk) dsRNA. 
 
Embryos were injected with Csk dsRNA and stained with BP104 mAb. and revealed phenotypes 
in the CNS and PNS.  A separation exists along the midline of the embryo, and there are distinct 
gaps in the normally continuous A/P longitudinal connectives.  Commisures are missing between 
the longitudinal connectives.  The peripheral neurons appear to be continuous with the those of 
the CNS and form clumps rather than distinct individual neurons (arrow). 
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Figure 43. Phenotype of embryos injected with Cyclin-dependent kinase 2 dsRNA. 
 
Embryos were injected with Cdc2 dsRNA and stained with BP104 mAb.  (A) The embryo lacks 
a clear “ladder-like” structure of the normal CNS and contains an extremely disorganized PNS.  
Ventral nerve cord has a wavy appearance (black arrow).  Many of the peripheral neurons are 
missing and/or are fused with those from adjacent segments (white arrow).  (B) Ventral nerve 
cord is  pinched together in some regions, but not in others. 
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3.3.4 Mushroom Bodies Tiny (mbt) 
Injection of dsRNA corresponding to Mushroom Bodies Tiny (mbt, CG18582) resulted in 
an abnormal CNS as well as an axon guidance defect in the PNS.  The commissures of the CNS 
are not distinct or are missing when compared to injection buffer control embryos that contain a 
typical ladder like structure.  Interestingly, there was a subtle phenotype in the PNS 
corresponding to an axon guidance defect, where an axon from segment A2 crosses over and 
connects to neurons contained in segment A3 (Fig. 44A,B,C).  PNS guidance in other segments 
appeared normal. 
 
3.3.5 p21-activated kinase 3 
Finally, injection of Pak3 (CG14895) also revealed a very subtle, but interesting 
phenotype of an axon guidance defect (Fig. 45A-D).  Axons from one segment crossed over the 
segmental border and joined with neurons from an adjacent segment.  There was some variation 
of the segments affected, but approximately 80% of the embryos exhibited crossing over from 
segment A1 to segment A2.  The CNS appears to be normal with commissures between the 
longitudinal connectives.  The validity of the Pak3 RNAi axon guidance defect was further 
demonstrated using a Pak3 loss of function mutant line (EF1191), containing a P-element 
insertion in the Pak3 gene.  Staining of EF1191 embryos with mAb BP104 revealed an axon 
guidance defect consistent with the RNAi phenotype (Fig. 45E).  
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Figure 44. Phenotype of embryos injected with Mushroom Bodies Tiny (mbt) dsRNA. 
 
Embryos were injected with mbt dsRNA and stained with BP104 mAb.  (A) Embryo shows a 
peripheral axon guidance defect between segments 2 and 3 (arrow).  (B) This embryo also has a 
peripheral axon guidance defect, but it is between segments 1 and 2 (arrow).  (C) Some of the 
peripheral nerves are not continuous within the segment (arrow), leaving a gap. 
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Figure 45. Phenotype of embryos injected with p21-activated kinase3 (Pak3) dsRNA. 
 
Embryos were injected with Pak3 dsRNA and stained with BP104 mAb.  (A) Axon guidance 
defect is present between segments 2 and 3 (arrow).  There is also an axon guidance defect 
between segments 8 and 9. (B) 10X magnification of defect in A.  (C) Another embryo showing 
an axon guidance defect between segments 2 and 3. (D) Axon guidance defect between segments 
7 and 8.  (E) Pak3 mutant containing a P-element insertion in the Pak3 gene. Pak3 mutant 
embryo exhibits an axon guidance defect similar to the RNAi phenotype. 
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3.4 Discussion 
Analysis of 54 Drosophila kinase genes using RNAi produced specific nervous system 
phenotypes for five of the genes: Egfr (CG10079), Csk (CG17309), Cdc2 (CG5363), Mbt 
(CG18582) and Pak3 (CG14895).  Indirect, non-specific phenotypes were observed with 
injection of dsRNA corresponding to 13 kinase genes and injection of dsRNAs to 36 kinase 
genes did not produce any nervous system phenotype (Table 1). 
 
3.4.1 Kinases affecting Drosophila Nervous System Development 
 
3.4.1.1 Epidermal Growth Factor Receptor (Egfr) 
RNAi silencing of Egfr (CG10079) resulted in a nervous system phenotype with a 
distinct loss of commissure tracks across the longitudinal connectives along the length of the 
ventral nerve cord leading to a fusion of the midline (Fig. 41A,B,C).  Moreover, the CNS was 
extremely disorganized and extended laterally beyond the normal region of the ventral nerve 
cord.  In addition, the normally segmented neurons of the PNS were replaced by clumps of 
random neurons (Fig. 41C).  Identification of a nervous system phenotype following injection of 
dsEgfr was encouraging, as numerous studies have implicated Egfr in nervous system 
development.  To begin with, an Ethyl methanesulphonate (EMS) screen for mutations affecting 
commissure formation in the CNS of the embryo resulted in eleven different Egfr alleles 
(Hummel et al., 1999).  It was also determined that excess Egfr signaling can override lateral 
inhibition in the proneural cluster, enabling adjacent cells to become Sensory Organ Mother Cell 
(SMC’s) and sensory organs (Culi et al., 2001).  In addition, Egfr signaling is critical for 
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 interactions in the early ectoderm, the region where neuroblasts and glial cell lineages 
delaminate, to determine fates of neuronal and glial cell lineages (Scholz et al., 1997).  At later 
stages of embryonic development, Egfr function is required in the midline glial cells (MG) and in 
its absence, the MG cells fail to differentiate or die producing a fusion between the commissures 
(Scholz et al., 1997).  Egfr signaling induces formation, patterning and fate specification of early 
forming neuroblasts along the dorsal-ventral axis of the embryo (Skeath, 1998).  Furthermore, 
Egfr signaling helps specify the fate of medial neuroblasts and promotes neuroblast formation in 
the intermediate column (Skeath, 1998).  Egfr signaling plays an instructive role in CNS 
patterning and exerts differential effects on dorsal-ventral subpopulations of neuroblasts (Udolph 
et al., 1998).  In addition to the role of Egfr in nervous system development, this kinase also 
plays roles in many other developmental processes.  Overall, the RNAi phenotypes observed in 
the present study appears to be consistent with the role of Egfr in nervous system development 
reported previously. 
 
3.4.1.2 C-terminal Src Kinase  
The RNAi induced phenotype of Csk (CG17309) results in both abnormal CNS and PNS.  
There is a large separation between the longitudinal connectives of the ventral nerve cord on the 
ventral surface of the embryo (Fig. 42).  Furthermore, the commissures between the two 
longitudinal connectives are completely missing, with a loss of the normal “ladder-like” 
appearance of the CNS.  Abnormalities are also present in the PNS of the Csk RNAi embryos.  
The axons of the PNS are not continuous along their individual segments, but rather there are 
breaks of continuity within the segment.  Studies in mice demonstrated that animals homozygous 
for a knockout of the Csk gene were embryonic lethal at mid gestation and exhibited neural tube 
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 defects including a failure to close their cephalic folds, a wavy and disorganized neural tube 
(Imamoto and Soriano, 1993).  Moreover, histological sections at the optic vesicle revealed 
cephalic folds that were interrupted by a layer of neuroectodermal cells (Imamoto and Soriano, 
1993). In rats, Csk is expressed at high levels in the CNS throughout embryonic development 
and the levels are reduced in the adult brain (Kuo et al., 1997).   In Drosophila, Csk has been 
implicated in regulation of cell numbers by inhibiting cell proliferation (Pedraza et al., 2004).  
Additional analysis is required to further explore the nature of this phenotype. 
 
3.4.1.3 Cyclin-dependent kinase 2 (Cdc2) 
A nervous system specific phenotype was also observed when dsRNA corresponding to 
Cdc2 (CG5363) was injected into embryos. The ventral nerve cord had a wavy appearance and 
lacked its normal “ladder-like” appearance compared to wild type embryos (Fig. 43A,B).  Some 
of the embryos exhibited a fusion of the ventral nerve cord along the midline (Fig. 43B).  In 
addition to the abnormal structure of the CNS, the PNS was also abnormal.  In some of the 
segments, the neurons were completely missing, in others they were fused with the neurons from 
adjacent segments (Fig. 43A).  It was not possible to determine exactly which neurons were 
missing with the antibody used, and additional antibodies would have to be used to identify if 
sensory or motor neurons were affected following RNAi.  The observed RNAi phenotype is 
validated by more recent studies in which Cdc2 has been linked to neural progenitor asymmetric 
divisions (Tio et al., 2001).  Segregation of cell fate determinants into one of the two daughter 
cells mediates asymmetric cell divisions (Tio et al., 2001).  Asymmetric division in Drosophila 
neuroblasts and progeny ganglion mother cells (GMCs) are mediated by preferential localization 
of cell fate determinants to either the apical or basal side of the cortical complex (Tio et al., 
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 2001).  Improper functioning of Cdc2 results in abnormal asymmetric divisions due to the 
improper localization of asymmetric components during mitosis and the failure of daughter cells 
to acquire the correct fates (Tio et al., 2001).  Therefore, when levels of Cdc2 are knocked down 
using RNAi, the process of asymmetric divisions may be compromised leading to the observed 
phenotypes.  It has been demonstrated that Par/aPKC complex is required for proper 
asymmetrical division and mutation in components of the complex led to mislocalization of fate 
determinants, Prospero and Numb (Kuchinke et al., 1998; Petronczki and Knoblich, 2001).  
Therefore, antibody staining using anti-Prospero or anti-Numb antibodies could be completed in 
embryos following injection with Cdc2 dsRNA to determine localization of these proteins and 
whether they are properly localized.   
 
3.4.1.4 Mushroom Bodies Tiny 
Mushroom bodies tiny (Mbt, CG18582) shares homology with Pak1 related kinase in 
humans, p21-activated kinase 3 in rats and Cdc42/Rac effector kinase in mice.  Mbt is a group II 
PAK, containing a C-terminal kinase domain and an N-terminal binding domain for Rho family 
of small GTPases (p21-binding domain, PBD), but lacks a C-terminal auto-inhibitory domain 
(AID) typical of group I PAKs (Dan et al., 2002; Jaffer and Chernoff, 2002; Pirone et al., 2001).  
RNAi with mbt resulted in a distinct axon guidance defect in the peripheral nervous system of 
injected embryos (Fig. 44A,B). In addition, there were peripheral nerves missing in some 
embryos (Fig 44C).  Mutations in the mbt gene perturb the survival or generation of Kenyon 
cells in the adult mushroom body therefore implicating Mbt’s involvement in adult CNS 
neurogenesis (Melzig et al., 1998).  Moreover, photoreceptor cells in the eye or neurons in the 
brain are frequently missing in mbt mutants suggesting a function of Mbt in cell proliferation, 
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 differentiation, or survival (Schneeberger and Raabe, 2003).  In contrast, mbt mutants in other 
studies did not exhibit axon guidance defects (Hing et al., 1999; Melzig et al., 1998).  It is 
interesting to have such a contradiction between mbt mutant studies and the RNAi phenotype 
showing an axon guidance defect.  One possible explanation for such a discrepancy is the 
analysis in the embryo following injection of mbt dsRNA compared to analysis in adults, as mbt 
may have different functions in nervous system development at different developmental stages.  
However, it is not known whether all the neurons have obtained their proper fate or survived in 
the embryos following RNAi, and this possibility would also have to be considered. 
 
3.4.1.5 p21-activated kinase 3 
The final candidate is p21-activated kinase 3 (Pak3, CG14895).  Pak3 is a group I Pak, 
sharing homology with other group I Pak kinases including mammalian Pak1-3 and Drosophila 
Pak1 (Dan et al., 2001; Jaffer and Chernoff, 2002; Pirone et al., 2001).  Group I Pak kinases, 
contain an auto-inhibitory domain (AID) which negatively regulates its activity via interaction 
with the kinase domain.  Function of the AID is abolished upon binding by activated Cdc42 or 
Rac, resulting in autophosphorylation and activation of the kinase domain (Jaffer and Chernoff, 
2002).   
Pak3 injected embryos exhibited a very subtle, but interesting axon guidance defect 
phenotype.  The peripheral axons from one segment crossed over into another segment, 
connecting with neurons of the adjacent segment (Fig 45A-D).  The CNS of injected embryos 
was normal and produced the typical ladder-like structure of commissures as “rungs” along the 
longitudinal connectives of the ventral nerve cord.  Since injection of Pak3 dsRNA produced an 
axon guidance defect and Pak1 has been implicated in axon guidance, it was necessary to 
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 confirm the observed phenotype using dsRNA to a different region of the Pak3 gene.  Injection 
of the alternate Pak3 dsRNA produced an identical phenotype to the original Pak3 dsRNA.  In 
mice, transcripts for both Pak1 and Pak3 are almost exclusively expressed in the brain and spinal 
cord but not in other tissues tested (Burbelo et al., 1999).  These findings propose a role for both 
PAK proteins in control of signaling or cellular architecture in the mouse CNS.  Furthermore, 
Pak1 acts as a downstream effector of Rac in the process of dendrite initiation in cortical neurons 
(Hayashi et al., 2002).  Studies in Drosophila suggest Pak1 acts downstream of Dock (an 
SH2/SH3 adaptor protein) and Trio (a guanine nucleotide exchange factor) in a pathway 
regulating R cell axon guidance to spatially restricted domains within growth cones and control 
direction of axon extension (Hing et al., 1999; Newsome et al., 2000).  The axon guidance defect 
observed following RNAi with Pak3 appears to be in line with the previously described function 
of Pak 1 as a downstream effector of Cdc42/Rac signaling to regulate R cell axon guidance.  
Further verification of the Pak3 RNAi axon guidance defect was demonstrated using a Pak3 
mutant fly line (EF1191), containing a P-element insertion in the Pak3 gene.  Staining of EF1191 
embryos with mAb BP104 revealed an axon guidance defect consistent with the RNAi 
phenotype (Fig. 45E).   
 
3.4.2 Comparison of results to another RNAi screen. 
A recent paper by Ivanov et al., 2004 described screening of 25% of the Drosophila 
genome using RNAi to identify genes required for nervous system development (Ivanov et al., 
2004).  The results describe the identification of two kinase genes, greatwall (gwl, CG7719) and 
Sak (CG7186), as having nervous system phenotypes (Ivanov et al., 2004).  Greatwall plays a 
role in motor axon guidance and synaptogenesis in larvae (Kraut et al., 2001), whereas injection 
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 of dsRNA into embryos resulted in an absence of commissures and disruption of longitudinal 
connectives (Ivanov et al., 2004).  In comparison, dsRNA corresponding to gwl (CG7719) did 
not produce a phenotype in the present study (Table 2).  It is not clear why this discrepancy 
occurred, but one possible explanation could be cross-reactivity of the dsRNA with another 
kinase gene.  Synthesis of dsRNA in the Ivanov study used general primer sequences 
corresponding to the vectors containing the cDNA, rather than primers designed specifically for 
each kinase gene.  Therefore, the dsRNA product may have corresponded to the kinase domain 
and was not specific for gwl.  Based on the results obtained by Ivanov et al., it would be 
necessary to determine the sequence of the dsRNA they used to verify its specificity, as well as 
to reevaluate our own result for the gwl gene.  Additionally, Ivanov et al. observed varying 
mutant phenotypes following injection of Sak (CG7186) ranging from early developmental 
defects to more specific nervous system phenotypes including reduced numbers of neurons, lack 
of longitudinal connectives and abnormal ventral nerve cord (Ivanov et al., 2004).  These 
findings are consistent with those observed in our study, but we eliminated this candidate based 
on observing earlier developmental defects. 
Overall, the screen successfully identified five candidate kinase genes involved in 
nervous system development.  Among the five candidates was Egfr, whose involvement in 
nervous system development has been verified by numerous studies.  Moreover, Cdc2, Csk, Mbt 
and Pak3 or their homologs have all been shown to be involved in some process relating to 
nervous system development in other organisms.  Further studies will be required to determine 
the exact role each of these kinase genes plays in the development of the nervous system in 
Drosophila. 
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 3.5 Future Studies 
Since the role of Egfr has been studied in Drosophila nervous system development, it 
would not be logical to pursue additional studies on this candidate.  However, additional studies 
would be completed on the other four candidates, with particular focus on the role of Pak3 in 
axon guidance.  To determine the expression of each of the four candidates, in situ hybridization 
would be completed on stage 14-17 embryos.  The expression would be analyzed to ensure that 
the genes are highly expressed in the CNS or PNS.  In addition, antibody staining would be 
completed with various markers for cells in both the CNS and PNS following injection of 
dsRNA to Cdc2 and Csk.  For example, mAb BP102 stains the anterior and posterior 
commissures and longitudinal connectives of the ventral nerve cord.  It would be interesting to 
examine the extent of disruption in the nerves of the CNS due to the RNAi phenotype visualized 
using BP104 that stains both CNS and PNS.  Further analysis would utilize mAb 22C10 that 
stains PNS neurons (sensory) (Zipursky et al., 1984), and a subset of neurons in the ventral nerve 
cord as well as mAb 1D4 (anti-FasII) (Vactor et al., 1993) to stain motor neurons and their 
axons.  Staining using mAb 22C10 and mAb 1D4 would be completed on embryos following 
injection with dsRNA to mbt and Pak3 to determine whether sensory or motor neuron axons are 
exhibiting the observed axon guidance defect.   
As stated above Pak3 would be the focus of further analysis, so the remaining 
experiments would be completed exclusively on Pak3.  Drosophila Deficiency lines spanning the 
region of the Pak3 gene would be analyzed to determine if each line displays a similar phenotype 
to RNAi embryos.  The Pak3 mutant fly line (EF1191), containing a P-element insertion in Pak3 
would be analyzed to determine the exact insertion site of the P-element, and attempts could be 
made to rescue the axon guidance defect phenotype by precise excision of the P-element.  Since 
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 a P-element exists in Pak3, P-element mobilization may generate additional alleles and possibly 
produce more severe phenotypes. 
Attempts to determine the function of a particular kinase in a signal transduction pathway 
controlling a specific process during development requires an understanding of what controls the 
activity of the kinase as well as identification of downstream targets of the kinase.  A genetic 
screen to identify genes that function upstream and targets downstream could be completed. 
 
3.6 Materials and Methods 
 
3.6.1 Identification of Drosophila Kinases and Primer Design 
A FlyBlast Search was used to identify Drosophila kinases based on homology with 
protein kinase catalytic core (dPar1) and those defined by Morrison et. al. (Morrison et al., 
2000).  Each primer pair was designed to span exon regions ~400-900 bp, not including the 
kinase domain, but this was not possible in all cases due to small exon size in some genes or 
absence of cDNA for the kinase.  If possible, the region chosen would be adjacent to the kinase 
domain in the same exon.  FlyBase and Berkley Drosophila Genome Project (BDGP) databases 
were utilized for EST and genomic sequence data.  Primer sequences were selected using Primer 
3 program (http://www-genome.wi.mit.edu/genome_software/other/primer3.html) to be 20-24 nt 
in length with a TM. of 60°C.  The 27 nt T7 promoter sequence 
TAATACGACTCACTATAGGGAGACCAC was added to the 5′ end of each primer.  A 
complete list of kinase genes, corresponding primer pairs, source of template DNA and size of 
PCR product/dsRNA can be found in Appendix B.  The average length of dsRNA is 478 bp. 
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3.6.2 Synthesis of dsRNA 
PCR was used to amplify region of genomic or cDNA for each gene and to add the T7 
promoter sequence.  PCR products were analyzed by 1.5% agarose gel electrophoresis to verify 
the products were the correct sizes and purified using Qiagen QIAquick PCR Purification Kit 
(Catalog #28104).  Concentration of products was determined using a Spectrophotometer.  Sense 
and antisense RNA was synthesized simultaneously using 1 µg of PCR template DNA and T7 
RNA Polymerase (NEB) and incubated 1 hour 30 minutes at 37°C.  Annealing of sense and 
antisense strands occurs during the synthesis reaction.  Following synthesis, template DNA was 
removed using RNase Free DNase (RQ-1, Promega) for 20 min at 37°C.  RNA products were 
Phenol-chloroform extracted and precipitated with ethanol and NH4OAc. dsRNA was dissolved 
in TE buffer and concentration determined by A260/A280  using a spectrophotometer.  5 µg of 
dsRNA was analyzed on 1.5% agarose gel to ensure RNA migrates as a single band.  Aliquots of 
dsRNA were stored as NaOAc/EtOH precipitate at -80°C until use. 
 
3.6.3 Preparation of dsRNA and injection apparatus 
Aliquots of dsRNA were spun for 10 min at 14,000 rpm, dissolved precipitate in injection 
buffer (0.1 mM NaPhosphate pH 7.8, 5 mM KCl) (Rubin and Spradling, 1982) to a final 
concentration of 5 µM.  Injection needles are borosilicate capillaries (World Precision 
Instruments TWF100-4) that were baked prior to use to remove RNases.  Needles were pulled 
using Narishge needle puller Model PP830.  Needles were sharpened against the edge of a slide 
at a 45° angle to the needle, enabling the fused tip to be opened allowing liquid flow.  Embryos 
were injected with ~85pL (range 65-110pL) of volume corresponding to ~0.2 fmoles of dsRNA 
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 per embryo using a pneumatic picopump (Picopump-World Precision Instruments).  Site of 
injection corresponded to the lateral side of the embryo, random from anterior to posterior. 
 
3.6.4 Injections for screening 
A line of flies expressing GFP under the control of a NS promoter ELAV (Lee and Luo, 
1999) were used during the initial screening process so live animals could be visualized using 
epifluorescence on a Nikon E800 microscope. 
 Eggs were collected on agar molasses plates for 45 min at 25°C, dechorionated for 2 
minutes in 50% Bleach, aligned on coverslips containing tape glue (double stick tape ~5cm in 
1ml heptane), desiccated for 12-15 minutes in a sealed container containing Drierite stones 
(W.A.  Hammond Drierite Company, Ltd), then covered with halocarbon oil (Halocarbon 
Products, Inc).  Syncytial blastoderm embryos were injected and older embryos were destroyed.  
Injected embryos were incubated at 18°C for 2 days (stage 16-17) in a humidity chamber and 
analyzed for nervous system phenotypes using epifluorescence.   
 
3.6.5 Immunohistochemical analysis of potential candidates 
Any potential candidate dsRNAs were reinjected into W1118 embryos and analyzed using 
mAb BP104 (Developmental Studies Hybridoma Bank) that recognized a nervous system 
specific splice variant of neuroglian.  Follow same protocol as indicated above, but embryos 
were incubated under halocarbon oil until stage 15-16.  Prior to fixing embryos, excess oil was 
removed from around the embryos using a razor blade.  The embryos were removed from the 
tape glue using heptane, allowing the loose embryos to collect in 60mm Petri dish with heptane 
and transferred to a glass vial of fix solution (10:3:7 (v/v) n-heptane/37% formaldehyde/PEM-
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vortexed to ensure saturation) using a P-1000 with a cut tip, Embryos were fixed at room 
temperature for 30 minutes, then were removed from fix/heptane interface using P-1000 with a 
cut tip, and placed onto fine mesh basket stuffed with Kim wipes allowing the embryos to remain 
on the mesh.  Embryos were gently picked using double stick tape and placed embryo side up 
into a 60mm Petri dish, then covered with PBS.  Embryos were manually devitellinized using a 
needle to nudge the embryos from the membrane and transferred to PBS + 0.1% Triton X-100 
(PBT). 
 
3.6.6 Antibody Staining 
Embryos were blocked in PBT + 10% goat serum for 20 minutes.  Blocking agent was 
removed, and primary antibody mAb BP104 added at a 1:3 dilution in PBT + 5% goat serum.  
Embryos were incubated in primary antibody overnight at 4°C.  Primary Ab was removed from 
embryos, and they were washed in PBT, then a biotinylated secondary Ab goat αmouse IgG 
(Vector Laboratories) was added at a 1:200 dilution in PBT + 5% goat serum, and incubated for 
30 min at room temperature.  Secondary antibody was removed, embryos were washed, and 
Avidin/Biotin Complex (AB Complex) that was preformed on ice for 30 minutes was added to 
embryos.  Embryos were incubated with AB complex for 15 minutes at room temperature, and 
then washed with PBT.  Staining was completed using 0.5 mg/ml diaminobenzidine (DAB) + 
0.003% H2O2 in PBS.  Staining reaction was stopped with PBS.  Embryos were equilibrated in a 
glycerol series to a final 85% glycerol/PBS concentration.  Embryos were mounted and viewed 
using Nikon microscope E800. 
 
  
APPENDIX A 
 
Primers used to generate UAS-brk constructs 
construct Primer Name Primer sequence    
brk53 M13 Forward gtaaaacgacggccagt     
      
    
  
     
     
      
  
     
      
     
      
      
      
     
     
      
      
brk53 gatcgaattcATTGTTGGCCACCGATGA
brkS M13 Forward 
 
gtaaaacgacggccagt     
brkS GATCGAATTCTGGGAGTAGTTGCTGCTG
brkNLS M13 Forward gtaaaacgacggccagt     
brkNLS GATCGGATCCGACCTTCCTCTTTTTCTTCGGGGGCTGTTGCTGATTGTTGGC 
brkNLSW M13 Forward gtaaaacgacggccagt     
brkNLSW gatcgaattcccatggtcgccaGGATCCGACCTTCCTCTT
brkStop1 
 
M13 Forward gtaaaacgacggccagt     
brkStop1 gatcgaattcGGCTGGTGTGGCAACCGC
brkA M13 Forward gtaaaacgacggccagt     
brkA1 gatcggatccGTGTGGAACCATGCCATT
brkA2 M13 Forward gtaaaacgacggccagt     
brkA6 gatcagatctGTGATGATGATGGGCGGC     
brkC M13 Forward 
 
gtaaaacgacggccagt     
brkC gatcgaattcCAGCTGATGGAACACCTT
brkStop1DA17
 
brkA7 gatcagatctCACCATCATGCCGCCCAC
brkA6 gatcagatctGTGATGATGATGGGCGGC
brkStop1NA brkA2 gatcagatctAATGGCATGGTTCCACAC
brkA3 gatcagatctCAACTGGTGCACCAGCGG
brkEA brkEiFbgl gatcagatctCACGCCGCCGCGGTGGGT
brkstop1B(bgl)
 
 gatcagatctGGCTGGTGTGGCAACCGC
brkEC brkE1Fbgl gatcagatctCACGCCGCCGCGGTGGGT
brkE1Rbgl gatcagatctCTCCTTCTGATGCTGCAT
brkED brkE2Fbgl gatcagatctGCAGCCAATGGCATGGTT
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brkstop1B(bgl) gatcagatctGGCTGGTGTGGCAACCGC
brkEF brkE3Fbgl gatcagatctGAGACACCTGCAACCATT
brkstop1B(bgl) gatcagatctGGCTGGTGTGGCAACCGC
brkStop1NAC 
 
M13 Forward gtaaaacgacggccagt     
brkStop1Ct gatcgaattcGGATCCGAGAGAGAGGTC
brkCM brkMA2 gagctagcggccgcTCTGGCTTCCTCTGCCCGCCGTCAA
brkMA1 gagctaagcggccgcCATTGCGGCTGGTGTGGCAAGCGC
 brkGM brkGro1 agctaagcggccgcAAATAGCTTGACCTGTTT
brkGro2 agctagcggccgcTTTGCTGGACGATGATGAG
brkGD brkMB2 agctgcatcgatGAGGAGCAGGATCATCAT
brkMB1 agctgcatcgatCAGCTTGTGCTCCTCCGG
 brkCMGM
 
see CM/GM
 
brkNA brkA2 gatcagatctAATGGCATGGTTCCACAC
brkA3 gatcagatctCAACTGGTGCACCAGCGG
brkNACM
 
brkA2 gatcagatctAATGGCATGGTTCCACAC 
brkA3 gatcagatctCAACTGGTGCACCAGCGG
brkNAGM
 
brkA2 gatcagatctAATGGCATGGTTCCACAC 
brkA3 gatcagatctCAACTGGTGCACCAGCGG
brk3M brkA2 gatcagatctAATGGCATGGTTCCACAC
brkA3 gatcagatctCAACTGGTGCACCAGCGG
brkS2NACM1 
 
M13 Forward gtaaaacgacggccagt     
brkStop5 gatcgaattcTTGACGGCGGGCAGAGGA
brkS2NACM2 
 
M13 Forward gtaaaacgacggccagt     
brkStop6 gatcgaattcCTCCAGCTTACTAATCTT
brkS2NACM3 
 
M13 Forward gtaaaacgacggccagt     
brkStop7 gatcgaattcCTCCACGTCCACCTCCAC
brkNLS4R
 
brk4RA gatcagatctGGATCCTCTGCCCGCCGT 
brkStop2E gatcagatctCAGCTTGTGCTCCTCCGG
brkD4R brk4RDA gatcagatctGAGAGAGAGGTCCATGGG
 174
       
      
      
brk4RDB gatcagatctCCCTCTAAACAGGTCAAG
brk4M brk4MN1 gatcgctagcGAGGAGCAGGATCATCAT
brkStop1N  gatcgctagcGGCTGGTGTGGCAACCGC
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 APPENDIX B 
Primer sequences, PCR product sizes and template used to generate dsRNA products 
Gene Gene Name 
 
Primer Left Primer Right PCR (bp) 
 
PCR template 
 CG1210  
    
  
Pk61C agcaactccgatgaagacgat
 
 ccaacgcctaattctgcacta 653 BACR48E09
 CG1227 CG1227 aattcaccctacgatcccatc ctacaagcgaccctccagttt 216 GH27612
CG1362 Cdc2rk gagatagcacagctggacatga cttgcttttcaggcactcttc   
     
      
     
    
     
     
     
     
     
     
    
    
      
     
     
      
     
      
      
    
     
  
     
   
234 SD02166
CG1388 tak ccacacagttaacaccgacaac gacagatccgtggtcatcatc 500 SD06739
CG1495 CaMKI
 
atggaaaagctgtcgatgtgt ctactgcgatgctgcatttgt 557 GH14309
CG2049 Pkn ttataccacagttggggaagc gtctcgagtcctccagattca 346 BACR10M14
 CG2615 ik2 cgagaatggaccaattgaatg
 
 tgcatctgcgagatcacatc 774 SD10041
CG2621 shaggy (sgg) gatcaggcggaactcacagt ggactgtgttctggccaattt 768 BACR30B01
CG2829 BcDNA:GH07910
 
 ccttcggtcacaatcagtcg ttcggtatcggtggctgaat 202 LD38852
CG2899 ksr gaaaggatcccctttggtaaa agtctccgtcttccgttgaat 638 BACR24024
 CG3051 SNF1A caatgtgatcgacacctacgc ttagcgagccagttgaatgat
 
859 GH12596
CG3068 aurora (aur) gctcccttctactcgaagaact gctgcctctacgtttcacttc 457 BACR03N24
 CG3086 MAPk-2-Ak2
 
aaccacggcctagccatatc gtcgcattggccatgtataac 407 LD17156
CG4224 CG4224
 
gtatgccaacaatctggagga gcggttgtttcagtgaggag 770 GH09326
CG4268 Pitslre aagatctggccaggatacacc gttattccagcgttcaggaca 467 LD39519
CG4379 Pka-C1 ggaggggctgttacagttgtt ggattgcgatcttccaaaag 350 BACR02I05
 CG4551 Smi35A
 
taaggtgctcatatcggttgc ccaccttctgcatgctattgt 533 GM04027
CG5072 Cdk4 tacaacagcaccgtggacat aggggttcctgctgaaagtaa 329 LD31205
CG5125 ninaC ggccatgttccagatcattc gcggaaattcctgcttgatt 452 BACR01E19
 CG5179 Cdk9 cagctatgcggctcctttac taccaaacccggtcaatcata 392 GH21935
CG5363 Cdc2 cgatatctggtccattggatg atttcgaactaagcccgattg 337 LD38718
CG5475 Mpk2 cgccgaatttttgaagaaga tctccagatatggatgggaaa
 
200 BACR29F06
 CG5680 basket (DJNK)
 
cgtttatgcaacggttacagc catccacttcctcagcatcat 258 HL02677
CG6114 CG6114
 
atcgcccacaacagttacctc caatggtcggacctgagttg 413 BACR18K24
 CG6518 inaC aagggtctcgaaatggtcaat taaaggcatccacacagggta
 
799 GH24781
CG6551 fused (fu)
 
atcatcttgagaccgatgtgg gcttttcctcattggtggaat 495 BACR17H16
 CG6620 ial gaacagcacggagagcaccta tcgttacacaatgcaaactcg 260 LD07127
 176
 177
      
      
     
   
    
     
     
     
     
    
   
     
     
    
     
     
    
      
    
     
     
    
     
     
   
CG7001 PKl17E accaaccagccaacacagtc tcgttcttgctggtctcctta 275 LD21956
CG7177 CG7177
 
ccggaatcatcgacaacatta aataactcgcaccaggcaact 475 GH11386
CG7186 SAK atgctcaaatggtggacactc ggacggcgtctttagtagctt 799 LD32344
CG7719 greatwall (gwl) gatgagtggcatcaacatgaa 
 
ccggtcatgaactcgtagaaa 744 LD35132 
CG7826 minibrain (mnb) tacatccagtcgcgcttctac ctgcactggatgaggagacc 646 BACR29H04
CG8173 CG8173 atgatgacacgaaggagaacg atcgctttctgtcgcaacatt 230 BACR42I14
CG8485 CG8485 gtgaggaggacgaagaggagt
 
 actgcgattgtccctcttttt 627 GH25405
CG8866 CG8866 actctgcaaaaggccattgat
 
aatccggttccagcatttct 352 GH23955
CG9222 CG9222 tcgcctatgatcctttcatgt ataccaagggtcctccttgac 242 GH07192
CG9774 rho-kinase (rok)
 
 tgcgtcaacacaactacaagg
 
 ttgttcgcgacacatagtacg 470 BACR03P14
 CG10033 foraging (for)
 
catttcttcggctgtcgtatc acgtgattcgtttgtctttgg 657 GH10421
CG10079 Egfr attcccggggataagttcac cgatggtctgggtgggtatc 511 LP11484
CG10579 Eip63E
 
ccaaaattagagaagcagcaga
 
ttattgttgctggtgttgtgc 554 LD46554
CG11228 hippo
 
agttcatacgcaacgccaag aagttcgactccagctccac 415 LD11983
CG12306 polo gcgacgagaacacagatcct
 
ccgttggtcaaatgcataact 394 LD02473
CG14217 CG14217
 
ttgcagctttgttgaactgtg ctgactactggctgccgatac
 
334 LD42442
CG14895 Pak3 accagtaccgcccaagaaat gttcccttgggtcatctgaat 308 GH15507
CG14992 Ack ggcacgagctgaaattgataa
 
agggatctcgctcccttacag 753 BACR48M07
 CG15793 Dsor1 ccaccctggagtcgatattc gtattacgctttggcgtcgat 316 LD41207
CG16973 misshapen (msn)
 
ctctggagatggctgagtcac agcccgagtagcgatagtcct 306 SD05170
CG17161 grapes (grp)
 
ttcctatgacctggtggactc gtgggtcctttaagcacgata
 
636 LD14845
CG17309 Csk cacagcatactgtccacgttt atggcgttcagtttgacctc 530 BACR11G22
 CG17342 LK6 ctggcgatgcaattgaagat ctaccactgccactgcttcc 760 SD09050
CG17998 Gprk2 cagcgacatcaatcacaagaa agctctcaaactcccggaac 338 LD20566
CG18069 CaMKII ttcttggtaaaaactgcaaagc ttttggggtataaaatcgaatg 256  
 
GM04335
CG18247 shark cattgatgacggtccctactg ctgatccaacagggatagcac 703  
    
BACR21B04
CG18582 mbt caattttgagcatcgtgtgc cgctactagctccacctactcc 500 BACR48E20
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